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Abstract 
Objective: Full-field Digital Mammography (FFDM) is employed in breast screening for the 
early detection of breast cancer. High quality, artefact free, diagnostic images are crucial to the 
accuracy of this process. Unwanted motion during the image acquisition phase and subsequent 
image blurring is an unfortunate occurrence in some FFDM images. The research detailed in 
this thesis seeks to understand the impact of motion blur on cancer detection performance in 
FFDM images using novel software to perform simulation of motion, an observer study to 
measure the lesion detection performance and physical measures to assess the impact of 
simulated motion blur on image characteristics of the lesions. 
Method: Seven observers (15±5 years’ reporting experience) evaluated 248 cases (62 
containing malignant masses, 62 containing malignant microcalcifications and 124 normal 
cases) for three conditions: no motion blur (0.0 mm) and two magnitudes of simulated motion 
blur (0.7 mm and 1.5 mm). Abnormal cases were biopsy proven. A free-response observer 
study was conducted to compare lesion detection performance for the three conditions. Equally 
weighted jackknife alternative free-response receiver operating characteristic (wJAFROC) was 
used as the figure of merit. A secondary analysis of data was deemed important to simulate 
‘double reporting’. In this secondary analysis, six of the observers are combined with the 
seventh observer to evaluate the impact of combined free-response data for lesion detection 
and to assess if combined two observers data could reduce the impact of simulated motion blur 
on detection performance. To compliment this, the physical characteristics of the lesions were 
obtained under the three conditions in order to assess any change in characteristics of the 
lesions when blur is present in the image. The impact of simulated motion blur on physical 
characteristics of malignant masses was assessed using a conspicuity index; for 
microcalcifications, a new novel metric, known as dispersion index, was used. 
Results:  wJAFROC analysis found a statistically significant difference in lesion detection 
performance for both masses (F (2,22) = 6.01, P=0.0084) and microcalcifications (F(2,49) = 
23.14, P<0.0001). For both lesion types, the figure of merit reduced as the magnitude of 
simulated motion blur increased. Statistical differences were found between some of the pairs 
investigated for the detection of masses (0.0mm v 0.7mm, and 0.0mm v 1.5mm) and all pairs 
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for microcalcifications (0.0 mm v 0.7 mm, 0.0 mm v 1.5 mm, and 0.7 mm v 1.5 mm). No 
difference was detected between 0.7 mm and 1.5 mm for masses.  
For combined two observers’ data of masses, there was no statistically significant difference 
between single and combined free-response data for masses (F(1,6) = 4.04, p=0.1001, -0.031 
(-0.070, 0.008) [treatment difference (95% CI)]. For combined data of microcalcifications, 
there was a statistically significant difference between single and combined free-response data 
(F(1,6) = 12.28, p=0.0122, -0.056 (-0.095, -0.017) [treatment difference (95% CI)]. Regarding 
the physical measures of masses, conspicuity index increases as the magnitude of simulated 
motion blur increases. Statistically significant differences were demonstrated for 0.0–0.7 mm 
t(22)=-6.158 (p<0.000); 0.0–1.5 mm t(22)=-6.273 (p<0.000); and 0.7–1.5 mm (t(22)=-6.231 
(p<0.000). Lesion edge angle decreases as the magnitude of simulated motion blur increases. 
Statistically significant differences were demonstrated for 0.0–0.7 mm t(22)=3.232 (p<0.004); 
for 0.0–1.5 mm t(22)=6.592 (p<0.000); and 0.7–1.5mm t(22)=2.234 (p<0.036). For the grey 
level change there was no statistically significant difference as simulated motion blur increases 
to 0.7 and then to 1.5mm. For image noise there was a statistically significant difference, where 
noise reduced as simulated motion blur increased: 0.0–0.7 mm t(22)=22.95 (p<0.000); 0.0–
1.5mm t(22)=24.66 (p<0.000); 0.7–1.5 mm t(22)=18.11 (p<0.000). For microcalcifications, 
simulated motion blur had a negative impact on the ‘dispersion index’.  
Conclusion: Mathematical simulations of motion blur resulted in a statistically significant 
reduction in lesion detection performance. This reduction in performance could have 
implications for clinical practice. Simulated motion blur has a negative impact on the edge 
angle of breast masses and a negative impact on the image characteristics of 
microcalcifications. These changes in the image lesion characteristics appear to have a negative 
effect on the visual identification of breast cancer.  
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Chapter One: Introduction and Thesis Outline 
1.1 Introduction 
 
Full-field Digital Mammography (FFDM) is the current standard imaging technique for the 
early detection of breast cancer. High quality, artefact free, diagnostic images are crucial to the 
accuracy of this process. Unwanted motion during the image acquisition phase and subsequent 
image blurring are unfortunate consequences in some FFDM images (Rosen, Baker and Soo, 
2002). It is thought that this could lead to a reduction in diagnostic performance. The cause of 
motion blur can be patient-based (e.g. breast and/or chest wall motion), or technology-based 
(e.g. paddle movement) (Geiser et al., 2011). This can lead to distortion of the image in one or 
more directions. Chest wall motion could be due to respiration, and by its nature, fairly 
predictable, but it is reasonable to hypothesise that breast motion could be more complex, and 
could be the outcome of a combination of paddle movement, thixotropic behaviour and blood 
being forced away from the breast due to the applied compression force (see section 2.7.3). 
Thixotropic behaviour represents a time-dependent reduction of viscosity and modulus induced 
by deformation when mechanical loading changes breast volume and results in the motion of 
fixed structures (glandular and adipose tissues) (Geerligs, Peter, Ackermans, Oomens and 
Baaijens, 2010). 
Anecdotal evidence within the National Health Service Breast Screening Programme 
(NHSBSP) suggests that image blurring requires images to be repeated, thus increasing patient 
radiation dose, anxiety, and service costs. The paucity of literature on this topic suggests that 
this technical issue continues to be under-reported. Recent research (  Ma, Aspin, Kelly, 
Millington, and Hogg, 2015) suggests that motion blur can be visible to practitioners at sub-
millimetre levels, but presently we do not know the impact of motion blur on breast cancer 
detection. At the current level of understanding it can only be assumed that motion blur will 
have a negative impact on cancer detection. Consequently, this thesis seeks to understand 
whether motion blur does indeed have an impact on cancer detection performance in FFDM. 
The methodological approach applied in this work uses novel software to perform a pixel shift 
simulation of motion to introduce simulated motion blur to clinical FFDM images. These 
images are the foundation of an observer performance assessment to realise the impact of 
simulated motion blur on cancer detection. 
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1.2 Aim 
The aim of this thesis is to assess the impact of simulated motion blur on lesion detection 
performance in FFDM using the free-response receiver operating characteristic (FROC) 
method. The research will evaluate the impact on lesion detection performance on two different 
magnitudes of simulated motion blur. The selection of two different magnitudes of motion blur 
was to determine whether performance would become incrementally worse with greater 
magnitudes of motion blur. 
 
1.3 Objectives  
1. Characterise non-simulated blurring in FFDM images and determine the magnitude of 
computer generated blurring required to simulate this. A validation study of the non-
simulated blur will be conducted to see if experienced FFDM observers could differentiate 
between real blur and simulated blur. 
2. Determine the impact of simulated motion blur on lesion detection performance. 
3. Determine the impact of simulated motion blur on physical characteristics of: 
a. malignant masses using Conspicuity Index, and, 
b. microcalcifications using a novel metric, described as the ‘dispersion index’.   
 
1.4 Research Questions 
What is the impact of different magnitudes of simulated motion blur on: 
 Lesion detection performance in FFDM images 
 Physical characteristics of lesion images  
 
1.5 Rational of the thesis     
Motion blur in FFDM images has the potential to obscure breast lesions; as a result, clinically 
significant abnormalities could go undetected which may have a negative impact on patient 
care. Anecdotal evidence suggests that many practitioners in mammography have realised the 
potential impact of motion blur in digital mammography but they do not know how much of 
an impact this can have on breast cancer diagnosis, or indeed, whether they are even detecting 
the smaller magnitudes of motion. If motion blur is detected, this could lead to repeated images 
or increased recall rates, both of which will increase radiation dose to the patient. If motion 
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blur is not recognised, this could lead to missed diagnosis, late detection or symptomatic 
presentation as an interval cancer. On the other hand, motion blur also has the potential to 
increase the number of lesion mimics (false positives), which may lead to unnecessary biopsy, 
with the consequence of an unnecessary invasive procedure and increased anxiety for the 
patient. Presently, no study exists to determine the impact of simulated motion blur on observer 
performance. Therefore, this thesis aims to evaluate the impact of motion blur on breast cancer 
detection performance in FFDM using novel image blurring software. 
	
1.6 The Contribution of this Thesis: 
This thesis demonstrates for the first time, that motion blur has a negative and statistically 
significant impact on the detection performance of malignant masses and microcalcifications 
in FFDM images. In view of this, caution should be exercised when making decisions about 
the acceptability of images that appear to contain blur as false-negative decisions could be 
reached. This thesis recommends further research is required to highlight the impact of this 
problem. This thesis also provides a number of recommendations to breast specialist clinicians, 
particularly radiographers and radiologists. Firstly, it has recommended that radiographers be 
aware about motion blur during quality assessment of images in the mammography imaging 
room. Secondly, clinicians during image reading, should be aware of the impact of motion blur 
on cancer detection, in relation to the potential for false positives and false negatives. 
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1.7 Thesis Structure 
This thesis is composed of eight distinct chapters, summarised in Figure (1.1).  
Chapter One– Introduction and Thesis Outline: comprises a brief introduction, aim, 
objectives and thesis rational.  
Chapter Two– Literature Review: This chapter provides a review of areas of interest that are 
of critical relevance to this thesis. In respect of one of the key objectives of this thesis, it is 
important that the anatomy of the breast is explored and understood in detail. In addition to this 
it was important to develop a working understanding of the presentation of breast cancer and 
the characteristics of breast tissue, as displayed in mammographic images. Since it has been 
hypothesized that image blurring may originate from the equipment used to generate the 
mammographic images it was also valuable to understand the detailed operation and technical 
aspects of these systems. This work is heavily influenced by the observers’ ability to detect 
cancer in images, so it is vitally important that the factors affecting diagnostic performance in 
mammography are understood. 
Chapter Three– Medical Image Assessment Methods: The relationship between visual 
performance and medical image interpretation is explored here, with a focus on the human 
visual system due to the fact that medical image interpretation is based on visual performance 
of an observer and visual appearance of the image. Image perception was evaluated to help 
understand the challenges presented to clinicians who evaluate FFDM images. The methods to 
evaluate observer performance were reviewed in detail and this helped inform the choice of 
optimal method to apply for the thesis research question. In addition to the perceptual 
evaluation by the observers, it was valuable to understand what is happening to the 
characteristics of the breast tissue and lesions, as presented in the images. Understanding how 
lesion characteristics change when simulated motion blur is applied and the methods available 
for physically evaluating these characteristics was another critical step in the literary analysis, 
as this help inform the design of the methods.  
Chapter Four– Methodology: In this section the methodological choices are explained and 
justified for the following components of the research: (i) the design of the free-response study, 
(ii) the method to apply simulated motion blur to the FFDM images, and (iii) the methods used 
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to measure the physical characteristics of the lesions. This section describes eight logical steps 
using five different software applications; each having a specific function in the thesis.  
Chapter Five– The Results of the Free-response Study: This chapter presents the results of 
the observer performance study. The main outcomes focus on the detection of malignant 
masses and microcalcifications under three conditions: (i) no motion blur, (ii) 0.7 mm of 
simulated motion blur, and (iii) 1.5 mm of simulated motion blur. In addition to this, a decision 
was made to investigate the impact of dual reader evaluations on detection performance in the 
presence of simulated motion blur. This was done following a method to combine the free-
response data of two observers. The aim was to mimic the double reporting scheme used in 
screening mammography. 
Chapter Six– The Results of Physical Measures: In this chapter the physical characteristics 
of the lesions are described and compared at different magnitudes of simulated motion blur. 
Generating this data also enabled an analysis of ‘missed lesions’ to try and establish whether 
simulated motion blur had a greater impact, thus causing a greater reduction in detection, on 
lesions of different characteristics. 
Chapter Seven– Discussion: This chapter evaluates the results of the free-response study and 
the physical measures. This chapter is set out in the same manner as the results chapter, where 
the data from each section is discussed separately. The impact of motion blur on the detection 
performance of breast masses and microcalcifications are  discussed. The missed lesion 
calculation method and the impact of motion blur on lesion characteristics image are discussed.   
Chapter Eight: Conclusion, Recommendations and Future work:  
This chapter summarises the results of the thesis in a concise manner. The final conclusions 
that were  obtained from free-response study, and then an overall conclusion regarding the 
impact of motion blur on physical characteristics of malignant masses and microcalcifications 
is presented. A statement of novelty and recommendations for future work is presented.  
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 Figure 1.1 A flowchart demonstrating the structure of this PhD thesis 
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 Missed Lesions Calculation Method of Microcalcifications 
 Visual Performance and Image Interpretation  
 Human Visual System (HVS) 
 Receiver Operating  Characteristics (ROC) Methods 
 Free-response ROC method 
 Perceptual measures 
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 Mammography 
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Chapter Six 
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Chapter Two: Literature Review 
2.1 Overview of the Chapter  
This literature review provides a critical analysis of previous studies, which investigated the 
cause and effect of motion blur in FFDM images. A literature search was undertaken, and was 
followed by assessment of study elements. This assessment offers justification for the method 
described in chapter four, in addition to the rationale for the research study described in chapter 
one. The literature search was implemented utilising Medline, Google scholar and Solar 
databases at the University of Salford, with different sets of the keywords such as motion blur, 
full field digital mammography, lesion detection performance, breast cancer. There were no 
limits applied for publishing dates. 
This chapter is organized into seven main sections. The first section (2.2) will focus on breast 
anatomy. The second section (2.3) will focus on breast cancer and factors effecting the risk of 
breast cancer. The third section (2.4) will focus on mammography and the characteristics of 
breast tissue in mammography images. The fourth section of this literature review will focus 
on the factors affecting diagnostic efficiency of breast cancer detection in mammographic 
images such as breast density, image quality and the effect of shape and margin of breast lesion 
on detection performance. In the fifth section (2.6), the focus will centre on the components of 
FFDM system. The sixth section (2.7) will focus on motion blur in mammography images and 
the contributory factors. The reviewed studies in this section were sub-divided for structure. 
The first (2.7.1) investigated the causes of motion blur in FFDM images according to extra and 
intra patient movement focusing into the causes of motion blur related to both patient and 
system parts; paddle movements, inadequate compression and pain related to paddle 
compression. The second (2.7.2) reviews the papers that investigated the visual detection of 
motion blur on FFDM using different types of monitors. The third (2.7.3) relates to the 
thixotropic behaviours of breast tissue. The seventh section focuses on the physics of 
mammography systems, X-ray production and X-ray incident on the detectors.       
2.2 Breast Anatomy   
The breast is tear-shaped and supported by the front of the chest wall. It is located over the 
pectoral muscles and attached to the upper border of the chest wall by fibrous ligaments known 
as Cooper’s ligaments. The composition of the breast is a mass of soft tissue consisting of fatty, 
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fibrous and glandular tissue (Hogg et al., 2015). The development of the breast begins during 
puberty when the female body undergoes changes to prepare for reproduction. Puberty often 
starts around the ages of 10 or 11 year when the breast responds to hormonal changes in the 
body. The production of two hormones, progesterone and oestrogen, signal the development 
of the glandular tissue of breast (Pathmanathan, 2006).  
The anatomical structures of the female breast are represented in Figure 2.1. The interior part 
of the female breast consists of three major tissue types: glandular or parenchymal tissue, fatty 
and fibrous tissue. The glandular tissues are typically divided into 15-20 lobes, wherein the 
production of milk occurs. The lobes are divided into smaller sections known as lobules and 
separated by fibrous walls (Darlington, 2015). The nipple is connected to the lobules by a 
network of small ducts (intralobular ducts). The ducts often start as tiny ductules at the lobules; 
after that they combine near the nipple to become larger sized ducts (Van De Graaff, 2001). 
The connective or fibrous tissue in the breast contains and supports both the ducts and lobules. 
The ducts and lobes (glandular tissue) can be grouped with fibrous tissue, together forming the 
fibro-glandular tissue. The fibro-glandular tissue is covered on the outside by a layer of fat or 
adipose tissue (Van De Graaff, 2001). The variation between adipose to glandular tissue 
proportion is due to age and individual characteristics. However, the features of the female 
breast are like a unique map for every individual; the breast structure alters over time according 
to age, hormonal changes, and menopausal status (Ossati, 2015). It is because of this that the 
interpretation of mammographic images is considered a complex task.   
Breast parenchyma comprises of three kinds of tissues–adipose and subcutaneous tissue, 
functional glandular tissue, and skin. The macroscopic anatomy of the breast, divides the 
component female breast into two main parts. The first part known as glandular component 
(milk production) and the second part comprising muscles, fascia (connective tissue) and fat, 
which are concerned with support and make up the breast (Darlington, 2015). The variations 
in breast structure can be illustrated by differences in breast density on mammography. 
Commonly, younger aged females tend to increase dense glandular tissue. Likewise, the breast 
density in older age females tend to have less density through the changing of fatty tissue 
instead of glandular tissue. Lactation and pregnancy are among some of the compounding 
factors that are indicative of being important in raising the density of breast tissue (McDonald, 
2015). 
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The microscopic anatomy of the breast was firstly described by Welling in (Wellings et al., 
1975). He identified the terminal ductal lobular units (TDLU) as the functional unit of the 
breast, consisting of acini (built up from 10 to 100 sac-like units), an extralobular duct and an 
intralobular terminal duct. The TDLU is important physiologically due to its responsibility for 
milk production during the period of lactation. Figure 2.2 illustrates a simplified drawing of 
the structure of a Terminal Ductal Lobular Unit (TDLU). During pregnancy and lactation, 
increases in oestrogen, prolactin and progesterone produce enlargement of the acini, an 
evolution in myoepithelial cells and hyperplasia of the lactogenic epithelium to prepare for 
milk producing. During lactation, the breast passes through many of changes and deferent 
degrees of involution, and its appearance might seem to consist of a smaller amount glandular 
tissue than before the pregnancy period. This process continues for about three months before 
returning to a new baseline. 
  
Figure 2.1 Structures of the adult woman breast:  (A1) schematic breast anatomy and (B1) the 
corresponding mammographic features (Hogg et al., 2015). 
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Figure 2.2 Demonstrates a simplified drawing of the structure of a Terminal Ductal Lobular Unit 
(TDLU). 
 
Breast size is fundamentally identified via the amount of adipose tissue (fat cells) in the breast. 
The adipose tissue reaches from the collarbone to the armpit and to the middle of the ribcage 
(Whitman and Haygood, 2012). Commonly, smaller breasts have a smaller amount of adipose 
tissue compared to their glandular tissue, while the larger size of breasts have a higher amount 
of adipose tissue compared to their glandular tissue (Spear et al.,  2004). The shape and size of 
the breast varies according to several factors: diet, age, race, the situation menopausal of 
women and parity (Williams, 1995). Physical techniques can be used to identify breast volume 
or size through either casting the breast in plastic or through immersion of the breast in water 
and identifying its volume by calculating the displaced water volume based on Archimedes’ 
principle. Precise identification of breast volume is not easy though can be achieved using 
digital techniques (Veitch, Burford, Dench, Dean, & Griffin, 2012). Alonzo-Proulx et al., 
(2012) utilised digital mammograms to investigate some of the breast features such as the 
breast volume for digital mammographic images of 15,351 females. They reported that the 
mean breast volume for all examined cases was 687 cm3 with small variances in several age 
groups. For instance, it was around 703 cm3 for 50-55 year and 736 cm3 for 55-65 year age 
groups. Diffey, (2012) found a highest mean breast volume about 820 cm3. However, Wang et 
al., (2013) used ultrasound to calculate breast volume of women and they reported that the 
breast volume for about 57% of 306 adult women was 400-800 cm3.   
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2.3 Breast Cancer  
Breast cancer is an uncontrolled growth and an abnormal change of breast tissue due to 
abnormal cell divisions (proliferation). In a normal condition, two types of genes are 
responsible for controlling the division of the cell, named as a tumour suppressor and proto-
oncogenes genes. These genes continuously mutate, this leads to uncontrolled cell division 
(Shannon & Chittenden, 2015). This cancer can metastasise or diffuse to other parts through 
the lymphatic system or the blood circulation (Shetty, 2015a).  
Breast cancer is characterised by malignant tumours that arise from the glandular tissue within 
the breast. It is an insidious disease that will affect one in seven women over their lifetime 
(Cancer research UK, 2016). There are several types of breast cancer which can be classified 
by the physical characteristics of the tumour and location within the breast. One of these types 
is known as cancer in situ. This appears as a non-invasive disease in which the cancer cells stay 
inside the basement membrane and do not invade the surrounding tissues. Another type of 
breast carcinoma is known as an invasive breast carcinoma. This invades surrounding tissue 
and has the ability to metastasise, which means that the cancer transfers from one part of the 
body to another through the lymph system or the blood stream (Evans et al., 2002). According 
to Danziger and Simonsen, (2011), Invasive Ductal Carcinoma (IDC) is an example of an 
invasive breast cancer which involves different subtypes (Papillary Carcinoma, Medullary 
Carcinoma, and Tubular Carcinoma), while Ductal Carcinoma in Situ (DCIS) is an example of 
a non-invasive breast cancer. Other types of breast cancer (American Cancer Society, 2014) 
such as carcinoma, sarcoma and adenocarcinoma, originate in various lobes of the breast. 
Carcinomas originate in the lining layer of the breast, Sarcomas originate from connective 
tissues (fat, blood vessels or muscle), and Adenocarcinomas originate in the glandular tissue 
such as the breast lobules.  
The American Cancer Society (2014) found that approximately 8 out of 10 invasive breast 
cancers could be categorised as IDC. The shape and margins of IDC are most commonly 
spiculated firm masses with ill-defined and irregular margins and it is difficult to detect. The 
second most common breast cancer, which starts in lobules or in the milk-producing glands, is 
Invasive Lobular Carcinoma (ILC). DCIS is the most common type and it originates in the milk 
ducts. It is also recognised that there are other types of breast cancer such as Lobular Carcinoma 
in Situ (LCIS) (Evans & Blanks, 2002; Winchester &Winchester, 2006).  
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The TDLUs are important units within the breast , as over 90 % of breast cancers originate in 
these units (Hogg et al., 2015). The ducts and acini consist of three layers including the 
epithelial lining, myoepithelial layer and the basement membrane. The epithelial layer is  
normally only one cell thick, but when converted to two or three cells thick it is named a 
hyperplasia. More proliferation is classified depending on a number of layer cells that are 
existent, and the appearance of the atypical cells; these situations range from atypical ductal 
hyperplasia to ductal carcinoma in situ. The function of the basement membrane is responsible 
for preventing the spread of cancer. When this membrane is breached, a carcinoma is named 
invasive. Male breast cancer is extremely rare compared to breast cancer in women, 
representing approximately less than 1% of all breast cancers (Garnett, 2015). In the UK, male 
breast cancer is of lower incidence than female breast cancer, with only one new case detected 
for every 100,000 males (around 350 to 400 cases per year).  The male breast is undeveloped 
but is affected by testosterone and oestrogen that influences some of the breast tissue located 
beyond the nipple. This undeveloped tissue of breast consists of rarely ductal lobular units and 
mainly major sub-areolar ducts (Cancer research UK, 2016).  
 
2.3.1 Factors Affecting Breast Cancer  
An individual’s likelihood of contracting breast cancer is their breast cancer risk. Many factors 
are responsible for breast cancer risk such as gender, age, family personal history, lifestyle 
factors and hormonal therapy. However, it is uncontrolled by large number of factors, and there 
is no full explanation about the mechanism of how these factors can stimulate the normal cells 
to become cancer cells (Hackney, 2015). The two essential unalterable risk factors are gender 
and age. In the context of gender, more than 99% of breast cancer incidences are from women 
(Kopans, 2007; Garnett, 2015). In women under 20 years of age, breast cancer cases are quite 
rare, and approximately 0.3% of the breast cancer incidences happen in women within the 20–
30 age group (Finkel, 2005). However, approximately (48 %) of the breast cancer incidences 
occurs in females within their fifth and sixth decade (50–69 year) (Hackney, 2015). This 
contributed to the rationale for supporting the UK NHS breast-screening programme to invite 
females within the aged 50–70 year for screening mammography every three years (NHSBSP 
Publication No 60, 2005).  
Other risk factors comprise family history, breast density and personal history. In relation to 
family history nearly 15% of the females with breast cancer have a family history of breast 
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cancer (Hackney, 2015). Breast density is a further risk factor and females that have a higher 
density of breast tissue have a higher incidence rate of breast cancer (Shetty, 2015a). In relation 
to personal history, females who have previous incidence of breast cancer are more liable to 
develop breast cancer by about three to five times than other females (Hackney, 2015). 
Additional risk factors are related to lifestyle, and they include diet, physical activity, drinking 
alcohol and smoking. Hormonal therapy can also cause an increase in breast cancer cases 
(Kopans, 2007; ACS, 2015; Hackney, 2015).      
Socio-economic circumstances are also important in incidence rate with recent studies 
indicating  that approximately 53% of breast cancer cases occur in developed nations 
(Hackney, 2015). There are significant differences between regions: it is at least 2-3 times less 
common in East Asian countries than in Western Europe and America, where the latter 
illustrate lesser proportions than African countries (United Nations Scientific Committee on 
the Effects of Atomic Radiation (UNSCEAR, 2008). Between 2002 and 2003, breast cancer 
studies demonstrated a significant decline of about (7%) in the United States. This decline 
might have come according to a decrease of using menopausal hormone therapy (ACS, 2011b). 
In the UK, however, obesity, hormone therapy, use of hormones as a contraceptive, and the 
lower proportion of pregnancies have contributed to a growing occurrence of breast cancer 
between 1975 and 2003 (Health Protection Agency, 2011).  In 2012, a study demonstrated that 
the proportion of breast cancer incidences have altered to be 39%, 28%, and 15% in Asia, 
Europe, and the United State respectively (ACS, 2015). Breast cancer death rates have 
gradually reduced in developed nations. For example, in England, it decreased by 37% between 
1971 and 2011 (Office for National Statistics [ONS], 2012). Likewise, a 5.2% per year decline 
is noticeable in North America between 1990 and 2011 (ACS, 2011b). This decline in death 
rate is related to earlier diagnosis of breast cancer via breast cancer screening programmes, 
primary prevention of breast cancer incidence reduction, and the development of better cancer 
treatment procedures (ACS, 2011b; Säbel & Aichinger, 1996).   
2.4 Mammography 
Mammography is a well-established imaging procedure which is utilised as both a screening 
and diagnostic mammography tool. In the United Kingdom (UK), females between 50 and 70 
years of life are offered mammographic screening examinations through a screening 
programme to identify those with breast carcinoma, so as to offer them treatment at the earliest 
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possible stage. At present in the UK a randomised controlled trial is ongoing to screen women 
50 years or older once every 3 years (Dewar, 2015). 
Digital mammography is considered one of the greatest new technologies in screening 
mammography due to its superior contrast performance (Muller, 1999; Rafferty, 2007). Digital 
mammography has many advantages which enhance and improve sensitivity and specificity 
and can enhance lesion detection performance; it has also been seen to decrease diagnosis 
errors (Pisano and Yaffe, 2005). An observer’s ability to detect cancer in its early stages is 
dependent on high-quality mammographic images being obtained (Kulama, 2009). Although 
there are several imaging modalities used for breast cancer detection, mammography is the 
most common, most cost effective and best screening tool for the diagnosis of breast 
abnormalities (Muller, 1999; Cole et al., 2003; Rafferty, 2007). There are different projections 
that can be taken, the most common being mediolateral oblique (MLO), and craniocaudal (CC) 
(Hogg et al., 2015). In screening mammography, these two projections of the breast are 
acquired. In situations wherein the breast lesions are not well visualised by the CC and MLO, 
additional mammographic projections involving the Medio-lateral (ML) and Latero-medial 
(LM) can be used (Lewin, D’Orsi and Hendrick, 2004; Whitman and Haygood, 2012). By 
utilising the different mammographic projections, the person reading / interpreting the image 
can study the breast anatomy and potential lesions from different perspectives in order to 
enhance lesion detection performance (Ortiz-Perez and Watson, 2015). Figure 2.3 
demonstrates the four mammographic projections. 
 
Figure 2.3 Mammographic Projections (Imaginis Corporation, 2014). 
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Figure 2.4 represents typical mammographic images; Cranio-Caudal Projection (A&B) and 
Medio-Lateral Oblique Projection (C&D) for left and right sides. The fact that there is little 
difference in contrast between normal breast tissue and lesions can create difficulties in lesion 
perception detail such as; boundaries, edges and shapes (Tabar et al., 2005; Kopans, 2006). 
However, other factors such individual differences in the relative proportions of high-low 
breast densities are found to affect accuracy in interpretation (Masotti, 2005; Al-osta, 2010). 
Furthermore, sub-optimal positioning  is a major contributor to accurate visualisation of 
abnormalities on FFDM images (Debono, 2012).  
 
Figure 2.4 Normal mammography- Cranio-Caudal Projection (A&B) and Medio-Lateral Oblique 
Projection (C&D). 
 
It is recognised that the composition of the breast varies among women and depends on the 
proportion of fibrous, glandular and adipose tissue. Breast composition changes with the age 
of women such that the quantity of adipose tissue will increase with age. The variations of 
breast tissue can be observed by mammography due to the attenuation of the x-ray beam that 
passes through different levels of tissue density. The adipose tissue is visualised as dark areas 
(radiolucent) in mammography while fibrous and glandular tissue appear less dark 
(radiopaque). Therefore, these variations of tissues are apparent in the image due to the 
absorption of x-ray by different densities and thicknesses of glandular and adipose tissues 
(Uchiyama, Nachiko & Zanchetta, 2012).  
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Breast tissues are highly sensitive to (x-ray) radiation and, as such, special characteristics of x-
ray tube are utilised in mammography. Mammography tube  characteristics are designed to 
achieve high image quality with low radiation dose (Uchiyama et al., 2012). Low-energy 
radiation is accomplished through the combination of filters and different x-ray tube targets. 
Mammographic x-ray tubes should have a small focal spot to achieve high resolution and 
sharpness (Wilson et al., 2011).  The increase of x-ray energy can lead to a decrease in the 
contrast between different breast tissues. Therefore, low-energy radiation is used in 
mammography because this differentiates breast densities in order to achieve high contrast 
(Whitman & Haygood, 2009). It is obvious that a weakness of mammography systems is 
ionising radiation. However, the radiation risk regarding using x-ray within mammography is 
far below the risk of breast cancer (Yaffe and Mainprize, 2011). Consequently, women should 
continue for the procedure of screening mammography (Ali et al., 2015). Research illustrates 
that screening mammography reduced the mortality rate from breast cancer by approximately 
1,300 per year in the UK due to the early detection of cancer (Cancer Research UK, 2014).   
2.4.1 Characteristics of Malignant Microcalcifications within Mammography Images  
Malignant microcalcifications have different distribution patterns; they can be clustered, 
diffused or punctate. Clustered microcalcifications present with a wide range of sizes compared 
to benign whereas malignant microcalcifications display homogeneous appearances and 
irregular shapes with a low-density (Kaiser, 2009; Bick, 2010) . In addition, individual 
malignant microcalcifications are reportedly varied in terms of their size and shape; some are 
linear and branching, others microscopic and fine or stellate-shaped (Schueller et al., 2008). 
Figure 2.5 illustrates examples of malignant microcalcifications of several shapes, sizes and 
distributions patterns. Malignant microcalcifications vary in number, density, size and shape. 
They are often clustered within one lobe at the breast. Malignant microcalcifications are 
divided into two types- granular and casting, due to their physical characteristics. The granular 
type are very small, often ‘uncountable’, with an extended shape. The casting type contains a 
large number of small calcifications with different lengths and irregular contours (Shetty, 
2015b). Many studies (Gathani et al., 2005; Hizukuri et al., 2013) have classified clustered 
microcalcifications into five different types due to histological origins: non-invasive 
carcinomas of the comedo type, non-invasive carcinomas of the non-comedo type, invasive 
carcinomas, fibroadenomas, and mastopathy. Benign microcalcifications however, are 
characterised by a sharp outline, a homogeneous shape and a radiolucent density (Shetty, 
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2015a). Table 2.1 demonstrates the main types of benign and malignant breast 
microcalcifications.  
 
Figure 2.5 Malignant microcalcifications in different shapes, sizes and distributions pattern. 
 
These characteristics can be difficult to interpret due to their small size and relatively little 
difference in contrast and this can have an impact on visual performance.  The image contrast 
can be affected by lesion characteristics and background, according to the density of the breast. 
The amorphous microcalcifications presentation (Figure 2.5, bottom left) is considered the 
most difficult lesion to identify due to its poor contrast and small size.  
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Lesion type Size Shape Density Appearance Distribution  
Pattern 
Malignant 
microcalcification 
Variation 
of sizes 
 
Irregular  Low 
density  
Inhomogeneous  Clustered 
innumerable 
Benign 
microcalcification 
Uniform in 
size 
 
Rounder shape, 
coarse oval 
High 
density 
Homogeneous Scattered or 
diffuse  
Malignant masses 3 sizes: 
Large, 
medium, 
small    
 
Circumscribed or 
spiculate 
High 
density 
Stellate spiculated 
with poorly define 
margins 
 
Benign masses  Rounded Low 
density 
Sharpe define 
margins 
 
Table 2.1 Main types of benign and malignant breast lesions  
 
Contrast within FFDM images refers to the difference in luminance between a breast lesion 
and its background (Apelt et al., 2009). A consequence of low contrast can be that malignant 
microcalcifications located within a dense breast are likely to be difficult to visualise as this 
represents a high-density lesion within a high-density background (Sabih et al., 2011). This is 
also true for malignant masses with poorly defined margins. However, many benign 
microcalcifications are often easy to recognise by the human eye due to their high-density and 
homogenous appearance, which are often characterised by good contrast with its surroundings.    
2.4.2 Breast Masses  
The shape and margin of breast masses or lesions can indicate if the lesion is benign or 
malignant. The margin can be micro-lobulated, obscured, indistinct, circumscribed, or 
spiculated (Shetty, 2015a). The shape can be either lobulated, round, irregular, or oval. Lesions 
which have a round or an oval shape and involve a circumscribed margin are commonly benign 
while lesions with an irregular shape or lobulated are most likely to be malignant (Shetty, 
2015b). Figure (2.6) demonstrates a set of the most common shapes and margins of breast 
lesions.    
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Figure 2.6 shapes and Margins of Breast Lesions (The radiology Assestant, 201 
 
Some cases of benign circumscribed masses contain cysts and fibroadenomas. Invasive ductal 
carcinoma (IDC)  is an example of a cancer with spiculated margins and irregular shapes, 
although these can also have well-defined margins (Ossati, 2015). Figure 2.7 illustrates some 
malignant and benign breast masses.  
 
Figure 2.7 Mammographic images demonstrating benign and malignant masses 
A: Cyst-round circumscribed, B: Fibroadenoma-lobular, low density and circumscribed, and, 
C: spiculated margins and irregular shape represents an Invasive ductal carcinoma (IDC) 
(Ossati, 2015). Specific lesion characteristics in mammographic images have different degrees 
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of detection difficulty. Some types of breast masses may be difficult to detect as the 
surrounding breast tissue obscures the spicules that radiate outwards (Lehman et al., 1999). In 
comparison, malignant microcalcifications, which are associated with a high false negative 
fraction (FNF), may be misdiagnosed because of the difficulty in identifying the nature of 
lesions of suspicious area of the image (Al Mousa et al., 2014). Architectural distortion has a 
subtle appearance and may appear similar to normal overlapping breast tissue; this can also 
result in missed lesions and lead to false negative presentation (Zwiggelaar, Schumm and 
Taylor, 1997). 
 
2.5 Factors Affecting Diagnostic Efficiency  
Breast cancer detection, in the early stages, can lead to the creation of more effective treatments 
and can result in a decrease in mortality rates. It is therefore a universal health priority when 
developing strategies to control breast cancer. Screening mammography represents the most 
efficient technique for the early detection of breast cancer; however, the sensitivity of 
mammography is in the 68–92% range (Beam et al., 2013). The high occurrence of breast 
cancer, aside from the rate of misdiagnosis, highlights the need for a better understanding of 
why some breast lesions go undetected.    
Many studies suggest that detection performance is related to the observer in terms of 
experience, cognitive skills and visual performance (Nodine & Kundel 1987; Chester 1992; 
Reed, 2005; Manning et al., 2006; Burgess 2011; Sabih et al., 2011; Lança et al., 2015). Other 
studies suggest that lesion characteristics can contribute to challenges in image reading 
accuracy. These characteristics include the type, size, contrast, distribution and location of the 
lesion within the breast (Figure 2.8). Small lesions with indefinite borders can lead to 
perception difficulties (Van Overveld, 1995; Tabar et al., 2005; Kopans, 2006). In the same 
context, other studies suggest that factors related to the characteristics of a mammographic 
image (image quality, artefacts, spatial resolution, sharpness and contrast resolution) can have 
an influence on detection performance.     
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Figure 2.8 Malignant microcalcification and mass with different lesion characteristics. 
 
Perception errors can be considered the main cause of missed cancers in mammography 
(Rawashdeh et al., 2014). Misdiagnosed  cancers in mammography are commonly located in 
the retro-glandular regions (Berlin, 2001a). Whereas, Huynh et al., (1998) highlighted that the 
misdiagnosis of cancers were more significant within lower density breasts; they were almost 
visible on only one of two projections and were smaller in size. Huynh and colleagues (1998) 
also found that masses, rather than calcifications, are more commonly undetected (Huynh, 
Jarolimek and Daye, 1998). This is a concern since a large number of lesions are present as 
palpable, non-calcified tumours (Yankaskas et al., 2001). However, within these studies it is 
noted that limited data exists on the effect of other image and lesion appearances, such as 
texture and shape.  
When interpreting a mammography image, the image can be divided into several quadrants by 
the image reader; this approach is known as the regions of interest (ROI) paradigm. The 
selections of ROIs are based on clinical considerations and the quadrants should be equal for 
all images. For instance, the mammographic image could be divided into four quadrants 
(external upper quadrant, internal upper, external lower and internal lower quadrant). The task 
of the observer is to rate each region for the presence of a breast lesion in that ROI (Al-osta, 
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2010). The rating of quadrants per image produces numeric data. It is supposed that the truth 
of each ROI is known, whether the lesion exists or absent in ROI and it cannot lesions that 
overlap ROIs.   
2.5.1 Mammographic Breast Density (MBD) Assessment 
There are many methods for measuring breast density. Some are quantitative whilst others are 
qualitative (Yaffe, 2008). Qualitative methods involve an observer scoring images using scales; 
examples of visual grading scales include Breast Imaging Reporting and Data System.  (BI-
RADS), Tabar, visual estimation and Wolfe’s (Wolfe, 1976). According to Gram et al., (1997), 
Tabar has categorised breast density into five types:  
I: A predominance of fibrous tissue with balanced proportion of all components of 
breast tissue (Cooper’s ligaments and scalloped contours) 
II: Fatty breast (predominance of fat tissue) 
III: Mostly fat tissue with oval-shaped lucent areas 
IV: Predominantly nodular and linear densities 
V: Extremely dense (mostly fibrous tissue)  
However, Wolfe’s (Wolfe, 1976) grading classified breast density into four types:  
(i) Fatty breasts (fibro-glandular tissues >25 % and almost all of the tissue appears to 
be fat 
(ii) Fibro-glandular breasts (Proportion of fibro-glandular tissue 26–50 % of the breast 
(iii) Heterogeneously dense breast (heterogeneously compose 51–75 % of tissues) 
(iv) Extremely dense (fibrous connective tissue composes more than 75 %)  
 
Breast Imaging Reporting and Data System (BIRADS) (American College of Radiology 2013; 
Carl  et al., 2013; Geller, et al., 2002) is a qualitative method to assess the density of breasts 
which is widely utilised in mammography. Figure 2.9 shows BIRADS for four main density 
classifications: (A) fatty breast; (B) fibro-glandular tissue; (C) heterogeneous dense breast; and 
(D) for the extremely high-dense breast. The BIRADS system categorises breast density 
according to a percent of its compounds, as follows: BIRADS (A) (the breasts are almost 
entirely fatty), BIRADS (B) (there are scattered areas of fibro-glandular density), BIRADS (C) 
(the breasts are heterogeneously dense, which may obscure small masses), and BIRADS (D) 
(the breasts are extremely dense, which lowers the sensitivity of mammography). In spite of 
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the BIRADS method being commonly used worldwide for reporting mammographic breast 
densities, the features of the mammographic image are identified subjectively (Taplin et al., 
2002); this method can be susceptible to visual errors and can be influenced by the experience 
level of the observer.  
 
Figure 2.9 Variations in breast density according to BI-RADS classification system  
 
2.5.2 Effect of Mammographic Breast Density on Lesion Detection Performance  
A number of studies have demonstrated that the sensitivity of mammographic image-observers 
to detect breast cancer increases with decreasing breast density (Byng et al., 1994; Lehman et 
al., 1999; Kolb et al., 2002; Kriege et al., 2006; Lip et al., 2010; Chiu et al., 2010; Cook et al., 
2010; Al-Mousa et al., 2014). Other studies demonstrated that lesion density contributes to 
challenges in screen reading accuracy (American College of Radiology, 2013; The Radiology 
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Assistant, 2013). It can be reasoned that small differences in contrast between lesion density 
and density of breast tissue (density of normal and abnormal tissue) could create difficulties in 
perception of important lesion details, such as margins or borders. Therefore, it is proposed 
that there is an inverse relationship between breast density and lesion detection performance; 
an increase in breast density leads to a reduction in detection performance and vice versa.  
Many researchers have studied the combined influence of breast density and age on the 
sensitivity of mammography and have generally demonstrated lower performance in high-
density mammographic images compared with the low-density breast images in both old and 
young age groups. For instance, Rosenberg et al., (1998) demonstrated that the sensitivity in 
females aged >50 was 8% higher in fatty breasts than in dense breasts and that for females aged 
<50 with fatty breasts, sensitivity was 19% higher than those with dense breasts.      
Kerlikowske et al., (1996) demonstrated that the sensitivity in females aged <50 years old was 
not significantly higher in low-density breast images (81.1%) compared with high density 
breast images (85.4%); nevertheless, the latter outcome may be accounted for by the small 
sample size. Just nine cases of breast cancer were included in the study. Kolb et al. (2002)  
demonstrated a correlation with a decrease in sensitivity of mammography and age for females 
with high mammographic breast density images. They concluded that sensitivity was 50% in 
females aged <50 years, compared to the 70.2% in females aged >50 years (p<0.035). 
Nevertheless, such age-dependency does not exist for low-dense mammographic images 
(Wivell et al., 2003). Chiu et al., (2010) demonstrated that less-dense breasts had a higher 
sensitivity than high-dense breasts (82% versus 62.8%) and this higher sensitivity was 
significant, regardless of age. In females within the age group >50 years, they found that 
sensitivity in higher-dense breasts was 55.3% and increased to 76.8% in lower-dense breasts. 
In the same context, a similar increment in females aged >50 years was found, with a sensitivity 
of 77.7% in females with dense breasts, which increased to 88.7% in females with fatty breasts 
(Chiu et al., 2010).  
Specificity is another indicator that is utilised to determine detection performance in 
mammography. Studies, such as Lehman et al., 1999 and Carney et al., 2003 suggest that 
specificity is reduced within dense breast tissue, with magnitudes shifting from 89.6-89.9% in 
females with higher density to 93.5-96.5% in females with almost low-density breasts and this 
was the same for both older and younger females (Lehman et al., 1999; Carney et al., 2003). 
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Lehman et al., (1999) also conclude that females with low-density breasts have a lower 
probability of resulting in false-positive (FP) mammography (10.4%) than females with fatty 
breast tissue (6.5%). Likewise, a study by (Kriege et al., 2006) shows that false-positive (FP) 
value decreases from 5.9 in high-dense to 8.3 in the low-dense breast. Cook et al., (2010) 
demonstrated that females with highly dense breasts were more likely to be recalled for further 
tests. This study also shows that the measurement of the relationship between an exposure, and 
a consequence known as the specificity odds ratio, decreased from 0.86 in an extremely dense 
breast to 1.85 in almost entirely fatty breast, however, there is no change in the positive 
predictive value (PPV) of breast density.   
2.5.2.1	Mammographic	Image	Assessment	
In the UK, a list of criteria to ensure the quality of an image has is recommended by the National 
Health Service Breast Screening Programme (NHSBSP). This should be utilised during the 
assessment of mediolateral oblique (MLO) images (NHSBSP Publication No 63, 2006). 
• The image should cover the whole breast  
• Breast Nipple should in profile  
• Correct annotations  
• Acceptable radiation dose  
• Adequate compression force  
• Absence of movement   
• Absence of skin folds   
• Artefacts free 
• Symmetrical images L (left) MLO versus R (right) MLO     
                                      
Likewise, the NHSBSP advise the following image quality criteria for craniocaudal (CC) 
images (NHSBSP Publication No 63, 2006): 
• Medial border should be imaged  
• Some axillary tail should be present  
• Pectoral muscle shadow may be shown  
• Nipple in profile  
• Correct annotations  
• Appropriate exposure 
2.5.3 Effect of Image Quality on Lesion Detection Performance 
The ability of image observers to identify small microcalcifications is dependent upon the 
production of high-quality images. Artefacts can reduce image quality in mammography and 
can obscure abnormal structures, causing interpretation errors. The identification of artefacts 
can improve interpretation and minimise the description of artefacts as breast disease 
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(Schueller et al., 2008). Image blurring, caused by unwanted motion, is a common reason for 
a repeat exposure to ionising radiation in mammography. The impact of image blurring is not 
currently fully understood within the literature.  Artefacts in digital mammography can lead to 
a reduction in image quality and may obscure true lesions. In addition, they can create pseudo-
lesions. As such, they represent a serious concern in quality assurance, as some image observers 
may be unfamiliar with all possible artefacts; the understanding and knowledge of the types of 
artefacts in FFDM and the causes of each type is extremely important for image observers and 
radiographers in order to minimise them in the diagnostic process. Overall, familiarity with the 
various artefacts encountered can enable the image reader to provide more accurate diagnoses 
(Choi et al., 2014). 
Chaloeykitti et al., (2006) divided the types of artefacts associated with mammography images 
into three causes; patient-related artefacts, software-processing artefacts and hardware-related 
artefacts; whilst Ayyala et al., 2008 and Schueller et al., 2008 described them as technical-
related artefacts and patient-related artefacts. Some of these artefacts are similar to the artefacts 
in screen-film mammography, however many are unique to digital mammography. The latter 
include artefacts due to digital detector deficiencies and software processing errors 
(Chaloeykitti et al., 2006). In addition, there are digital mammographic artefacts according to 
the detector type (direct or indirect). Therefore, an observer is required to be able to 
differentiate artefacts from pathology in order to improve interpretation and prevent the 
identification of artefacts as breast disease (Chaloeykitti et al., 2006).  
The spatial resolution of FFDM equipment means its ability to identify two neighbouring 
structures, or an edge (sharpness), as separate entities. Geometric blurring can cause losses of 
spatial resolution. Focal spot size of the x-ray tube, object image distance (OID) and subject 
image distance SID impact onto geometric unsharpness. Other factors might also cause loss of 
spatial resolution such as a detector element effective aperture and pitch, and relative motion 
of the X-ray source, and the breast or the image detector during image acquisition. The impacts 
of spatial resolution on clinical image quality can be observed when imaging fine pathological 
detail in the breast such as spiculations radiating from a microcalcifications or mass.  
Geometric blur can by caused by the shape and design of a mammographic X-ray tube. The 
rotating type of the anode with slight anode angulation is used in FFDM equipment to minimise 
geometric blur by decreasing the size of the focal spot (Yaffe & Madiment, 2014). In a 
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mammographic X-ray tube, the typical size of the focal spot is 0.1 mm and 0.3 mm for small 
and large foci respectively. The small focus is often utilised for magnified views, while the 
large focus is used for conventional mammography. The geometric focal spot unsharpness can 
be increased due to small focal-object distance is utilised in magnification mammography. To 
eliminate geometric blur, the smallest focal spot is employed. However, utilisation of a small 
focal spot can increase the thermal load of the X-ray tube which is accounted for by utilising 
of the longer time of exposure. This can increase the probability of patient movement blur. 
Despite the fact that image processing introduces many advantages to image quality, the user 
should also be aware of the potentially harmful consequences of utilising certain image 
processing techniques with FFDM. For instance, using some software for processing raw 
images or altering the display of the images can improve the sharpness of mass lesion margins; 
however it can make indistinct masses appear more circumscribed (Medicine, 2005; Kanal et 
al., 2013). Likewise, histogram-based intensity windowing can enhance the conspicuity of 
edges but at the cost of losing detail outside of the denser parts of the image. Figure 2.10 
demonstrates an example of using different image processing algorithms to process raw data 
of same breast image. The spatial resolution of image (a) is less than in image (b) for the same 
mammographic image.   
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Figure 2.10 Demonstrate same breast image with different spatial and contrast resolution.  
(a) Raw FFDM image reprocessed utilising image processing algorithm                    
(b) Raw image as in 3.10(a) but reprocessed utilising different algorithm (Zanca et al. 2009). 
 
Contrast resolution of the image (mammographic image contrast) refers to the amount of the 
signal difference between the object within the region of interest and its surrounding 
background in the displayed image. It is affected by subject contrast and display image contrast 
(Woudenberg, Thijssen and Young, 2001; The American College of Radiology, 2014). 
Obtaining high mammographic contrast is of particular importance as it enables us to identify 
small differences in soft-tissue densities in normal and abnormal structures of the breast, the 
concurrent requirement to detect and characterise the structural characteristics of margins of 
masses (which is governed more by contrast resolution) and very small microcalcifications 
(which is governed more by spatial resolution). However, high-contrast images display two 
intensity levels; high and low. Therefore, the ability to identify the difference between the 
levels of intensity is necessary because it provides the observer with sufficient information 
regarding  the region of interest within the mammographic images (The American College of 
Radiology, 2014).  
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According to Wilson et al., (2011) there are many specific requirements which should be taken 
into account to obtain acceptable mammographic image quality: fibrotic strands and small 
microcalcifications should be imaged sharply, with a low level of noise and high contrast 
resolution. Although high contrast can be achieved, the mammography image should ensure 
the sufficient assessment of regions with large density variations. These can be the tissue 
overlying the pectoralis muscle, areas of dense fibrocystic tissue in large breasts or, in small 
breasts, fatty areas that might be found behind the nipple or close to the skin.   
Since some types of breast cancer can have a similar density to glandular breast tissue, high 
image contrast is necessary to distinguish normal areas from suspicious lesion appearance. 
There are many factors can influence the contrast between lesions and surrounding areas. These 
involve exposure factor optimisation, utilisation of adequate compression force and accurate 
breast positioning. Therefore, appropriate techniques are required to ensure sufficient lesion 
visibility.  
 
2.5.4 Mammography Image Interpretation 
Many studies examined the performance accuracy of radiographers to detect breast cancer and 
evidence has been provided which demonstrates that suitably trained and experienced 
radiographers have the equivalent accuracy to radiologists (Mucci et al., 1997; Debono, 2012a). 
Other studies have provided evidence of the capability of radiographers to participate in 
enhancements of the accuracy of the screening programmes. Most importantly are those that 
combine radiographer and radiologist in image reading to increase breast cancer detection 
efficiency (Wivell et al., 2003; Duijm et al., 2009; Miglioretti et al., 2011; Haneuse et al., 2012). 
In the UK, radiographers have been trained to be able to read and interpret the mammographic 
image with high accuracy. Consequently, radiographers have been employed within NHSBSP 
to read mammograms in the same way as radiologists (Debono, 2012; NHSSCP, 2011). Many 
studies have investigated the performance of radiologists and radiographers in the detection of 
the breast cancer. Some studies found radiographers have abilities to detect malignant breast 
masses in mammography (Duijm et al., 2007; Duijm et al., 2008; Duijm et al., 2009). Wivell 
et al., (2003) have found that radiographers are capable of detecting microcalcifications.    
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2.6 Full-field Digital Mammography  
The U.S. Food and Drug Administration (FDA) was the first to approve FFDM systems for 
clinical utilisation in 2000 (Hendrick, et al., 2010). In 2006, digital radiography systems were 
gradually introduced in Canada. Since then, these systems have been utilised extensively in 
many countries (Brooks & Morley, 2013).  
The principle of full field digital mammography equipment is similar to conventional film-
screen mammography; however, digital detectors have replaced the film-screen system 
(Heddson et al., 2007; Data et al., 2009; Hambly et al., 2009; Schulz-Wendtland et al., 2009; 
Diekmann et al., 2011; Souza et al., 2013; Knox et al., 2015). Digital detectors were initially 
utilised for general radiography and after that were extended into mammography. There are 
many potential advantages of digital compared with film-screen mammography. These 
include: lower radiation dose, improved contrast resolution and the provision of a wider 
dynamic range (Souza et al., 2013). An easier archiving process, soft copy reviewing and 
patient data sharing are additional advantages of digital mammography (Taplin et al., 2002; 
Samei, 2003). Digital mammography machines can provide two field sizes (24×30 cm and 
18×24cm) or a single field size (18×24cm) depending on the manufacturer. Magnification 
techniques include the electronic magnification of the image and a physical magnification 
platform on the FFDM machine (Whitman & Haygood, 2012). 
Digital radiography (DR) systems differ due to the type of detector technology and are 
subdivided into indirect and direct digital radiography (Uchiyama et al., 2012). The direct 
digital system uses amorphous selenium photo-detectors. The detector in this type of system 
has a high intrinsic resolution, high X-ray absorption efficiency and low noise levels. The 
indirect digital system utilises Caesium iodide doped with thallium (CsI:Tl)  to absorb the X-
rays. These systems produce light scintillation which is detected by an array of photodiodes 
(Pisano & Yaffe, 2005). The early digital mammography (DR) devices used indirect 
conversion detectors. These detectors utilised charge couple devices (CCD) for image 
capturing (Aslund, 2007). The CCD technique utilises phosphor, installed with millions of 
optic fibres on coupling plates. The main purpose of the optic fibers is to transfer light from 
the phosphor to CCD. In the latter, the light is converted into an electronic signal, this is then 
digitised (Muller, 1999; Rafferty, 2007). The early CCD was possible for small field sizes 
(5cm×5cm). These detectors coincided with slit collimated X-ray beams to scan the breast in a 
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perpendicular direction to a patient’s body producing a 22x30 cm image. Due to slit collimation 
of the X-ray beam, the scatter radiation is minimised, eliminating the need for a grid (Pisano 
and Yaffe, 2005).  
Computed radiography (CR) is also known as cassette-based technology. The principle of CR 
devices depends on photostimulable luminescence. These devices involve photostimulable 
phosphor known as storage phosphor screen (SPS) which absorbs the X-ray photons, before a 
laser scanning mechanism is used to extract this data. Subsequently, the SPS is scanned with a 
red laser light in a separate device, the reader, to convert the latent image to a blue light signal, 
proportional to the amount of incident X-ray on the SPS. After that, a photomultiplier in the 
reader changes the light signal to an electronic signal which is then digitised (Rafferty, 2007). 
To ensure that the SPS is free from any residual charge, it is then scanned with a high-intensity 
white light. The main drawback of this sort of digital detector is the lack of spatial resolution 
due to light scattering by the detector. It is worth noting, however, that thicker phosphor layer 
detectors are more sensitive to radiation however greater light scattering is produced (Pisano 
and Yaffe, 2005; Aslund, 2007). 
2.6.1 Components of FFDM Systems  
The FFDM system consists of many parts; each part with a specific function in the image 
production process. These include a collimator, anode / focal spot, field of view, automatic 
exposure control (AEC), grid, compression device, collimator, and compression paddles. 
Technical review grade computer monitors are also components of such systems. X-ray tubes, 
AEC and breast compression functions are utilised to produce optimised mammographic 
images. The x-ray tube is an example of an electronic device known as a diode, consisting of 
two electrodes the negative part is known as a cathode and the positive part is known as an 
anode (Aslund, 2007). In most FFDM systems, the cathode consists of two tungsten-thorium 
filaments, one for the large focal spot and a second one for the small focal spot (Muller, 1999). 
The electrons that comprise the tube current within the x-ray (milliampere mA) are emitted 
thermionically. The current of the x-ray tube is often reduced at high or low kilovolts peak 
(kVp) (Pisano and Yaffe, 2005). Figure (2.11) demonstrates the main components of a Full- 
felid digital mammography unit. 
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Figure 2.11 Full- field digital mammography equipment (Ossati 2015; Hologic Inc., 2014). 
 
Breast compression is a significant factor in mammographic practice to ensure optimal 
diagnostic performance and can be described as the compression of the breast describes that 
between the compression paddle and the support table. Compression of the breast is applied to 
increase image quality by reducing the amount of scattered radiation, while also reducing the 
mean glandular radiation dose. In addition, it spreads apart overlapping tissues, and in this way 
can allow for a reduction of false negative and false positive findings (Kallenberg & 
Karssemeijer, 2012). Decreased breast thickness can also result in several benefits, such as 
shorter exposure time. Compression also aids in immobilisation of the breast, which can reduce 
movement unsharpness (blur). 
High image quality is required and is essential for the early detection of breast cancer. 
However, certain image quality measures are subjective. Image quality can be assessed in terms 
of exposure, positioning, the sufficiency of compression force utilisation, noise, sharpness and 
contrast (Kallenberg and Karssemeijer, 2012; Murphy et al., 2014). Sharpness is linked with 
several factors, including an absence of client/equipment motion, positioning and the 
sufficiency of compression force and application exposure. Appropriate exposure is essential 
to achieve adequate image contrast, also to produce an appropriately noise-limited image 
(Haimo Liu, 2012). 
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2.6.2 Automatic Exposure Control (AEC) 
Automatic exposure control (AEC) as a key component in mammography has a vital function 
in FFDM. It offers appropriate optimal image exposure despite variances in the skill level of 
the radiographers, breast density and breast size (Bick & Diekmann, 2010). It is used to 
determine the intensity of the X-ray does not increase up to the limit of the digitizer or detector 
(Yaffe, 2010). Though the importance of AEC is essential to determine the exposure level to 
the breast and detector, the main function of AEC is to achieve appropriate exposure rather 
than identifying the brightness or contrast of the image and to help perform the signal to noise 
ratio (SNR) (Yaffe, 2010). 
2.6.3 Paddles 
The paddle is a plastic ‘plate’ in a mammography system that is used for compressing and 
fixing the breast during image acquisition. The compression process is performed between 
the support table and the compression paddle. The shape and size are different according to 
the purpose of mammography test. Choosing the suitable size of the paddle has an impact on 
image quality. Using a large paddle for small breast may prevent access to the breast. 
Likewise, the using a small paddle on a large breast might lead to inadequate compression 
and can cause inadequate compression of some border areas (Defreitas, Pellegrino, Farbizio, 
Janer, & Hitzke, 2008). Several sorts of paddles can be utilised for diagnostic and screening 
purposes depending mammography procedure. In spot compression, the concentration of 
compression is on a specific region of the breast; consequently, a small paddle is utilised to 
acquire the mammographic image. Spot compression can also be utilised to detect 
microcalcifications (Canadian Cancer Society, 2014). Biopsy, magnification and male breast 
paddles are additional forms of paddles used for different mammographic purposes (AR 
Custom Medical Products, 2007). Usually, in breast screening mammography two sizes of the 
paddle (24x30 cm and 18x24 cm) are used.  These parallel and flat paddles equivalent the 
detector size. Flat rigid paddles can be replaced by flexible paddles during the obtaining 
mammograms. The tilting mechanism of these spring-loaded paddles gives more uniform 
compression from the chest wall to the nipple (Bushberg, Seibert, Leidholdt, & Boone, 2012). 
Although manufacturers of mammographic systems have recommendations for using the 
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flexible paddles to minimize discomfort and the pain for females, there is no robust study 
regarding the correlation between the pain experience and these two kinds of paddles. 
However, the rigid paddle has been recommended for use in CC and MLO Projections 
because it promotes better contrast (Broeders et al., 2015).  Ma et al., (2016) suggested one 
solution to reduce the probability of motion blur is to utilise the fixed paddle with caution, as 
their results demonstrate that there is a significant difference in motion for flexible and fixed 
paddles.  Ma et al., (2014) demonstrated that flexible paddles have approximately less motion 
in the compressed state than fixed paddles. Therefore, the radiographer should take extra 
caution with fixed paddles when positioning clients.   
 
2.7 Motion Blur in Mammography Images 
Motion blur occurs due to the motion of the patient or imaging system, distorting the image in 
one or more directions (Cao, Zhao and Ni, 2010). In mammography, motion blur results when 
the breast structures or the paddle are relaxing and are moved during time; this motion can 
produce blur or motion unsharpness (Massanes and Brankov, 2011; Choi et al., 2014). The 
movement of patient or body organs, such as respiratory system and chest wall, is also a source 
of motion blur in FFDM images. It appears as un-sharpness in the detail of mammographic 
images, especially with low contrast edges of breast tissues. However, this type of artefact can 
be reduced by minimising exposure time to reduce the movement of the patient during image 
acquisition (Lu et al., 2005).  
Image blurring in FFDM images has the potential to obscure breast lesions and lesions which 
have low contrast to background ratios; as a result, clinically significant abnormalities could 
go undetected which may impact negatively on diagnosis. The source of motion in FFDM can 
be related to the patient or equipment (Chaloeykitti, Muttarak and Ng, 2006). The movement 
of the patient is one of the problems during the exposure time (Allec et al., 2012). It can be 
acknowledged that FFDM images are more vulnerable to image blurring with the increase in 
image resolution. Image blurring was no doubt apparent within conventional film 
mammography yet probably more difficult to detect due to variation in image resolution (Allec 
et al., 2012; Choi et al., 2014; Geiser et al., 2011).  
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Although there are anecdotes within the UK National Health Breast Screening Programme 
(NHSBSP) in the UK about image blurring and the requirement to repeat the images because 
of blurring, this technical problem continues to be under-reported and there is a scarcity of 
literature about it. According to the NHSBSP, (2005) the repeat and technical recall images for 
screening have a duty to be under 3% with a target of 2% within the (Public Health England 
and NHS Screening Programme, (2017). Some studies (Berry-Smith & Lonsdale, 2000; Wilson 
et al., 2011; Bisset, 2014; Rourke et al., 2016) have calculated the repeat and technical recall 
with direct reference to image blurring. A study by Rourke et al., (2016) found, within one 
screening service, that 86% of females were recalled due to image blurring, forming 
approximately one third (29%) of the 3% maximum admissible rate for repeated images 
(Rourke et al., 2016). Another study by Seddon et al., (2000) found that more than 90% of their 
total technical recalls were due to image blurring. Other studies have shown that image blurring 
is one of the highest reasons behind repeat mammographic images (Kelly at al., 2012;  Ma et 
al., 2014). However, more research studies are required to determine the causes and effects of 
this blurring phenomenon in FFDM.  The need to repeat mammography images due to blurring 
has a direct effect on the female in question; this includes an increase in radiation dose, if a 
repeated image is required, coupled with an increase in patient anxiety. Repeated images will 
also increase the work load on the mammographic units, which requires effort and is time 
consuming. 
Ma et al., (2016a) proposed that some of the blurred images can be only detected if they are 
displayed on 5MP monitors during reporting of mammograms. In many cases, motion blur 
goes undetected during the assessment of images for technical accuracy in mammography 
imaging rooms as these use lower grade monitors (less than 5MP). Ma et al., (2017) suggested 
that this lack of detection of blurring could be related to the low quality of the non-diagnostic 
monitors utilised in clinical rooms coupled with variable and generally brighter ambient 
lighting compared to reporting rooms. However, surprisingly, little research has been 
conducted into the technical review monitors specifically for the technical review purposes 
utilised within imaging rooms (Ma et al., 2017). 
In breast cancer screening mammography, the first study by Kinnear and Mercer, (2016) aimed 
to compare different types of monitors used in breast screening. They reported the capability 
of observers to detect simulated image blur visually in FFDM images on 1MP and 5MP 
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monitors. They found that higher resolution monitors resulted in a higher visual detection rate 
for blurred images. Following this Ma et al., (2017) utilised a more robust method to compare 
different monitors in the detection of motion blur visually. Compared with Kinnear’s work, 
Ma’s was superior in quality, and they increased the number of observers allowing inter-
observer variances to be considered (28 observers evaluated 120 images for motion blur). 
Second, simulated motion blur was utilised in Ma’s study in which the magnitude of motion 
blur was known exactly, so this allowed for better control of the experimental conditions. 
2.7.1 Causes and Effects of Image Blurring  
There are several publications that have studied the causes and effects of blurring on image 
quality  (Van Overveld 1995; Badano, 2003). However, there is no precise description about 
the magnitude of image blurring which can influence the appearance of anatomical structures 
within the image and how image blurring can affect the visualisation and sharpness of 
abnormalities within general radiographic images. To better understand image blurring, 
researchers have added simulated blurring to images using algorithms that apply a Gaussian 
mask. This was carried out to determine the effect of blurring on edges and to establish how 
the impact of image blurring could be minimised using de-blurring (Elder & Zucker, 1998;  
Yap et al., 2003;  Wee et al., 2007; Wallis & Georgeson, 2009).  
Consideration of image blurring has increased in recent times because FFDM images are more 
vulnerable to blur with the improvement of contrast resolution. Several studies have 
investigated methods to reduce the impact of image blurring with image processing software 
(Badano, 2003; Young et al., 2008; Cao et al., 2010). These studies are encouraging, however 
there is a noticeable absence of accurate identification of the amount of image blur which can 
cause obscured or unperceived breast lesions. Therefore, there is a requirement for an index to 
demonstrate how much image blurring can obscure the breast lesion within FFDM images. 
Also there is a paucity of information about repeated mammographic images relating to the 
amount of motion blur within FFDM images. Saunders et al., (2007) demonstrate that the 
existence of blurring and noise within the image can significantly decrease the accuracy of 
lesion detection. They examined the influences of various noise levels and resolution on task 
performance in digital mammography. The noise influences were most common for the 
detection of microcalcifications and the discrimination performance of breast mass. They 
reported that the changes of noise from full clinical dose to quarter clinical dose could lead to 
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a decrease in the detection performance of microcalcifications from 89% to 67%. Likewise, 
this change can lead to a reduction in the discrimination of breast mass from 93% to 79%, 
whereas malignant mass detection performance stayed comparatively constant with values of 
88% and 84%, respectively. 
 
2.7.2 Paddle Movement Effects 
(Hauge et al., 2011) were the first researchers to report that compression paddles move slightly 
after compression force had ceased. Subsequently, research by  Kelly et al., (2012) 
hypothesised that paddle motion may cause image blur.  Ma et al., (2014) assessed ‘Paddle 
Motion’ and they utilised a breast phantom to assess six FFDM paddles to determine whether 
paddle movement occurred. The breast phantom was mounted in a semi-mobile fashion to a 
rigid backboard. Calibrated linear potentiometers were used to document paddle motion at 0.5-
second intervals for 90 seconds. The paddle motion for all acquisition conditions was an 
average of 1.8 mm and a range of=0.44–7.46 mm. This research gave the first insight into 
paddle movement during exposure times in FFDM. However, the limitation of this study is that 
the breast phantom they used cannot completely represent the compression characteristics of 
the female breast. The silicone within breast phantom demonstrates a purely elastic 
compression characteristic, while the woman’s breast demonstrates a visco-elastic compression 
characteristic (Geerligs, Peters, Ackermans & Oomens, 2010). 
Another study by Ma et al., (2014a) introduced a new method to assess image blurring, by 
considering compression paddle motion in FFDM machines. Image blurring was determined 
by measuring the distortion of the ball-bearing diameter using a computer software. It showed 
that ball-bearing diameters were increased, indicating the impact of compression paddle motion 
on the images. The largest alteration in ball-bearing diameter affected the nipple area. They 
concluded that the increase in ball-bearing diameter means that image blurring caused by 
paddle movement could be utilised as an indicator of movement severity (Ma et al., 2014a). 
The advantages of this study were introduced a novel method to measure paddle movement 
leading to important initial results. However, some limitations in this study were related to the 
limited number of points in time during which exposures that could be made after compression 
force ceased. Previous studies into paddle movement demonstrate that about 60% of motion 
happens within the first 20 seconds of paddle compression (Kelly et al., 2012). Whereas, the 
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mammography system used in Ma’s (2014a) study only allowed for repeat imaging after an 
average time of 29.5 seconds (Ma et al., 2014). Therefore, many exposures per unit time would 
be better, from the point after compression forces ceases to be applied. 
A more recent study by Ma et al., (2014b) suggested that patient movement occurring during 
the exposure time represents a source of image blurring. In his work two calibrated linear 
potentiometers were used to measure the movement at the paddle. A hypothesis was proposed 
between the amount of movement and the amount of blurring that could lead to a lesion being 
obscured due to movement-related unsharpness in the image. It was suggested that the quantity 
of extra patient movement during FFDM imaging could be assessed utilising a linear 
relationship between paddle movement and the change in compression force (Ma et al., 2014b). 
There are some limitations to this study related to the materials and the method. Firstly, the 
FFDM system was only one type; so, the results are likely to be restricted to that system - 
Hologic Selenia Dimensions machines. Secondly, only one type of breast phantom was used 
to simulate real breasts. Female breasts differ in size, composition and shape,  therefore, the 
phantom used by Ma et al., (2014b) did not simulate the potential range of women’s breasts. 
Recent research by (Ma et al., 2016) identified paddle motion being present in a number FFDM 
machines during in the clamping phase, with estimates of motion being as high as 1.7 mm. 
Compression paddle motion has been reported to occur during the ‘clamping’ phase and it has 
been hypothesised that this may cause image blur (Ma et al., 2016). They utilised a deformable 
breast phantom to simulate a woman breast. Vertical motion at the paddle was calculated 
utilising two calibrated linear potentiometers. The motion in millimetres was calculated every 
0.5s for 40s for each paddle, whereas the compression force of 80N. They concluded that most 
motion occurred within the first 10s of clamping, and after 4s, paddle motion will probably be 
clinically insignificant. However, the limitation of this work related to the phantom utilised by 
Ma et al., (2016) cannot fully represent the compression features of the woman breast.  
Other research by Ma et al., (2015) identified the amount of simulated image blurring that can 
be detected visually. The findings of this study have determined that the amount of simulated 
motion blur for a hard edge software/mathematical simulation mask is 0.8mm and soft edge 
software/mathematical simulation mask is 0.7mm, while Gaussian blur software/mathematical 
simulation mask is 0.4mm. Whilst the sample size in this study was small (25 cases, 2 
observers) and did not provide adequate statistical power, the results are however of interest. 
  
39 
Another study by W. K. Ma et al. (2016) assessed the visual detection of motion blur on a 
2.3MP monitor and a 5 MP monitor of report grade; also they suggested an observer standard 
for the detection blurring visually on a 5 MP monitor. The findings of this study demonstrated 
that the technical recall rate for 2.3 MP monitor is 20.3 % while for 5 MP monitors it is 9.1%. 
The minimum magnitude of motion blur which can be detected visually is 0.4 mm of motion 
blur on 5-MP monitors. For a small amount of motion blur (0.2 mm), the visual detection 
difference was not statistically significant between the 5 and 2.3 MP monitors. This study has 
some limitations for instance the viewing environment may not fully represent the normal 
screening scenario. For instance, practitioners in clinical imaging rooms predominately do not 
work in dim light levels consistent with standard conditions of reporting and the volunteers in 
Ma’s study possibly had different amounts of time compared to image observers and 
practitioners to interrogate the image to determine whether blurring is present. 
2.7.3 Thixotropic Behavior and Breast Tissue Characteristics   
Thixotropic behaviour, the proportion of adipose tissue within the breast, mechanical properties 
of breast tissues, patient movement, paddle movement, and the amount of breast compression 
during the mammographic image acquisition are all factors that can cause motion blur in FFDM 
images. Geerligs et al., (2010) suggested that thixotropic behaviour of the breast tissue may be 
one of the main causes of movement at the paddle. Thixotropic behaviour of the breast tissue 
is related to the structural changes in the adipose tissue caused by mechanical loading during 
paddle compression. Geerligs et al., (2008) examined the long-term behaviour of adipose tissue 
under slight pressure and its response to several large compression magnitudes. The outcomes 
demonstrate that the shear modulus increases dramatically when increase loading period, but 
returns to its initial value within three hours of recovery from loading. They concluded that 
adipose tissue probably behaves as an (anti-) thixotropic material.  
Mechanical load transfer from a superficial contact region on skin to deeper tissues has an 
impact on various tissue layers. A previous study by Geerligs et al., (2008) on the linear 
behaviour of adipose tissue demonstrated that the linear strain is valid only for low strains 
(Geerligs et al., 2008). In most fields, however, much higher deformations happen in the 
adipose tissue for a longer period of time and with higher pressure. In uniaxial tension 
experiments, adipose tissue shows a non-linear stress against strain response; at small strain 
levels, the response is linear while at high strain levels, the tissue ‘lock-up’ and the stress level 
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rises promptly. Adipose tissue is capable of changing its microstructure such that at high strains 
or long periods of harmonic excitation the material behaviour changes dramatically. This 
structural change is reversible after long periods of rest.  
A study by (Peters, 2010) reviewed many published studies to provide data on the behaviour 
of adipose tissue, most of these are inadequate, and either only concentrate on some sides of 
the substance, such as relaxation or creep behaviour (Linder-Ganz et al., 2007) , only compare 
the characteristics of tissues (Patel, Smith and Patrick, 2005) or are highly concentrated on one 
sort of tissue. However, neither of these studies is comprehensive enough to establish a specific 
description about the importance of adipose tissue and breast compression. On the other hand, 
some researchers (Samani, Zubovits and Plewes, 2007) used the mechanical properties of 
breast tissue to increase the detection performance of breast cancer. Several studies suggested 
imaging the stiffness distribution in breast tissue to improve detection of breast lesions 
(Wellman et al., 1999). They proposed that cancers are much stiffer than the surrounding tissue. 
A study by (Wellman et al., 1999) proposed that there is a relationship between elastic modulus 
in compression and histological diagnosis. They also hypothesised that cancer exhibits non-
linearity and its change in modulus with pressure is larger normal breast tissue. The study 
results reported that there is a significant difference in the stiffness and the rate of increase in 
stiffness with compression between benign and malignant breast tissues.   
2.8 Physics of Mammography System  
2.8.1 X-ray Spectrum  
A mammography system is provided with distinctive anode/filter configurations in order to 
work in the suitable range of kilo-voltage (kVp). The typical kVp range differs depending on 
several studies. For instance, the International Atomic Energy Agency (IAEA) proposed the 
typical range of kilo-voltage as (24-32 kVp), whereas Zhang and Liua, (2012) suggested the 
typical range is (18-42 kVp) for conventional mammography (Zhang & Liua, 2012). Likewise, 
Ranger et al. (2010) considered the kVp settings ranged between 23–35 kVp (Ranger, & Samei, 
2010). These differences in settings of kilo-voltage among several studies may be due to 
utilising different models and makes of mammography machines from various manufacturers.  
In conventional mammography equipment, the anode/filter combinations are commonly 
molybdenum/rhodium (Mo/Rh) or molybdenum/molybdenum (Mo/Mo). Some mammography 
systems are provided with a dual-track anode which gives more flexibility to the radiographer 
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for choosing either rhodium or molybdenum (Sprawls, 1995). Moreover, due to developments 
in modern digital detector devices, additional anode/filter combinations such as 
tungsten/rhodium (W/Rh) and rhodium/rhodium (Rh/Rh) can be used in the mammography 
equipment (Chevalier et al., 2012). Mo/Mo or Mo/Rh are typically utilised in mammography 
units (e.g. Hologic Selenia). A study by (Baldelli, Phelan and Egan, 2010) demonstrates that 
the W/Rh target/filter is the better choice regarding image quality with the optimal dose of 
radiation. This target/filter combination is able to work as the best selection for all breast 
structures and thicknesses for diagnosis abnormalities (Baldelli, Phelan, & Egan, 2010). The 
energy spectrum of molybdenum comprises of a Bremsstrahlung and characteristic energies 
(see Figure 2.12). The molybdenum anode produces two types of characteristic X-ray energies 
(19.5 keV and 17.9 keV). These provide high contrast mammographic images for breasts with 
average thickness. The X-ray beam that has energies higher than (20 keV), are removed by a 
molybdenum filter and the mammographic image results from the low-energy spectrum. Most 
Bremsstrahlung energies above the binding energy of the K-shell electrons are attenuated when 
using a molybdenum filter (Figure 2.12). The removal of high energies X-ray spectrum above 
20 keV enhances the subject contrast (Huda & Slone, 2007; Sprawls, 1995). 
 
 
Figure 2.12 Molybdenum / Molybdenum spectrum (Sprawls, 1995) 
 
A  rhodium  filter  which  is  either  chosen  by  the  radiographer  or  the mammography system  
utilising  AEC  is  an  alternative  filter. This is commonly contained within mammographic 
systems with double filters. The k-edge boundary is shifted to a higher energy (23.22 keV) 
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compared to a molybdenum filter (20 keV) (Figure 2.13). Moving to a higher energy  means  
that  the  Bremsstrahlung  radiation  between  (20  and  23.22  keV)  is included in the beam of 
the X-ray. This extra radiation has a higher penetration and can be utilised for thicker or denser 
breasts (Sprawls, 1995). For most clients, the Mo/Mo filter is used. However, for denser/thicker 
breasts, a Mo/Rh setting with a higher kVp is automatically designated (Yaffe, 2010). 
 
Figure 2.13 Molybdenum / Rhodium spectrum (Sprawls, 1995). 
 
The interaction of X-ray is often among different types of detectors. Three essential atomic 
interaction forms happen between the photons of X-ray and the detectors of mammography 
system. These interactions involve the photoelectric effect, Compton (inelastic) scattering, and 
elastic scattering (Yaffe, 2010). In elastic scattering, the emitted photon from the matter has 
the same energy as the incoming photon. This means the energy of the scattered emitted photon 
does not disperse when interacting with the material. In Compton scattering (Figure 2.14), 
some of the photon energy is absorbed when the photons liberate a recoil electron which is a 
low binding electron. The rest of the energy stays in the scattered photon (Yaffe, 2010). 
Consequently, elastic scattering leads to contrast reduction, increased noise and loss of spatial 
resolution (Toennies, 2012). The Compton scattering amount increases with the increase of 
photon energy. The scattered photon can be dissipated in any orientation and also can be 
dangerous for the operator of X-ray system (Zhang, Li and Liu, 2012). 
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Figure 2.14 The interaction of X-ray through Compton scatter (Haidekker, 2013). 
  
The probability of photoelectric absorption per unit mass is related to the following equation. 
୞య
୉య    …………. (2.1) 
Where: Z is the atomic number of object and E is the energy of the X-ray (Bushberg, Seibert, 
Leidholdt, & Boone, 2012). This equation demonstrates the opposite relationship between the 
increment of energy and the photoelectric interaction. At low kVp levels the photoelectric 
interaction dominates over Compton scattering, while at high kVp levels, Compton interaction 
happens more often. Therefore, since a low energy is required in mammography, the 
photoelectric effect represents the essential interaction of X-ray in the detectors (Saha, 2013).  
The types of material utilised as detectors have an important impact on the increase of the 
photoelectric effect. The high atomic number materials are appropriate materials for making 
detectors such as selenium and iodine. At 20 keV, 96% of the interactions of X-ray will occur 
via photoelectric interaction for selenium and 94% for iodine (Yaffe, 2010). As photoelectric 
absorption needs low photons energies and low photons energies are required in mammography 
to obtain images with better visibility, these types of materials are appropriate for 
mammography detectors.  
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2.8.2 X-rays Incident on the Detector  
As Figure 2.12 and Figure 2.13 illustrate, mammographic machines operate using on low-
energy photons. In order to clarify the cause of utilisation low-energy photons to output 
mammographic images, the relationship between the thickness of the region of interest in the 
breast, the attenuation coefficient of the breast abnormality and the mammography detector 
are discussed. Since the photon of an X-ray transmits through tissues of the breast, different 
reactions occur between X-ray and difference densities of the breast tissues (Yaffe, 2010). 
Figure 2.15 illustrates two samples of paths that an incident X-ray transfer through the 
breast, A and B. In path A, the photon moves through the normal tissue, in path B there is a 
breast abnormality with the thickness ‘a’. 
 
Figure 2.15 The pathways of transmitted X-ray A: through normal tissue of breast B: during interest 
structure (Yaffe, 2010). 
 
2.8.3 Digitization 
In digital mammography, the process of converting the analogue data to a digital signal is 
named digitisation. This process includes two stages: sampling and quantization. The analogue 
data is produced by a detector initially, and then the detector converts it to digital data using 
special electronic circuit named analogue-to-digital convertors (ADCs). The digital signal 
transfers to a computer in order to digitize and store it digitally. In digital mammography, the 
last step in the process of image formation is the image processing application. Image 
processing is utilised to improve the diagnostic information within the image. This can be 
achieved by improving the contrast and edge definition or through decreasing image noise 
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(Warren et al., 2014). Every manufacturer utilises their own image processing algorithms, and 
the appearances of the image after this processing can vary between manufacturers. Many 
studies have investigated the impact of these variations in image appearance (Pisano et al., 
2000; Sivaramakrishna et al., 2000) and objective studies (Chen et al., 2010; Goldstraw et al., 
2010; Kamitani et al., 2010; Warren et al., 2012). Some studies concluded that the difference 
between several image-processing algorithms was significant (Goldstraw et al., 2010; Visser 
et al., 2012), and others found that the difference was not significant (Kamitani et al., 2010; 
Cole et al., 2003; Warren et al., 2014). In digital images many reviewed studies have attempted 
to detect and estimate motion blur in digital images. A study by (Ramakrishnan, 2010) 
investigated some algorithms which used to detect blurred images. However, no robust 
empirical study has been published to detect image blurring in FFDM images mathematically. 
Accurate identification of motion blur visually in digital images is not easy and can be carried 
out using mathematical methods. 
2.8.4 Pixel Size in Mammography  
Pixel size and spacing affects the spatial resolution of a digital mammogram.  However, more 
pixels do not always offer a higher spatial resolution due to the fact that image blurring can 
produce scattering of X-ray, scattering of light, and scattering of both in the detector (Chotas, 
Dobbins & Ravin, 1999). For instance, the pixel size of direct selenium (about 70 μm) has 
higher spatial resolution than a scintillator based system which has larger pixel size of about 
(100 μm) per pixel. Commonly, the pixel size on current detectors of mammography systems 
is between the range 50 -100 μm per pixel (Freitas, Kemp, Louveira, Fujiwara, & Campos, 
2006).   
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Chapter Three: Medical Images Assessment Methods 
 
3.1 Chapter Overview  
Image quality assessment (IQA) is increasingly important to medical image enhancement 
applications. These applications use several technologies to improve the visual appearance of 
the medical images. Conventional IQA indices, such as signal-to-noise ratio (SNR) and mean 
squared error (MSE), are used extensively but they do not take into account the human visual 
system (HVS) (Krupinski, 2011). Medical images require human interpretation, and despite 
software approaches like computer-aided detection, image analysis ultimately requires visual 
and cognitive skills. A number of the IQA metrics based on HVS are used to assess perceptual 
image quality. The assessment of medical imaging procedures or systems should involve the 
observer since the observer’s opinion is considered an integral part of the medical diagnostic 
procedure. The measurement of physical parameters is not sufficient to assess the success of 
the process. Receiver operating characteristics (ROC) methods are considered a robust 
approach involving performance of observer and imaging techniques (Thompson, Manning & 
Hogg, 2013). Figure 3.1 demonstrates the relationship between visual performance, image 
interpretation and image quality assessment methods.   
This chapter is organized into six main themes. The first theme will focus on the relationship 
between visual performance and medical image interpretation (section 3.2). The second theme 
will focus on the human visual function (section 3.3); the third theme will focus on the receiver 
operating characteristics (ROC) methods (section 3.4). The fourth theme will focus on a 
location sensitive method of observation study, the free-response receiver operating 
characteristics (FROC) method (section 3.5), which will be used for data collection. The fifth 
theme will focus on perceptual measures (section 3.6), and finally the sixth theme will focus 
on the physical measures of mammographic images and the factors which affect the conspicuity 
of the breast lesions (section 3.7).   
  
47 
 
Figure 3.1 Relationship between visual performance, image interpretation and image quality 
assessment methods. 
 
3.2 The Relationship between Visual Performance and Medical Image 
Interpretation 
Visual perception represents the ability to interpret the surrounding environment by processing 
information that is contained in visible light. Research in neuroscience, cognitive science and 
psychology, collectively referred to as vision science, concerns certain physiological 
components which make up the visual system ( Watson & Null, 1997; Manning, 1998). 
Medical image interpretation is based on visual performance of an observer and visual 
appearance of image. A psychophysical study by Apelt et al., (2009) has illustrated that human 
detection performance does not predict pattern recognition performance, which has contributed 
to the creation of a visual processing hierarchy. The process evolves as follows: detection→ 
discrimination→ identification→ recognition. However, it is often impossible to predict the 
results at a given hierarchy level based on the results obtained at a different level (Apelt et al., 
2009). Factors affecting error in mammographic image reading are complex and difficult to 
isolate. One prospective source of error could be related to reduced visual performance, which 
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in turn decreases an observer’s ability to correctly identify tiny breast lesions (Reed, 2005). 
Errors related to visual perception can be classified into two categories:  cognitive or visual 
errors. Cognitive errors represent approximately 45% of all errors and this concerns the 
observer who makes the incorrect decision (Samei & Krupinski, 2010). Visual errors represent 
approximately 55% of all errors and relate to an incomplete search of the image. Manning et 
al., (2004) concluded that most errors in image perception were failures of decision-making 
instead of detection (Manning, Ethell and Donovan, 2004b). Visual errors may occur due to 
not seeing the abnormal area or not focusing on lesion location for enough time (Samei, 2003).  
Interpretation of mammographic images can be a tedious task, given its repetitive nature of this 
task; but the unique nature of each mammogram means there is a unique map for every 
individual. Furthermore, the mammogram of a woman changes through time, related to the 
age, menopausal status, and hormonal changes (Zuley, 2010). Since breast cancer is a 
commonly diagnosed cancer in females, it is important to understand visual perception in 
mammography (Zuley, 2010). According to Zuley (2010), the mistakes in perceiving 
mammographic images can be categorised into three types: search errors, recognition errors 
and decision-making errors. If a lesion is not identified by the observer this is considered a 
search error. However, if the lesion ‘catches the observer’s eye’ but is then quickly dismissed 
it is considered a recognition error. This will lead to the lesion going unnoticed. Other errors 
such as decision-making errors can happen when the lesion is present, however the assessment 
of its nature is made incorrectly. This can result in a lesion being falsely identified as 
malignancy; a false-positive (FP), or dismissed as benign when it is actually malignant, a false-
negative (FN). Anatomical noise or normal tissue structure in mammography can mask the 
abnormal tissue. Decision-making errors can lead to either FP or FN decisions whereas search 
and recognition errors can lead to only FN (Zuley, 2010). Figure 3.2 demonstrates the three 
categories of perceptual mistakes in observing mammograms.  Therefore, there is a well-known 
search type called ‘satisfaction of search’ to demonstrate why the lesions stay undetected after 
finding the initial lesions (Mello-Thoms, Trieu, & Brennan, 2014). Satisfaction of search can 
play an essential role in missing pathologies within an image. In this condition, an expert image 
reader may be ignoring other possible lesions after locating the first one.     
  
49 
 
Figure 3.2 Three categories of perceptual mistakes in observing mammograms (Zuley, 2010; Ossati, 
2015). 
 
3.3 Human Visual Function   
Vision is the eye's ability to detect an electromagnetic spectrum of light; the brain then 
interprets this information. The main function of the eye is to convert light into electrical signals 
which are then transferred to the brain by the optic nerve (Gao et al., 2010). This process 
includes several stages, starting with the light of an object passing through the lens to a reversed 
visible image on the retina (Chester, 1992). There are several main concepts related to human 
visual function; these can be evaluated with visual tests such as visual acuity, contrast 
sensitivity and stereopsis. These visual parameters  are recommended to evaluate and decide if 
an observer has adequate eye function to participate in medical imaging observer studies 
(Lanca et al., 2014). The expression visual acuity is used to designate the capacity of the eye 
to resolve the size of an object. Contrast sensitivity makes the discrimination of low and high 
contrast frequency information possible. This can be linked to the perception of complex 
patterns in FFDM images (Apelt et al., 2009). Stereopsis can describe depth perception of 
objects in the central visual area, enhancing vision quality through binocular summation. 
Perceived visual errors are computed based on the visual error sensitivities to various factors 
of HVS, such as brightness, contrast sensitivity and visual attention (Gao et al., 2010).  
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The main functions of the human eye are to distinguish colours and shapes and to reveal light 
in the darkness. This process usually happens when light passes through the lens to a reversed 
visible image on the retina (Osberger, 1999; Nadenau et al., 2000). Figure 3.3 illustrates the 
anatomical structure of the human eye. The light passes through the cornea and is focused by 
the lens to form an image on the retina. The retina is located at the back of the eye. It contains 
two types of photoreceptors: the first, known as cones, are responsible for colour and high-
acuity (photopic) vision; the second, known as rods, are responsible for low light level 
(scotopic) vision. At light levels between the photopic and scotopic range, i.e., the mesopic 
region, both cones and rods provide vision (Gao et al., 2010). Rod cells are extremely sensitive 
to small levels of luminance, however, they are capable only of low resolution and are therefore 
of little relevance to medical imaging (Kundel, 1995). The pupil works as a diaphragm to 
control the amount of light entering the eye. The lens elastically focuses at different distances; 
a process referred to as accommodation. The diameter of the eye’s pupil at relaxation is 
approximately 1.5 mm (Chester, 1992).  
 
Figure 3.3 Anatomical structures of the human eye (Van De Graaff, 2001) 
 
The construction of an image can be put through many processes at several steps in the visual 
pathway from the retina to the cortex area. The retina consists of bipolar and ganglion cells, 
which are responsible for transmitting electrical impulses to the brain. Cells such as horizontal 
and amacrine work on lateral connections between ganglion and bipolar cells. The transmission 
of electrical signals from cones to bipolar cells is responded to with a chain of electrical 
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impulses. The strength of response is coded at all the nervous systems, according to the 
frequency of the electrical signal (Osberger, 1999). The visual cortex contains cells which are 
responsible for image analysis and is located at the back of the brain. It can be categorised into 
simple, complex, hyper-complex and higher-order hypercomplex cells. The primary visual 
cortex contains simple cells which have Receptive Fields (RFs) and are characterised by 
extremely structured and restricted regions of space. In spite of the fact that a limited quantity 
of image processing may occur in the retina and lateral geniculate bodies, the visual cortex is 
considered the essential part of image analysis (Chester, 1992).  
3.3.1 Visual Acuity  
Visual acuity is a measure of the eye's ability to distinguish detail. The ability of the eye to 
detect small detail is a significant factor in the diagnosis of medical images. The processing of 
visual information by the HVS is connected to the ability of an observer to interpret the medical 
image (Safdar et al., 2009). Visual acuity is the most commonly measured aspect of visual 
function (Colenbrander, 2001; Kaiser, 2009). This function could determine an observer’s 
ability to determine small objects correctly, such as solitary pulmonary nodules (Bass & Chiles, 
1990; Thompson et al., 2017). Several factors influence visual acuity, including illumination, 
contrast, refractive error and the site of the retina being stimulated (Holladay, 2004). The 
impact of the tested object features on visual acuity is related to different factors, such as 
contrast of the test object, luminance distribution in the field of view, colour, movement of test 
object and criterion for detection of detail (Kaiser, 2009). However, visual acuity is a complex 
task. The lowest separation concerns the decision of the site of a visual target, commonly 
related to another part of the same target (Holladay, 2004).  
3.3.2 Contrast Sensitivity  
Two concepts must be considered and differentiated in the discussion of contrast sensitivity 
such as objective and subjective contrast. Objective contrast (photometric) concerns the 
variation in luminance of objects or adjacent grounds. Subjective contrast (physiologic) 
concerns subjective phenomena, such as the modification in the ostensible brightness of objects 
of a given luminance, which is related to the luminance of the background. Overall, visual 
acuity reduces with a decline in photometric contrast; this becomes clearer with small test 
objects (Watson & Null, 1997). The influence of physiologic contrast is important. The 
borderline between a dark and luminous surface causes a blurred, unfocused retinal image to 
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be produced by the veiling effect of stray light and the optical aberrations of the eye. These 
impacts are off-set by physiologic contrast. The image on a white background appears whiter, 
the image on a black background appears darker and the border becomes sharp when the two 
edges meet each other (Apelt et al., 2009). With low contrast levels, visual acuity changes 
significantly; but at high degrees of contrast, comparatively great variations in objective 
contrasts have minimal impact on visual acuity (Jackson, 1996).  
3.3.3 Visual Function Assessment 
There are different techniques that can be used to measure and specify visual acuity and in its 
measurement, it is essential to use eye-validated charts. Typically, these contain capital letters 
organised in rows with the largest letters at the upper part of the chart decreasing gradually to 
the smaller letters at the bottom of the chart. There are several charts which can be used for 
visual acuity measurements, examples include senllen and ETDRS (Kaiser, 2009). The  
ETDRS chart is considered to be the gold standard for vision measurement in clinical trials 
(Kaiser, 2009). Visual acuity measures are used to describe the capacity of the eye to resolve 
the size of an object. It is the sharpness or clearness of vision and this is defined based on the 
clarity of focus in the retina of the eye. However, the processing of visual information by the 
human visual system describes the ability of the observer to interpret and understand the 
(medical) images. The reduced visual acuity might significantly raise the contrast threshold 
required to identify high-frequency information. Visual acuity hinges on the site of the retinal 
stimulus and reduces sharply with a rise in the distance of the image of an object from the 
centre of the fovea. The complex patterns of mammography perception are related to the 
contrast sensitivity of the visual system (Apelt et al., 2010). Pattern-detection ability is 
provided by eye contrast sensitivity for stimuli of various sizes and if abnormal contrast 
sensitivity is present, low-contrast targets are difficult to appreciate and can be missed. The 
limitation of visual acuity is caused by aberrations, diffraction and photoreceptor density in the 
eye (Holladay, 2004). In comparison, contrast sensitivity measurement is known as the ratio of 
the average background intensity to the peak amplitude of the spatial sinusoid at the threshold 
that is used as the test stimulus.  
There is an additional factor which affects visual performance measurements known as 
contrast sensitivity function (CSF). Grading the contrast sensitivity function is a valuable 
measure of visual function. It quantifies the capability of an observer to perceive small changes 
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in luminance between areas which are not isolated by definite borders (Arden, 1978; Apelt and 
Peitgen, 2008). Higher contrast sensitivity includes the identification of sinusoidal gratings, 
which are a model of black parallel bars and parallel light  that measure the sensitivity of the 
eye   through bar widths or a range of spatial frequencies (Drum, Calogero and Rorer, 2007). 
Visual Attention is the process of concentration in the sense of excitation, whether this 
excitation is sensory or mental. Perceptual quality measures are based on models of human 
visual perception. Several perceptual image quality metrics are proposed as alternatives to 
objective metrics, such as methods incorporating models of luminance adaptation and Contrast 
Sensitivity Function (CSF)(Gao et al., 2010). An early study by Riggs (1965) described the 
relationship between luminance intensity and visual acuity; it has been utilised within test 
objects within a white background. Riggs (1965) illustrated that visual acuity is low at dark 
levels where peripheral rod receptors or parafoveal dominate. As the light intensity level rises, 
the cone receptor thresholds increase and acuity rises sharply. As the intensity increases once 
more, a level of maximum acuity is reached and this can be maintained across further increases 
in intensity. The influence of luminance on visual acuity includes the pupil size. The ideal 
visual acuity is related to the pupil size of approximately 2 mm. However, the optimal size 
changes with levels of luminance, the size of the test object and other characteristics. A large 
pupil means more light will pass through the eye but this can also lead to visual aberrations. 
Luminance of the ambient lighting in a radiology reporting room typically should be below 10 
lux. These aberrations are reduced with a smaller pupil size, but a very small pupil size can 
lead to decreased visual acuity because the impact of light diffraction, through decreasing 
retinal luminance, is raised. Luminance of the ambient lighting can significantly affect the 
detection of microcalcifications in high density breasts (Thompson et al., 2017).  
 
3.4 Receiver Operating Characteristics (ROC) Methods 
The receiver operating characteristic (ROC) method is considered a valuable tool to evaluate 
the combined performance of the imaging system and observer in radiology. The historical 
background of ROC was established upon the fundamental principles of signal detection theory 
(SDT) (Li et al., 2010). This paradigm originated in the 1950s when it was used to establish a 
radar’s ability to detect approaching aircrafts. In 1960, a number of studies and books were 
published by Dr Lusted that encouraged the utilisation of ROC analysis in diagnostic radiology 
(Metz, 2008). However, this recommendation was not implemented until the 1970s, when 
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many laboratory studies were conducted by some researchers at The University of Chicago that 
led ultimately to the adoption of ROC analysis in medical imaging, and this lead to the 
development of new analytic techniques (Metz, 2008).  
There are many applications for ROC methods; they can be utilised in several modalities for 
different purposes. The ROC modalities can be used to compare old imaging techniques with 
a modern alternative. For instance, the ROC method can be used to make a comparison of the 
diagnostic performance between different models and it is a common choice of model (Bator 
and Chmielewski, 2008). Also, the ROC method can be used to compare between two new 
technologies in mammography such as digital mammography versus digital breast 
tomosynthesis (Gennaro et al., 2010). In digital mammographic image screening trials, both 
film screening (SF) and full field digital mammography FFDM can be obtained in each patient 
and the diagnostic performance of the observers for the two mammograms can be compared. 
The ROC paradigm can be generally described as a graphical curve that shows the performance 
of a binary classifier process, which consists of the true positive fraction known as sensitivity 
(equation 1) plotted against the false positive fraction known as 1-specificity (equation 2) 
(Metz, 2008).  
ܵ݁݊ݏ݅ݐ݅ݒ݅ݐݕ ൌ ௡௨௠௕௘௥	௢௙	௧௥௨௘	௣௢௦௜௧௜௩௘	௖௔௦௘௦௧௥௨௘	௣௢௦௜௧௜௩௘	௖௔௦௘௦ା௙௔௟௦௘	௡௘௚௔௧௜௩௘	௖௔௦௘௦ ………………………. (3.1) 
ܵ݌݂݁ܿ݅݅ܿ݅ݐݕ ൌ ௧௥௨௘	௡௘௚௔௧௜௩௘	௖௔௦௘௦௧௥௨௘	௡௘௚௔௧௜௩௘	௖௔௦௘௦௘ା௙௔௟௦௘	௣௢௦௜௧௜௩௘	௖௔௦௘௦ ……………………… (3.2) 
 The performance of any screening programme can be evaluated by three relevant parameters: 
sensitivity, specificity and positive predictive value. The expression of sensitivity and 
specificity is a measure of the observer performance of a binary decision; yes or no. This is a 
limitation in that it is difficult to help the observer estimate the probability of lesions in 
individual cases (Akobeng, 2007). A true positive (TP) decision occurs when the disease is 
present and identified by the observer while a false negative (FN) decision occurs when the 
disease is present and either overlooked or misinterpreted by the observer (Equation 2). The 
remaining possibilities are true negative (TN) decisions, wherein the disease is absent and the 
observer agrees, and false positive (FP) decisions, wherein the disease is absent and the 
observer disagrees (Obuchowski, 2005). 
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Positive predictive value and negative predictive value can be affected by disease prevalence.  
Negative predictive value is the probability that the lesion is not present when the result of the 
test is negative while positive predictive value means the ratio of the actual number of cancer 
cases to the number of abnormal cases detected by the programme (Equation 3). The same test 
can produce different results in two populations (Chakraborty, 2011). 
ܲ݋ݏ݅ݐ݅ݒ݁	ܲݎ݀݁ܿݐ݅ݒ݁	ݒ݈ܽݑ݁ ൌ ࢚࢛࢘ࢋ	࢖࢕࢙࢏࢚࢏࢜ࢋ	ࢉࢇ࢙ࢋ࢙࢚࢛࢘ࢋ	࢖࢕࢙࢏࢚࢏࢜ࢋ	ࢉࢇ࢙ࢋ࢙ାࢌࢇ࢒࢙ࢋ	࢖࢕࢙࢏࢚࢏࢜ࢋ	ࢉࢇ࢙ࢋ࢙ ………………. (3.3) 
The operating characteristics can be expressed in several forms projected by the search method 
from which they have been extracted. Table 3.1 outlines concisely several ROC methods. 
Table 3.1 Summary of development and comparison between ROC methods. 
Full name Abbreviation Description Description 
of plot 
Properties  & 
comparison between each  
method 
Receiver 
Operator 
Characteristic 
ROC Differentiates between 
normal and abnormal 
images 
TPF versus 
FPF 
Does not consider the 
location of the lesions. 
Low statistical power 
Localisation 
ROC 
LROC Identifies localisation of 
one abnormality in the 
images. This can be 
used as it is still a single 
rating per case/image 
TPF versus 
FPF 
Incorrect location of lesion 
considered as false positive 
Free-response 
ROC 
FROC Identifies and localises 
several abnormalities 
within the images 
Discriminates between  
malignant and benign 
LLF versus 
NLF 
localised several 
abnormalities 
Mark-rating according to 
BI-RADS 
Confidence level 
Multi-reader multi-cases 
Jackknife 
alternative 
FROC  Analysis 
JAFROC A re-sampling method 
that does not assume 
independence of 
responses within the 
same study applied to 
FROC 
AFFROC 
curve is a 
plot of LLF 
versus FPF 
A high statistical power 
method required multiple 
observers and multi-cases 
The ROC curve is the graphical scheme of true positive fraction (TPF) versus false positive fraction (FPF) 
while the FROC curve is the graphical scheme of lesion localisation fraction (LLF) versus non lesion 
localisation fraction (NLF) and the AFROC curve is the scheme of LLF versus FPF 
 
The ROC modalities have several measures which can be used, according to the design or the 
purpose of each study. According to Metz (2008), the ROC study can be divided into two types 
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of designs: clinical and laboratory studies. This refers to where the image-reading data is 
collected, either in clinical or laboratory based research, and it is important to understand the 
pros and cons of each approach. In laboratory studies, data collection can be most closely 
controlled so that statistical variation is decreased with increased statistical power, and the 
situations that led to the study’s conclusion are better understood (Gur, 2007; Metz, 2008). 
However, in the routine clinical practice, the data collection better represents the ‘real world’ 
with regard to a condition which we would like to draw conclusions about (Metz, 2008).  
ROC analysis considers the ability of human observers to distinguish between patients that are 
actually negative and positive for disease, which has been previously confirmed by a suitable 
arbiter (Metz, 2008). Since the performance in ROC methods depends on the human observer, 
there is a reasonable probability that the performance may be affected by the individuality of 
the observer; for instance the expertise of the image reader, fatigue, display environment and 
other conditions (Chakraborty and Yoon, 2008). Rating scales utilised in ROC analysis allow 
an observer to provide a numeric rating to an image, based on the perceived probability that 
disease is present (Chakraborty, 2002). This rating is used to assess the disease existence or 
absence. The low confidence level means that the observer believes that the image is more 
likely to be negative for disease (normal). In contrast, the higher confidence ratings reserved 
for cases  that the observer believes are positive for disease (abnormal) (Chakraborty, 2011). 
The decision threshold is a scalar quantity; not a random variable, used in an observer 
performance study. It is different from the confidence level; a random variable.     
The capabilities of the classic ROC analysis can be limited in some applications. For instance, 
the location of the lesion is ignored and the task of the observer is just to decide if a case is 
normal or abnormal (Chakraborty and Yoon, 2008). The true positive (TP) is insufficient if the 
lesion location is obscure or incorrectly localised (Chakraborty and Berbaum, 2004). In 
addition, the classical method may not take into consideration if there is more than one lesion 
present in the same image. This can lead to clinical consequences resulting from missing 
lesions and can have an effect on the truth of image quality description (Svahn and Tingberg, 
2005). The ROC method is extensively described (Park et al., 2004; Chester, 1992; Metz, 2008) 
and has been the method predominantly chosen to assess the detection performance of a single 
pathology for many years. However, there are some limitations associated with the classic 
method. For example, not all of the information available within an image is taken into account 
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and the system has trouble coping with multiple pathologies. Although ROC methods are 
considered the typical process to evaluate performance and ROC is very useful for evaluating 
diffuse disease such as chest infection or pneumonia, the limitations discussed above are 
considerable and have led to the development of more advanced methods such as FROC and 
AFROC.  
3.5 Free-Response Receiver Operating Characteristics (FROC) Method  
The free-response ROC (FROC) method takes into account the precise location of disease, 
where it can accurately measure cancer detection performance in FFDM images (Ruschin, 
Timberg and Båth, 2007a). In a FROC study, theoretically unlimited numbers of abnormalities 
can be localised in a single image by observers, with each localisation requiring an individual 
rating to describe the observer’s certainty that the abnormality (suspected lesion) is malignant. 
The FROC method allows observers to localise multiple lesions in each case (Chakraborty and 
Berbaum, 2004). The main aspect of the FROC method is the ability to penalise incorrect 
localisations and to reward correct localisations, this means making the use of location 
information efficient. It should be acknowledged that the FROC method has more clinical 
relevance than the ROC for masses and lesions; however, it is a demanding perceptual task for 
the observer. In the FROC method, the observer does not know the number of lesions that 
might exist in an image. Thereby, the observer’s task is to search the image for disease and 
mark all areas which raise suspicion of an abnormality; for each of these marks they must also 
provide a rating from a confidence scale; this process is known as creating a series of mark-
rating pairs, which is considered the basic unit of data.  
The fundamental variations between ROC and the Free-response ROC methods are in the 
figure of merit (FOM) quantifying observer performance and in the data collection step 
(Chakraborty and Yoon, 2008). In the ROC paradigm, lesion localisation is not required and a 
single rating is collected for each image, while in the free-response ROC paradigm, the data 
involves mark-rating pairs. These are classified into lesion-localisation (LL) and non-lesion 
localisation (NL) by a proximity criterion (Chakraborty, 2002). Secondly, in a ROC study, the 
FOM refers to the areas under the ROC curve. In contrast, computation of the FROC FOM 
includes creating two lists: an abnormal-list and a normal list. The abnormal-list is a record of 
the ratings for each lesion. The normal list is a record of the higher mark-rating (essentially a 
non-lesion) for each normal image (Chakraborty, 2010a). The number of normal images 
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represents the number of entries in the normal list. The total number of lesions is the 
corresponding number for the abnormal-list. The calculation of FOM includes making all 
probable comparisons between the quantities in the two lists (Chakraborty and Berbaum, 
2004). The FOM is considered as the possibility that a lesion rating skips all non-lesion 
localisation ratings on normal images (Ruschin, Timberg and Båth, 2007a). 
3.5.1 Constructing Curves from FROC Data  
In FROC, the observer’s task is to search the image and mark areas, which are expected to have 
lesions. The ROC curve can be computed in a similar process to those for the FROC curve. 
Nevertheless, they are normalised to a different denominator. The LLF is normalised to the 
number of lesions whereas the NLF stays normalised to the number of cases. The significant 
variation between accounts of the operating points for the FROC curve is that it covers all of 
the ratings that are made for each image within its calculations, whereas the ROC curve only 
considers the highest ratings.   
The overriding value of observer performance studies is the calculation of a figure of merit 
(FOM) to summarise the performance of the imaging system and observer, which rewards 
correct decisions and penalises wrong decisions. It provides a single value summarising 
performance which can be compared statistically. For instance, to compare two types of 
imaging systems, one calculates a FOM for each method and a statistical test is performed to 
identify the difference between two FOMs and whether the difference is considered large 
enough to be different in consideration of the pre-test value of alpha (Chakraborty, 2011). The 
value of probability is quantified by the p-value (Chakraborty, 2011) When the p-value is 
smaller than 0.05, one deduces that there is a significant statistical performance variation 
between two modalities - a difference greater than would be expected by chance alone. The 
calculation of the overall regions of interests (ROIs) produces the nonparametric area under the 
curve (AUC) of a receiver operating characteristic curve known as a figure of merit (FOM) 
(Chakraborty et al. 2011). 
The AFROC curve is represented as the plot of LLF versus FPF. It can be noted that the 
difference between the ROC curve and AFROC curve is just in the descriptions of the y-axes, 
which means TPF versus LLF. Lesion localisation can be distinguished in good assessments 
by using the FOM or the area under the AFROC curve while non-lesion localisations on the 
normal image can be penalised to different marks. For instance, an upper rated FP is penalised 
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more than a lesser rated FP. Figure 3.4 demonstrates use of the FROC method to localise breast 
lesions. In the FROC method, two different types of the curve can be generated: the FROC 
curve and the alternative FROC (AFROC) curve. On the FROC curve the y-axis is normalised 
to the number of lesions (LLF) rather than the number of abnormal cases, as in ROC analysis. 
Thus, ROC is a case based analysis and the observers make case based decisions, whereas 
FROC is lesion based analysis.  
  
3.4(A)                                                                 3.4 (B) 
Figure 3.4 The use of FROC methods to localise breast lesions 
(A) 5 confidence levels and other available functions (Chakraborty, 2002).  
(B) ROCView tools utilised within in this study 
 
3.5.2 FROC Data Analysis  
An increase in the number of observers that read or assess the same image set, leads to an 
increase in the statistical power of the study. This procedure is known as the multi-reader multi 
cases (MRMC) method. Furthermore, an increase in the number of cases in the study leads to 
an increase in the statistical efficiency. JAFROC analysis successfully overcomes obstacles 
such as the limitations in the classical ROC method, through the use of the multi-reader multi 
cases method (Federica Zanca et al., 2012). The JAFROC figure of merit refers to the 
probability that lesions ratings (LL marks) are rated higher than all noise sites (NL marks) on 
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normal images (Chakraborty & Berbaum, 2004). There are two approaches for MRMC 
analysis, (i) the Obuchowski-Rockette (OR) method and (ii) the Dorfman-Berbaum-Metz 
(DBM) method. The OR and DBM methods are equivalent and are precisely equal when the 
jackknife method is utilised (Hillis, Berbaum, & Metz, 2008). The DBM-MRMC process is a 
widely utilised method in ROC analysis, whereas the AUC (Area under the curve) is utilised 
as the FOM and data are analysed utilising analysis of variance (ANOVA) (Obuchowski et al., 
2004; Buissink et al., 2014). The DBM method distinguishes between the variables of case 
difference and the variance within and among observers to evaluate whether the observed 
difference is caused by the observers or by the cases of the study. This is known as the jackknife 
method, where pseudovalues are computed  by systematically excluding one case at a time and 
then searching the variance in accuracy assessments between the evaluation of all data and with 
that case excluded (Chakraborty, 2010a).  
3.5.3 Jackknife Analysis of FROC Data (JAFROC) 
The JAFROC method is the equivalent method for analysing free-response rating data and the 
JAFROC figure of merit refers to the probability that lesions ratings (LL marks) are rated 
higher than all noise sites (NL marks) on normal images. The JAFROC figure of merit is the 
trapezoidal under the AFROC curve, θ. The JAFROC figure of merit can be described by 
equation 4: 
ߠ ൌ ଵேಿ		ேಽ 		∑ ∑ ߰ሺ ௜ܺ
ேಽ௝ୀଵ
ேಿ௜ୀଵ , ௝ܻ	ሻ…………….. (3.4) 
Where Xi is the maximum noise rating (mark on a normal case) for a case i, Yj is the rating for 
the jth lesion, NN is the number of normal cases, and NL is the number of lesions. The psi (ψ) 
function is the comparison of the highest rated noise rating and the lesion rating (Chakraborty, 
2010c). For the ψ function, if Xi (abnormal) is greater than Yj (normal) then ψ=1; if Xi is less 
than Yj, then ψ=0; if they are equal ψ=0.5 (Chakraborty, 2010b). 
Chakraborty et al., (2006) illustrated that the statistical power of JAFROC is greater than the 
statistical ability of the previous ROC methods (Chakraborty and Berbaum, 2004). JAFROC 
was developed as a multi-reader, multi-cases process in order to be able to deal with the 
limitations in the classic ROC method. The statistical power of diagnostic performance of 
JAFROC analysis is increased according to the sample size, in comparison with ROC.  
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The similarities are recognised by the pseudovalue denotation in JAFROC analysis (Equation 
5): 
ܲ ௜ܸ௝௞ ൌ 	்ܰߠ݆݅ െ ሺ்ܰ െ 1ሻߠ	௜௝ሺ௞ሻ  …………… (3.5) 
Where the pseudovalue for each modality i, observer j and case k is defined by PVijk, NT is the 
total number of cases, θij is the figure of merit for modality i and observer j for all data, and 
θij(k) is the figure of merit with case k removed – identifying the dependence of each case 
(Chakraborty and Berbaum, 2004).  
3.6 Perceptual Measures 
When comparing methods of image quality assessment, perceptual and physical methods, 
perception methods are considered more helpful to determine diagnostic abilities than objective 
methods (Goossens et al., 2013). However, some human observer studies, such as two alternate 
forced choice (2AFC), may be time consuming, and therefore expensive, so supplementary 
objective measures are helpful to support human observer studies (E. Burgess, 1994; Richard 
and Siewerdsen, 2008). The 2AFC method can be utilised to compare the subtle variances 
between the performances of different imaging modalities (Burgess, 2011). Revesz et al., 
(1974) calculated the conspicuity of lung nodules. Image observers were requested to find the 
existence of a lesion and localise it. They concluded that the computed conspicuity correlated 
with the possibility to detect an abnormality within a limited range of conspicuity values. Samei 
et al., (2003) calculated the contrast-diameter product, according to local anatomical noise, and 
concluded a correlation between the ability to detect lesions and this measure. However, 
attempting to find a correlation between human observer studies and objective measures has 
not proved successful (Samei et al., 2003). Manning et al., (2002) demonstrated a poor 
relationship between the measure of conspicuity index and undetected lesions in chest 
radiography and pointed out that decision errors were more common detection errors. 
However, it must be noted that the study size was small, and only four regions around the lesion 
(four profiles) were used which means that the computing of conspicuity had some limitations. 
The study also included other categories of observer error as initially mentioned by Kundel et 
al., (1974) (Manning and Ethell, 2002). Mello-Thoms et al. (2005) demonstrated, through an 
eye tracking study, that undetected lesions predominantly received sufficient visual attention. 
Other eye tracking studies such as (Chesters, 1992; Manning, Ethell and Donovan, 2004a; 
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Mello-Thoms, 2006) demonstrated that lesion conspicuity, or the period of time it is viewed, 
is not the only reason they go undetected.  Mello-Thoms et al., (2005) assessed the effects of 
breast masses’ conspicuity on the decision outcome of the observers. They suggested that 
breast mass conspicuity has an impact on the visual search in a mammography reading. They 
compared the visual search strategy utilised by an expert in mammography and concluded that 
most undetected malignant masses did attract a certain amount of visual attention; nevertheless, 
it was in the processing of the produced information in the lesion location that most errors 
happened. In summary, errors in Radiology are unlimited to observers missing lesions because 
they are poorly clarified; it is valuable to inform efforts to enhance the radiological task with 
calculated image quality that utilise functional data on visual performance (Mello-Thoms et 
al., 2005). 
 
3.7 The Physical Measures of Mammographic Images  
The image quality of mammographic images can be assessed in several methods. Medical 
imaging devices are quality controlled utilising structured phantoms; measures such as spatial 
resolution, in terms of modulation transfer function (MTF), signal to noise ratio (SNR) and 
contrast to noise ratio (CNR) are utilised to assess if the equipment is working within 
acceptable performance standards (Samei, 2003; NHSBSP Equipment Report, 2007). 
However, these physical parameters are not exemplifications of a diagnostic image and their 
output measure is not related to any particular radiological task (Samei, 2003). Therefore, there 
is a requirement that these measures (SNR and CNR), and other parameters, are utilised to 
determine the effect of image quality on detection performance and to provide support 
investigations about the influence of physical measures on visual appearance of lesion futures 
within the images (Desai, Singh & Valentino, 2010). Other parameters such as the conspicuity 
of lesions, the size and contrast of lesions is helpful to characterise lesion features (Manning et 
al., 2004a).           
3.7.1 Measuring Conspicuity Index   
Initially, conspicuity was introduced as a concept to quantify errors made by observers in 
radiology. The conspicuity of a lesion represents a ratio between the contrast of a lesion and its 
surrounding complexity. A study by Kundel et al., (1976), introduced a new method to describe 
and determine the conspicuity of the lesion. They utilised a measurement of lesion conspicuity 
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to describe the probability of detection of a lung nodule in the chest X-ray. The lesion contrast 
is represented by the density alteration around the lesion edge, while the surrounding 
complexity is the rate of change of the density around the lesion border. This produces a 
description of anatomical, or structural, noise which puts into consideration the surrounding 
structures and artefacts. However, Szczepura & Manning, (2016) identified that this equation 
does not take into account other characteristics that can affect lesion conspicuity such as noise, 
contrast and lesion size. 
In observer studies, Likert scales are commonly utilised in attempts to measure conspicuity, 
whilst drawing comparisons between different acquisition parameters or utilising varying 
contrast agents (Van Ravesteijn et al., 2013; Marin et al., 2013). The Likert scales within these 
studies were quite different in terms of the number of points included on the scale and terms 
set for each point. This means that the scale is entirely task dependant. However, Likert scales 
are open to bias as both cognitive and perceptual errors may become involved within the task, 
as such the use of Likert scales is not an ideal measure of conspicuity (Weiner, 2010). 
Conspicuity can be measured utilising just noticeable difference techniques, such as two 2AFC 
methods, which the task of the observer is to select between two images. The first image is 
known as a static reference image and the other differs based on the research question being 
asked. According to the design technique of the studies, this method is more likely to be un-
bias than Likert scales and has a low variability (Szczepura & Manning, 2016). The 2AFC 
method requires a considerable group of images and is time consuming, according to the 
number of observers that are required; this leads to raise the cost of the study. Furthermore, the 
observer can be asked a number of questions via 2AFC, not only about conspicuity, which can 
lead to the obtainment of a more complex depth of data (Burgess, 2011). In 2AFC, the order 
of data should be taken into account. This means a creation of ordinal data, where the images 
are arranged in order, and the variance between the ranks are presumed to be equal. Thus, the 
outcomes are in accordance to the dataset utilised within the study. Brook et al., (2013) and 
Chang et al., (2013) utilised region of interest data to evaluate conspicuity with a comparison 
made between the lesion and its surrounding background. In spite of being an objective method 
to quantify lesion conspicuity, it does consider other factors such as sharpness and lesion size, 
which affect the conspicuity of a lesion.    
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3.7.2 Factors Affecting Conspicuity 
Szczepura & Manning, (2016) summarised the factors affecting lesion conspicuity; these 
factors are the; sharpness of the edges, lesion size, structural noise (within and surrounding a 
lesion) and contrast. Following is a review each of these factors individually: 
3.7.2.1	Sharpness	
Sharpness means the capability of the system to demonstrate distinctive anatomical structures 
within the object being imaged (Samei, 2003). For example, the sharpness of the edge of a 
lesion is important because it affects its visibility. There are mathematical methods to quantify 
the sharpness of system. Point and line spread functions and their Fourier transform, the MTF, 
all measure the resolving ability (Samei, 2003) or spatial resolution of a system. They take a 
number of things into consideration that can lead to blurring of borders, such as: the poly 
energetic beam, focal spot size and any magnification. Blurring can also occur because of 
movement of the imaging system or patient. Blurring is the reason behind reduction of visibility 
of fine details, decreased spatial resolution and minimal sharpness of image.  
3.7.2.2	Lesion	Size	
The size of a focal lesion is a significant factor used to determine the conspicuity of a lesion. A  
study by Plöckinger (2012) demonstrated that small lesions, of less than 1cm, can be undetected 
when imaged by 2-dimensional images (Plöckinger, 2012). According to Delrue et al., (2011) 
3mm is considered the threshold size limit for perceiving a lesion. If the edges of the tested 
object are parallel to the X-ray beam, or when the borders are bevelled (either caused by blur, 
or anatomical reasons) then this affects the visible threshold size (Delrue, Gosselin & Ilsen, 
2011). Birdwell et al., (2001) demonstrated that in mammography about 81% of undetected 
lesions in their study were less than 20mm. In addition, a study by Michealson et al., (2008) 
demonstrated that the median size of detected lesions by screening mammography was 7mm, 
with 40% of lesions measuring 5mm (Michealson et al., 2008). Anatomical structure 
superimposition: during the measurement of contrast to noise ratio or signal to noise, the noise 
is commonly calculated from a background that does not involve complex surrounding 
structures; thereby these complexities that affect the lesion detection can be unrecognised with 
these standard measures (Eckstein and Whiting, 1995).    
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3.7.2.3	Noise	
Noise refers to undesirable changes within an image that do not exist within the imaged subject. 
(Samei, 2003), when considering lesion conspicuity, said there are two types of noise that 
should be taken into account, radiographic noise and structural noise. Radiographic noise can 
be calculated utilising SNR, and offers information about the capability of the system, 
nevertheless it does not give the full information about the noise within a clinical image. It is 
stochastic in nature and due to several factors, such as the detector capability and the exposure 
factors utilised (Samei, 2003). Radiographic noise, however, is not dependent on the subject 
being imaged (Szczepura & Manning, 2016). During the explanation of radiographic noise, 
two terms should be clarified: absolute noise and relative noise. The term noise is commonly 
utilised to describe both quantities, (relative and absolute). Relative noise represents the 
amount of image changes relevant to the signal existing in the image; for instance, it is equal 
pixel standard deviation divided by mean signal. Relative noise represents the relevant factor 
in the detection of lesions. When unqualified, the term noise is predominantly referring to 
relative noise whilst absolute noise is referring to the absolute amount of changes within the 
image, which equals pixel standard deviation (Samei, 2003). 
3.7.2.4	Contrast	
Contrast is an important measurement of the diagnostic ability of a device. SNR and CNR are 
standard measurements used to characterise this within the clinical evaluation of images and in 
quality control. They refer to the variance in signal amplitude between the lesion and the 
background (Michaelson et al., 2003). Both SNR and CNR are utilised as an objective measure 
of the image quality. Calculations are made based on the signal of the abnormality and the 
signal of the surrounding regions; this data is then utilised to measure either the SNR or the 
CNR.  
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Chapter Four: Methodology 
4.1 Chapter Overview   
This chapter gives an overview of methods used in the thesis. The chapter commences by 
outlining the design of the free-response study and how simulated motion blur was applied to 
the FFDM images. The study comprised of 8 logical steps, using five different software 
applications; each having a specific function in the study.  
Step 1: Image selection- In the first step it was necessary to identify a selection of suitable 
FFDM mammography images with half of them containing disease (malignant mass or 
microcalcification) and the remaining half being disease free. The cases were selected via a 
retrospective review of 420 cases from a single UK Hospital Trust. 
Step 2: Image assessment- The selected images were assessed by an experienced reporting 
consultant radiographer with two purposes in mind (i) to ensure that the images were free from 
motion blur, and (ii) to confirm the precise anatomical location of all malignant lesions.  
Step 3: Applying and validating simulated motion blur- Novel mathematical simulation 
software was used to mimic the effect of blurring produced by breast movement during image 
acquisition. Different magnitudes of simulated blurring were applied to the images. A face 
validity check was performed with 8 mammography practitioners. This was done to establish 
whether a difference in appearance could be detected between simulated blur and real blur.  
Step 4: Observer performance study- The design of the free-response study gave due 
consideration to sample size, in order to produce a statistically powerful outcome. Other aspects 
to consider included data collection, monitor specification, ambient lighting, fatigue, case 
memory, training, the truth status (location of disease) of the images, and the acceptable level 
of error for localisation. 
Step 5: Statistical analysis- Data analysis of free-response data was performed using Rjafroc 
(Chakraborty and Zhai, 2015); where I also used alternative FOMs to provide values of 
sensitivity (FOM = HrSe) and specificity (FOM = HrSp). A method is also described for 
combining data to represent the dual reporting that occurs in clinical practice in the UK. 
Step 6: Lesion conspicuity (Masses) - Conspicuity software was used examine the physical 
parameters of malignant lesions; this included the conspicuity index, edge angle, contrast, and 
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SNR. The objective is to identify a relationship between physical parameters, lesion 
detectability, and the impact of different magnitudes of simulated blurring. 
Step 7: Dispersion Index (Microcalcifications)- It is not possible to evaluate conspicuity for 
very small objects. A Dispersion Index (DI) is proposed to evaluate the detectability of 
microcalcifications: this accounts for the spread of microcalcifications (units of distance), 
contrast, and SNR.  
Step 8: Missed lesion analysis- This was completed in an attempt to establish a reason why 
observers failed to detect lesions, and where the changes in detection occurred because of 
image blurring. The following question was posed: What affects the ability of the observer to 
differentiate/characterise lesions into benign and malignant categories? The method for this 
thesis is summarised into the following steps (Figure 4.1). 
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Figure 4.1 Key Steps within thesis methodology 
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4.2 Step 1: Image Selection	
In total, 420 retrospective cases were provided by the Predicting of Cancer at Screening 
(PROCAS) data set under the supervision of a Hospital Trust; ethical approval was granted via 
organisational management consent (Appendices A, B & C). Each case included four images 
(Right and Left CC and MLO), 150 of these cases were classified as normal and 270 cases 
were reported as abnormal and contained biopsy proven cancers. The abnormal cases were 
further classified into microcalcifications (120 cases) and masses (150 cases). All abnormal 
cases were evaluated by a reporting consultant radiographer with 17 years reporting experience 
to confirm the presence and precise location and disease and to determine (i) the distribution 
of different types of breast cancer (according to shape, size, and distribution) and (ii) breast 
density within this sample. The Breast Imaging-Reporting and Data System (BI-RADS) was 
used to categorise cancers by shape, distribution, and size of lesion. This reporting consultant 
radiographer also assessed the images to ensure that they were free from motion blur. Tables 
of the Collected Data (see section 4.12) demonstrate the features mammographic images (view 
of image, breast density, and number of lesion per image). The characteristics of malignant 
breast masses with different shapes of margins, lesions’ BI-RADS and sizes of lesions are 
presented in (Appendix G). 
The GE Seno Essential FFDM system was used to acquire images for all the cases in the 
PROCAS dataset. This FFDM unit has a 23x19.2 cm2 field of view, alpha-Si flat panel coupled 
with a CsI (Tl) scintillator image receptor with 100-micron pixel size and spatial resolution of 
7.1 lp/mm; this conforms to the standards of the UK Breast Screening Programme. This system 
was operating within the NHSBSP quality assurance guidelines for mammography quality 
control in the UK (NHSBSP Publication No 60, 2005; NHSBSP Publication No 63, 2006; 
NHSBSP Publication  No 59, 2011). The working principle of the FFDM machine has been 
discussed in Chapter 2.  
4.3 Step 2: Image Assessment  
The normal images were previously formally reviewed and identified as normal through the 
standard NHS Breast Screening Programme double reading process by two breast imaging 
professionals. In addition, two different breast imaging professionals verified the images were 
correctly classified as normal. The verification task was conducted with ambient lighting levels 
set to less than 10 lux, being similar to hospital reporting rooms.      
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Artefact-free mammographic images were selected from a set of FFDM images. The images 
were assessed visually to ensure that all anatomical structures had distinct /sharp edges. Two 
clinicians classified the images and then subdivided according to the following criteria: 
a) Type of lesion (malignant microcalcification and malignant masses) 
b) Lesion localisation (determining the location of the lesion within the breast and marking 
the lesion) 
c) Denoting whether the image is sharp/unsharp (free of motion blur or not) 
d) Identifying lesion size (measurement the size and create the acceptance radius).  
e) Determining the lesion BI-RADS according to suspicion suspicious of malignancy of 
breast lesion.  
f) The breast density: the images were subdivided into four groups according to BI-
RADS. 
When denoting whether the image was sharp or unsharp the two clinicians took the following 
into consideration (Taplin et al. 2002; European Commission 1996): 
a) Visualisation of pectoral muscle margin fibrous strands and all vessels should be sharp 
(absence of movement) 
b) Visually sharp medial breast tissue and lateral glandular tissue.  
c) Visualisation of skin structure along the pectoral muscles should be sharp.  
d) Visualisation of the retroglandular fat tissue and skin outline should be sharp.  
 
4.4 Step 3: Applying & Validating Simulated Motion Blur 
A mathematical model was used to simulate motion in the FFDM images (Ma et al., 2015). 
Simulated motion blur was applied using a convolution mask that provided a 3 standard 
deviation (3SD) distribution of blur over the desired blur radius. The 3SD range is consistent 
with the application of a Gaussian blur mask, typically used to generate generic blur effects 
(equivalent to a semi-transparent film being placed over an image). However, the Gaussian 
distribution profile did not match the characteristics of a typical blur effect. To determine an 
appropriate blur distribution function a simulation of image pixel motion, under elastic 
restitution, was made. This allowed an individual pixel to be displaced by a random vector 
(within the range of the blur effect) and the pixel contribution to the overall image sampled by 
sub-steps, as the pixel returned to the central position. Sampling of the motion pixel was 
enacted as a pixel sized Gaussian distribution within a super-sampled image frame to allow for 
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fractional motion within each sub-step. Repeated iterations of this process enabled a 
representative distribution profile to be generated that showed a sharper central peak, more 
rapid initial distribution decay, and longer continuation, than with a traditional Gaussian 
function. Multiple applications of the simulation were made to define an average distribution 
function. To ensure that the intensity window of the pixel values remained the same after 
blurring, the pre-blurring minimum and maximum pixel intensities were corrected post-
blurring through intensity scale and shift. 
Ma et al. (2014) suggested that paddle motion could be one source of motion blur. They 
concluded that the extent of paddle motion, through acquisition of mammographic images, 
could be as much as 1.5 mm in the vertical plane. Ma et al. (2015) illustrated that simulated 
motion blur at 0.7 mm is the minimum amount of simulated breast movement required for 
visual detection of blurring. Therefore, the minimum and maximum visual levels for blurring 
were selected as 0.7mm and 1.5mm respectively. Figure 4.2 shows an example of FFDM 
images, with and without simulated blur imposed.  
 
Figure 4.2 Example of FFDM images with two levels of simulated blur and without simulated blur 
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4.4.1 The Convolution-based Operations and Blurring masks 
The fundamental process in image processing is a digital convolution in the spatial domain and 
is utilised to either sharpen or smooth an image. It includes a “shift” and a “sum-of-products” 
operation.  The main concept is that a kernel or mask, principally a matrix of k × k elements, 
is rotated by 180° and animated in a bitmap model across an input image of M×M pixels; k is 
normally an odd integer, considerably lesser than the linear size of the image. Every pixel of 
the output image is the weighted sum of the input pixels within an area known via the mask, 
with the elements of the mask which set the weights (Tobergte & Curtis, 2013).  
When the input image is F (of size M×M), and the convolution mask is H (size k × k), the 
output image G is given by: 
ܩ ൌ 									ܨ	∗	ܪ            ………… (4.1)         
                              
The above mathematical process is demonstrated in Figure 4.3. The mask is rotated by 180° 
and is placed on top of the input image beginning at the upper left position. The mask 
components are doubled by the corresponding pixel value in the image beneath and the outputs 
are summed and normalised to create a measured restraint, which is the value of the product 
pixel at the placement congruous to the middle of the mask. Nearly all the mask k is selected 
to be odd so that the middle of the mask is readily visible. After that, the mask is moved one 
place to the right, the total of products re-studied and normalised to show the following pixel 
amount in the production image. This operation is reduplicated as the mask is passed towards 
the inserted image in a raster scan (Tobergte & Curtis, 2013).  
 
Predominantly, the “sum-of-products” formulation can result in pixel overflow. Normalisation, 
by dividing the total of the mask components, produces a weighted response that stays within 
the initial range of pixel values in the input image. The product of output image pixels 
predominantly have non-integral values. Therefore, working with floating-point numbers is 
important to avoid “round-off” errors (Young et al., 2008).  
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Figure 4.3 Digital convolution: the mask is put on the original image, mask components are multiplied 
pixel values, and the outcomes added to form an output pixel (Tobergte & Curtis 2013). 
 
The primary rotation of the mask through 180° is not obvious when the mask is circularly 
symmetric, as it is for several common masks utilised in sharpening and smoothing.   However, 
this is not usually the case for the masks utilised in locating vertical and horizontal edges in an 
image. This initial rotation is what distinguishes correlation from convolution. The cross-
correlation includes two images that are approximately similar sizes, while the sum of product, 
scanning and replacement processes happens without the initial 180° rotation.  The outcomes 
of the cross-correlation function are utilised predominantly for locating the characteristics of 
one image that appears in another and can be utilised for registering or aligning images.  
Gedraite & Hadad, (2011) and  Fallis, (2013) demonstrated that the pixels surrounding the 
boundaries of the input image have deficiency a full series of neighbours. For convolution with 
a 3 × 3 mask this includes pixels in a boundary one pixel wide surrounding the input image, 
while for convolution with a 5 × 5 mask, the boundaries are two pixels wide, and so on. It is 
not an important problem if k is much smaller than M. It can be alleviated through extending 
image (A) using different techniques such as repeating its boundary pixels, or stuffing it out 
with zeroes or considering that the input image wraps surround the vertical and horizontal 
trends (cyclic convolution). The complexity calculation for the convolution of an image of 
M×M pixels with a mask of size k × k is the organisation of k 2 per pixel, according to the 
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number of multiply and-adds (MADDs). This can lead to problems for big masks, like this 
alternative process to convolution utilising calculations within the spatial frequency field. 
Gaussian blurring is commonly utilised in graphics software to change image quality and to 
reduce fine detail and image noise. However, the simulated motion blur in this thesis is based 
on a real motion of the subject through the capture time of the pixel. Therefore, it is not 
appropriate to replicate the features of blur viewed in this type of image (Ma et al., 2015).  
Despite the convolution mask utilised in the Gaussian blurring method, the same magnitude of 
simulated motion blur is used as with the soft edge method, it is creates a larger distribution of 
the pixel intensity through a more gradual spread of the function within the specific motion. 
The simulation technique, which has been implemented by replicating the motion of the subject 
as a stochastic sampling procedure, illustrates that the profile of distribution within a motion-
based blur is described by a function in which the intensity drop-off is much more rapid (Ma 
et al., 2015). This shows that the same level of simulated motion applied by a Gaussian-based 
function produces a larger level of visual blur than the estimated mask used in this thesis 
proposes. This explains the reason why the human visual system is more sensitive to the 
Gaussian blurring method at smaller magnitudes.   
The visual impact of the smooth blur of the Gaussian technique is similar to displaying the 
image using a translucent screen (Yap et al., 2003). On the other hand, computer vision 
algorithms use Gaussian smoothing as a pre-processing stage to enhance image constructs at 
different scales (Yap et al., 2003). Applying the Gaussian blur to an image mathematically is 
similar to convolving the image with a Gaussian function. Figure 4.4 shows a wireframe image 
of two-dimensional Gaussian function (Ma et al., 2015). It has the impact of decreasing the 
high-frequency of image structures; therefore, a Gaussian blur acts as a low pass filter (Waltz 
& Miller, 1998).  
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                                 A                                                                              B 
Figure 4.4 (A) Demonstrates wireframe image of two-dimensional Gaussian (Ma et al., 2015)  
(B) Demonstrates Gaussian profile (one-dimensional) (Tobergte & Curtis, 2013) 
 
A simple example of the smoothing process is that of neighbourhood averaging; this means 
that every pixel in the output image is created from the average of the pixel values in a region 
around the pixel in the input image at that location. The mask that implements this is a k × k 
mask, with all coefficients equal to unity (Figure 4.5 (i) and (ii)) acting as constant pre-
multiplier of 1/k2; it is known as an averaging or box mask. The averaging procedure decreases 
the abrupt differences in local pixel values, smoothing the input image by decreasing its noise. 
A reduced smoothing effect can be obtained by utilising a weighted-average mask (Figure 
4.5(iii)). 
 
Figure 4.5 Shows different convolution masks; (i) averaging mask (3x3); (ii) averaging mask (5x5);  
(iii) weighted-average mask (3x3) (Tobergte & Curtis, 2013). 
 
According to Fallis (2013), the fact that the averaging mask blurs the edges in an image is a 
significant drawback. However, smoothing an image can minimise the signal-to-noise ratio and 
shift the grey-level histogram of the images. Therefore, there are many advantages of this 
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operation. One function of smoothing is to blur out features smaller than the mask. In addition, 
smoothing can be helpful as a precursor to segmentation of an image into a region of interest. 
Furthermore, it can be utilised as a mask to smooth out the false contours that can happen in 
images obtained with an inadequate number of grey levels. In practice, the size of the mask, k, 
must be larger than or equal to 2w + 1 when characteristics of diameter (w) are to be blurred 
out; k must be lesser or equal to 2w − 1 when characteristics like these are to be retained while 
decreasing the overall noise. 
 The novel motion simulation software used in this thesis can be applied with 15 magnitudes, 
from 0.0 to 1.5 mm stepping through 0.1 mm increments. This produces a total of 15 images 
with different magnitudes of blur from each original image (no blur). Simulated motion blur 
was achieved mathematically via the accumulated pixel points moving randomly. The 
simulated motion blur software can add blurring equivalents to the actual motion to the 
mammographic images. This blurring has been created using image processing techniques to 
produce soft edge mask estimation (Dougherty, 2009). 
 
4.4.2 Validation Method for Simulated Motion Blur Software  
Simulated blur has been used as it is extremely difficult to control  and/or measure sub-
millimetre movement of the breast during mammography in a physical study.  Attempting to 
replicate motion in patients at the point of imaging would result in an unwanted and unethical 
increase in radiation dose. Since simulation was being performed, it was important to ensure 
that simulated motion blur gave the same appearance as real blur. A validation check was 
performed with 8 mammography practitioners who had been trained to recognise the 
appearance of real blur. The practitioners comprised mammography qualified radiographers, 
ranging from basic grade through advanced practitioner to consultant level. A forced choice 
study was prepared to evaluate the performance of practitioners in recognising simulated blur, 
and thus indicating the overall success of the procedure to simulate motion blur. The 
practitioners were informed that all images contained blur; either real or simulated and that 
they must decide which was present. 
Twenty images containing real blur and 20 images containing simulated blur were shown to 
the 8 practitioners in a different randomised order. The twenty images containing real blur had 
been selected by an expert in mammography reporting. These images contained a range of 
magnitudes of real blur, affecting different image features, including breasts of different shapes 
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and density. The twenty images containing simulated blur had two magnitudes of simulated 
blurring (10 at 0.7mm and 10 at 1.5mm). For images containing simulated blurring the average 
incorrect rate was 34% (SD=13.8); for real blur, the average incorrect rate was 34% (SD=20). 
The incorrect rate refers to the proportion of images incorrectly identified as either real blur or 
simulated blur. On this basis, it can be proposed that the visual appearance of simulated blur to 
be comparable to that of a real blur. 
 
4.5 Step 4: Observer Performance Study  
The free-response receiver operating characteristic (FROC) method has been determined to be 
the appropriate method as it accounts for the precise localisation of lesions and can deal with 
multiple decisions (localisations) per case. This is an advantage over traditional ROC methods 
that only permit a single rating to be applied to each case and do not distinguish between correct 
and incorrect identifications of pathology on abnormal cases. Several previous studies have 
applied FROC methods in detection studies in mammography (Obuchowski et al., 2000; 
Chakraborty & Berbaum, 2004; Bator & Chmielewski, 2008; Chakraborty, 2011; Biltawi, Al-
Najdawi & Tedmori, 2012; Zanca et al., 2012). In an FROC study the observer is instructed to 
localise all suspicious areas of the image, as defined by the task. In this thesis the observers are 
instructed to localise all lesions (masses or microcalcifications) that they believe may be 
malignant. For each localisation, the observers are required to provide a confidence rating. The 
higher the level of suspicion of malignancy, the higher the rating. The lower end of the rating 
scale can be used for lesions where the observer is unsure if the lesion is benign or malignant. 
One of the most important aspects of an observer study is to ensure that there is sufficient 
statistical power to ensure that the results of the study are meaningful. This requires a statistical 
power calculation based on several different criteria relating to the design of the study. 
Fortunately, this process has been made relatively straightforward with sample size estimation 
tables provided by Obuchowski (Obuchowski, 2000).The sample size calculation in this thesis 
was based on recruiting a minimum of 6 observers. All observers participate in the NHSBSP 
approved biannual external audit which evaluates their performance for difficult cases 
specifically selected by expert radiologists (Wivell et al., 2003; Van den Biggelaar et al., 2008). 
Local Directors of screenings would be notified of any outliers regarding poor performance. 
One of the difficulties in an observer study is getting the balance between a sufficient number 
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of abnormal cases to test the intervention proposed (in this case simulated motion blur) against 
the prevalence of disease in a clinical situation. It is nearly impossible to accurately represent 
the reality of a screening population, where the prevalence of disease is extremely low. The 
burden on the group of observers would be too high when trying to get a meaningful evaluation 
of detection performance in the presence of simulated blur. The primary outcome of the study 
is not to evaluate the performance of individual practitioners, but to test the impact of simulated 
blurring. This is a key concept to remember. 
It was decided that a 50:50 ratio of normal-to-abnormal images would be selected. This would 
ensure adequate variation in the type of lesion and the density of the breast. In total, 124 cases 
(62 normal, 62 abnormal) were selected for the evaluation of masses and the same number for 
microcalcifications. These would be displayed to each observer in the following three 
conditions (i) no simulated blur (0 mm) and two magnitudes of simulated blurring, (ii) 0.7 mm 
and, (iii) 1.5 mm. Overall, this would require three image evaluations, assessing 248 images 
on each occasion. These were reviewed visually to identify a range of BIRADS density grades 
and to ensure that the cases did not contain blurring. Cases were chosen from a bank of 300 to 
ensure a representative distribution of breast density (A=10%, B=40%, C=40%, D=10%) while 
also excluding cases where the pathology was too obvious to control difficulty and also 
excluding cases that contained artefacts other than blurring. Table (4.1) shows the number of 
cases used, with the normal distribution of population breast density.   
Table 4.1 Demonstrates the sample size of the images and the number of the observers with the normal 
distribution of the population of breast density for this study. 
Number 
of 
observers 
Number of 
images 
NO. OF 
Images 
Total sample size Breast density 
7 62 normal  62 breast 
masses 
124 A 12 
B 50 
C 50 
D 12 
7 62 normal 62 single 
calcification 
124 A 12 
B 50 
C 50 
D 12 
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It would have been acceptable to have one single set of normal images which could have been 
used in both FROC studies. However, a decision was taken to use two separate sets of normal 
images. This increased case variation which made for a study which more closely simulated 
clinical routine in breast screening. Microcalcifications and masses could have been included 
as one large dataset and then that dataset could have been split into two sub-sets for the observer 
study. This approach would have achieved the same outcome as the use of one dataset for micro 
calcifications and one for masses, however it was hypothesised that simulated image blurring 
may have a different impact on micocalcification and masses. Therefore, a decision was taken 
to separate the images into masses and microcalficiations dataset. Furthermore, the use of 
separate masses and microcalcifications datasets allowed for easier display and analysis. 
Importantly, observers were blinded to what the case mix was, in terms of microcalcifications 
and masses, and they did not know whether they were looking for microcalcifications or 
masses.  
The following factors were taken into account during the design of the protocol in order to 
reduce error and minimise unwanted variation. To minimise the influence of inter-observer 
variation, seven observers (advanced and consultant radiography mammography practitioners) 
with approximately similar years of experience (average 10 years’ experience reporting 
mammograms) participated in the study. The purpose of performing a multi-reader multi-case 
(MRMC) study is to decrease the effect of observer experience and variance in the difficulty 
of the interpreted images such that any observed variance between the compared modalities 
(magnitudes of simulated blurring) is not masked (Chakraborty, 2011b). The environment 
where image viewing occurs makes a contribution to the overall accuracy of the procedure 
(Gur et al., 2003). Viewing conditions were therefore carefully controlled, with ambient 
lighting set to be lower than 10 lux for all image evaluations. A 5-megapixel grey-scale 
reporting grade monitor (2560x2048, 21.3”EIZO RadiForce GS521-CL-LCD, 12-bit) was used 
to view the mammographic images for all aspects of the work (case selection, validation of 
simulated blurring, observer study). The monitor was calibrated prior to each image evaluation 
to the digital imaging and communications in medicine (DICOM) greyscale standard display 
function (GSDF) standard (Wilson et al., 2011). The images were presented in a random order 
to observers for both microcalcification and masses datasets. Observers were also blinded to 
the proportion / number of confirmed cancer cases within each dataset, whether blurring was 
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present or whether they were looking for microcalcifications or masses.  ROCView (Thompson 
et al., 2012) was used for image display and recording of free-response data. 
For the observer study, it is necessary to mark the true location of lesions (masses and 
microcalcifications) in each abnormal case. This was done using the data provided by the 
experienced image reader, as described in Step 1. This localisation data is saved in a database 
in ROCView and all subsequent localisations made by the observers are compared to these 
marks. The marks made by the observers are classified as true (lesion localisation, LL) or false 
(non-lesion localisation, NL) by a proximity criterion, which in this case is an acceptance 
radius. The size of the acceptance radius has been determined by the size of the masses or the 
spread of the cluster of microcalcifications. The acceptance radius, was based on the largest 
lesion size (Chakraborty, 2011; Haygood et al., 2012) emanate from the centre of the lesion. 
The acceptance radius was set at 42 pixels  (11 mm) for masses and 50 pixels (13 mm) for 
microcalcifications. This was based on measurements made in ImageJ (Schindelin et al., 2012). 
If the localisation made by the observer is within the acceptance radius emanating from the 
centre of the true lesion, then the localisation will be considered as LL; otherwise it will be 
considered NL. All LL marks are stored in a database that indicates the observer number, 
modality (magnitude of simulated blurring), case number, lesion number, and the rating 
(confidence). All NL marks are stored in a separate database that indicates the observer 
number, modality, case number, and rating. Notice that there is no lesion number for the NL 
database as these all represent incorrect localisations, where no real lesion is present. 
The aims and objectives of the study were explained to all observers (Appendix H); those who 
agreed to take part were trained to use the software and how to using the rating scale to assign 
a confidence rating to localisation. Prior to their first evaluation, a 5-minute presentation was 
given to explain the difference between a mammographic report and the FROC study, and what 
was required from the observer. The observers were then able to familiarise themselves with 
the software and task with a training dataset of 15 cases, that were not used in the main study. 
The cases included different lesion types and different magnitudes of simulated blurring. 
Each abnormal image contained 1 or more lesions. The observers were asked to localise any 
areas of the image that they thought were suspicious of malignancy and then rate their suspicion 
of malignancy using a confidence scale. Figure 4.6 (A&B) demonstrates a mammographic 
image containing a malignant mass and demonstrates a scoring with a high level of confidence. 
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(A)The main image (scaled) demonstrates a mark that prompted the confidence scale to appear. 
(B) The image in the top right hand corner of the screen shows the main image at 100% size, 
without observer marks for a re-evaluation of uncertain areas.  
 
Figure 4.6 Screenshot of ROCView   
    
Figure 4. 6  (C) Confidence scale variant. 
Figure 4.6 (C) demonstrates the confidence scale variant. The observer clicks the mouse and 
the slider bar appears; the observer then rates their confidence from relatively low (left side of 
the bar) to high (right side of the bar) and can leave the cursor at any point in between these 
two points. A minimum period of 2-weeks was imposed between image evaluations to reduce 
the influence of case memory. Each observer completed the evaluations (0 mm, 0.7 mm, and 
1.5 mm) in a different order to reduce the dependence of evaluation order on the overall figure 
of merit (FOM). Observers interpreting the images then marked the suspicious locations in the 
image (Figure 4.7); the marked locations were checked against the true locations using the 
acceptance radius within ROCView. The raw data was then automatically collected into a log 
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file and exported to MS Excel, where it was transformed and saved as a text file to be analysed 
by the JAFROC software. In this way, the data was analysed very shortly after its production. 
 
Figure 4.7 A mammographic image containing malignant clustered microcalcification and the mark 
placed in the centre of the clusters using ROCView software. 
 
4.6 Step 5: Statistical Analysis   
The equally weighted jackknife alternative free-response receiver operating characteristic 
(wJAFROC) figure of merit (FOM) defines the empirical weighted probability that a lesion 
rating (LL) is rated higher than a non-lesion rating (NL) on a normal case (Chakraborty & 
Berbaum, 2004). The wJAFROC FOM is the equivalent to the trapezoidal area under the 
wAFROC curve. Chakraborty et al., (2006) demonstrated that the statistical power of JAFROC 
is greater than the statistical ability of the previous ROC methods. JAFROC has been developed 
as a solution to the analysis of MRMC data when it is desirable to account for the precise 
localisation of pathology.  The statistical power of the JAFROC analysis method can be 
measured by d-parameter. A low d-value means that it is comparatively difficult to identify a 
difference between two technique conditions while a high d-value is considered relatively easy 
to detect a contrast between each status (Chakraborty & Yoon, 2008). The statistical power of 
diagnostic performance of JAFROC analysis is increased according to the sample size, and this 
is something that does not happen with ROC. The JAFROC method requires an accurate 
response from the observer, which includes mark-rating of confidence information and lesion 
localisation for each suspicious lesion in the image (Zanca et al., 2012). The wAFROC curve 
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is determined as the plot of lesion localisation fraction (LLF) vs false positive fraction (FPF) 
plus a straight-line segment linking the uppermost operating point to (1, 1).  
4.6.1 Data Analysis for Single Observer Free-response Method 
Data analysis was performed using Rjafroc (Chakraborty & Zhai, 2015) where alternative 
FOMs were used to provide values of sensitivity (FOM = HrSe) and specificity (FOM = HrSp). 
Test alpha was set at 0.05 to control the probability of Type I error. The calculation of 
wJAFROC FOM is performed to reward true lesion localisations and penalise incorrect lesion 
localisations. It provides a single value summarising performance of single observer which can 
be compared statistically. For example, comparing two magnitudes of simulated blurring one 
calculates a FOM for each method and a statistical test is performed to identify the difference 
between the two FOMs. When the difference is large enough to be different in consideration 
of the pre-test value of alpha (0.05), then there is a statistical difference, if the result of the 
overall F-test is also significant (Chakraborty, 2011). The result of the overall F-test and the 
95% confidence interval (CI) of each pair of modalities must not include zero for a difference 
in detection performance to be considered significant. The F-statistics, the denominator degree 
of freedom (the numerator degree of freedom was always one) and the p-values. The observer 
averaged FOM and 95% CI will be reported for all magnitudes of simulated blurring. 
4.6.2 Data Analysis for Combined Observer Data Method 
The double reporting method in screening mammography involves two observers interpreting 
the same case independently (Taplin et al., 2000). The aim of the double method is to analyse 
the combined two observers’ reports in the same process in clinical practice (Tanaka et al., 
2015). Consequently, additional analysis method was conducted utilising the same data from 
FROC study obtained (248 cases) to determine the benefit of double reporting on lesion 
detection performance in sharp and blurred FFDM images. In this analysis method, the 
simulated double reporting evaluations were conducted by performing a comparison between 
free-response data from one observer, with combined free-response data from two observers. 
This is a secondary analysis of data from a first free response study which evaluates the impact 
of simulated motion blur on observer performance. The single observer analysis demonstrated 
a detrimental effect of simulated motion blur on the detection of masses and microcalcifications 
for the sample of seven observers. Secondary analysis of data was deemed important partly 
‘mimic’ this combined data result.  
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The observer study was split into two components: the evaluation of (i) microcalcifications and 
(ii) masses. Seven observers (15±5 years’ clinical reporting experience in mammography) have 
previously evaluated images with no simulated blurring (0 mm), and with 0.7 and 1.5 mm of 
simulate blurring. These have acted as the distinct modalities (1st, 2nd, and 3rd) that were 
compared statistically. In this secondary analysis of data, these three modalities have been 
combined. The 1st modality in the current work comprises of all observer data created for 
images of 0.0 mm, 0.7 mm, and 1.5 mm of simulated motion blur for six single observers. The 
2nd modality in the current study comprises of the combined observer data for the six single 
observers with each combined with an additional (seventh) observer. It has used the following 
rules to combine the data from the free-response study. For lesion localisations (LL) the highest 
rating for the two observers was adopted, regardless of whether one or both of the observers 
had successfully localised the lesion. For non-lesion localisations (NL) all unique data was 
maintained. This follows a similar method to the work of (Tanaka et al., 2015). The overall F-
test, p-values for FOM pairs (pairs of motion blur  levels), and the observer averaged FOM and 
95% confidence interval (CI) of double reporting for each magnitude of simulated motion blur  
are reported. The F-statistics, the denominator degree of freedom (the numerator degree of 
freedom was always one) and the p-values are also reported. The rating score in combined two 
observers’ data congruent cases was automatically assigned the highest rating provided by one 
of the two observers see (Table 4.2).  
 
 Table 4.2 Shows the single and combined two observers’ data assessments and the rating score for 
each case 
 Single 
observer 1 
Single 
observer 2 
Double 
observer  
Rating score  
Situation 1 True   True  True  Higher rating adopted 
Situation 2 True  False True  Rating of true observer  
Situation 3 False  True  True  Rating of true observer 
Situation 4 False False  Rejected  Rejected  
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4.7 Step 6: Lesion Conspicuity (Masses)   
Measuring the conspicuity of lesions attempts to characterise the visibility of a lesion in terms 
of the imaging systems diagnostic capabilities, and the lesion structure within the tissue 
surrounding it (Kundel et al., 1976). The purpose of this method is to identify physical 
parameters, such as lesion conspicuity, SNR, and lesion edge angle and the relationship they 
have with detection in the presence of different magnitudes of simulated motion blur. In 
addition, the behaviour of image blurring software has been evaluated. A new conspicuity 
software programme and associated Excel spread sheet has been used to perform objective 
measures of the expected visual detectability of focal breast lesions (masses) (Szczepura & 
Manning 2016). However, the conspicuity index using this software could not be applied to 
microcalcifications due to their individual size and their wide distribution pattern.  
Manning and Ethell, (2002) initially suggested a procedure to evaluate lesion conspicuity; this 
method combines the factors that define conspicuity into a single equation (Manning et al., 
2002). The conspicuity equation, which takes into consideration all factors that influence 
conspicuity of a lesion, depends on the appearance of the image characteristic to the visual 
system. Line profiles were built around a lesion, covering the immediate surrounding 
background and the equation for conspicuity measure was developed, and can be given by: 
χ ൌ ݀tanሾߠെ1ሿ∆ܩܮ
ටߪݏ2൅ߪ2݊
……………… (4.2) 
Where:   
χ = conspicuity index  
d = maximum lesion dimension 
θ = is the maximum slope angle to the edge of the lesion profile in degrees 
SNR	for	the	nodule ൌ ∆ܩܮ/ඥߪ௦ଶ ൅ ߪ௡ଶ	
σs = mean noise within the lesion 
σn= mean background noise 
A study by Manning et al., (2004) used the physical characteristic measurements of the lesions 
to determine the conspicuity (x) of the nodules and to investigate possible causes of false 
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detection. The term conspicuity helped to understand why some lesions are missed by the 
observers (Manning, Ethell & Donovan, 2004a).    
This part of the thesis is focused on the physical measures of mammographic images. It utilises 
a new software implementation by Szczepura and Manning, (2016) for measuring the 
conspicuity of lesions and other physical parameters, such as edge angles of lesions, contrast 
and SNR. The method is as follows: 
1. A JAVA based programme allows the operator to draw a region of interest (ROI) 
around a lesion (Figure 4.8) 
2. Line profiles are then drawn 180° surrounding the area of interest and are extended by 
one lesion dimension outside the drawn lesion (Figure 4.8) 
3. A fit is applied for every line profile (Figure 4.8 and Figure 4.9) wherein: 
a. The edges of the region of interest drawn by the operator are denoted by green 
lines  
b. The line profile is denoted by a blue line 
c. The plotted fit is denoted by a red line 
4. The regions of interest data sets are stored as TSV files in the same directory as the 
analysed images 
5. The image file name is labelled first, the region of interest second (starting at 0). 
6. The data is transferred from the TSV file into the Raw Data worksheet in the Excel 
spreadsheet. 
7. Conspicuity is automatically calculated in the conspicuity index worksheet (Table 4.3)  
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         A                                                        B 
Figure 4.8 The conspicuity software demonstrates the measurement of a breast mass. (A) Demonstrates 
the first stage through selecting the region of interest while (B) shows the second stage, where line 
profiles are drawn 180° surrounding the region of interest and are extended one lesion dimension 
outside the drawn lesion.  Only DICOM images can be utilised with this software. 
 
 
Figure 4.9 Line profiles are drawn 180° surrounding the region of interest. 
The X and Y are co-ordinates of each of the plotted fit edges (X0, Y0; X1, Y1; etc), the standard 
deviation of the Y values between X2 & X3 (SDTop) are utilised to represent the lesion noise 
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and the standard deviations of the Y values between X0 & X1 (SD1) and X4 & X5 (SD2) are 
utilised to represent the noise of background.  
  
Table 4.3 Illustrates the physical measures of breast lesion with three levels of simulated motion blur 
using conspicuity software 
Blur  
Level 
mm 
Conspicuity 
Index 
d (max 
lesion 
diameter) 
θ 
(degrees) 
ΔGL σ  
Lesion 
σ  
Background 
μ  
Lesion 
μ 
Background 
 
Cases 1 
   
0.0 51.631 24.450 63.765 88.903 42.734 69.744 192.939 104.036 
0.7 66.389 18.589 61.030 93.344 21.061 40.134 194.894 101.550 
1.5 74.993 17.133 59.797 93.600 16.109 31.417 194.417 100.817 
Cases 2 
0.0 71.577 42.183 69.151 69.483 60.864 82.009 178.011 108.528 
0.7 101.672 39.644 67.259 70.189 34.217 51.973 178.272 108.083 
1.5 110.622 38.578 66.415 69.886 27.714 45.491 178.044 108.158 
 
4.8 Step 7: Dispersion Index 
The second part of the physical measures analysis in this thesis is focused on the physical 
features of microcalcifications. ImageJ software was utilised for measuring a new metric, 
which has been called the Dispersion Index (D.I). Dispersion index of microcalcifications 
repsesents the number of calcifications within a specified area divided by the area (equation 
4.2). DI was measured because the conspicuity index could not be applied to 
microcalcifications due to their individual size and their wide distribution pattern. This takes 
into account the contrast of lesions, SNR and D.I. x contrast. The purpose of this method is to 
demonstrate the relationship between dispersion index, contrast, SNR and lesion detection. The 
aim was to assess the impact of simulated motion blur on the detection of microcalcifications. 
The method is as follows: 
1. A JAVA based programme (ImageJ) allows the operator to draw a region of interest (ROI) 
around a cluster of microcalcifications for three levels of simulated motion blur (Figure 4.10).  
2. The area of a cluster of microcalcifications will be measured using analysis tool manager 
of imageJ software (Figure 4.11 A). 
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3. The ROI data sets are stored as TSV files in the same directory as the analysed images 
(Figure 4.11 B). After that, the data is transferred from the TSV file into the Raw Data 
worksheet in the Excel spreadsheet to calculate the dispertion of microcalcifications. 
4. The number of microcalcifications per cluster are calculated manually by the operator for 
each image of with for three conditions: no motion blur  (0 mm) and two magnitudes of 
simulated motion blur 0.7 mm and 1.5 mm (Figure 4.12). A quality control test was performed 
to minimise error on this, two observers have counted them individually and were blinded to 
each other’s answers.  
5.    Dispersion index, lesion contrast and SNR are automatically calculated in the Excel 
worksheet (Table 4.4).  
 
The equation for the dispersion index measure was used and can be given by: 
D.I = C/A………… (4.3) 
Where:   
D.I = Dispersion Index 
C = the number of single calcifications per clustered 
A = Area of selected region of interest   
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Figure 4.10 The Imagej software demonstrates the measurement of breast microcalcification.  Shows 
the first stage for selecting the region of interest 
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A 
B   
Figure 4.11 (A) Demonstrates the step 2 of measurement of breast microcalcification using Imagej 
software. (B) demonstrates the regions of interest data sets are stored as TSV files in the same directory 
as the analysed images for three levels of simulated motion blur. 
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                   0.0 mm                                         0.7mm                                     1.5mm 
    
Figure 4.12 Demonstrates the same region of interest for clustered microcalcification for the three 
levels of simulated motion blur. 
 
 
 
Table 4.4 Demonstrates the physical measures of breast lesion with three levels of simulated motion 
blur using ImageJ software 
 
Area1 Mean1 StdDev1 Min1 Max1 Calc. 
NO. 
DI Contrast DI x 
Con 
SNR  Detect 
ability 
 Case 1  
0.0 mm  13.731 2609.767 62.231 2457 2933 11 0.801 0.890 0.220 41.937 1.00 
0.7 mm 13.731 2607.006 39.558 2544 2774 11 0.801 0.940 0.753 65.903 1.00 
1.5 mm 13.731 2604.941 32.185 2555 2718 11 0.801 0.958 0.768 80.936 0.85 
Case 2  
0.0 mm  23.549 2967.666 89.657 2702 3361 25 1.062 0.883 0.937 33.100 1.00 
0.7 mm 23.549 2966.361 73.434 2766 3191 25 1.062 0.930 0.987 40.395 1.00 
1.5 mm 23.549 2965.665 69.593 2776 3137 25 1.062 0.945 1.004 42.614 0.85 
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4.9 Step 8: Missed Lesion Calculation Method 
The calculation of missed lesions was used to identify the detectability of each lesion by each 
observer. A comprehensive table has been created to present a full detailed explanation to the 
seven observers on three levels of simulated motion blur. This table shows the sensitivity of 
each lesion for all images related to the each level of simulated motion blur (Table 4.11). The 
detectability of each lesion represents the number of observers detect the lesion divided on the 
total number of observers. For instance, when all the observers detected the lesions (7/7), this 
means that the percentage detecting the abnormality is 100% in 0.0 mm of motion blur. 
Whereas, if only six observers detected the lesion from seven (6/7) the detectability will be 
reduced to 85.8 % for 0.7 mm of simulated motion blur , and to 57.2% (4/7) for 1.5 mm of 
simulated motion blur  (see case 3 and case 5 Table 4.5).    
         Table 4.5 demonstrates the missed lesion calculation method 
 Observ
er 1 
Observe
r 2 
 
Observe
r 4 
 
Observe
r 5 
 
Observe
r  6 
 
Observe
r 7 
 
Observe
r 9 
Detectability of 
each lesion by the 
observers  
 0
.
0 
0
.
7 
1
.
5 
0
.
0 
0
.
7
1
.
5 
0
.
0 
0
.
7 
1
.
5 
0
.
0 
0
.
7
1
.
5
0
.
0
0
.
7
1
.
5
0
.
0
0
.
7
1
.
5
0
.
0
0
.
7
1
.
5
0.0 0.7  1.5 
1 ✓  ✓  X  ✓  ✓ X  ✓  ✓  X  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00 1.00  0.572 
2 ✓  ✓  X  ✓  ✓ ✓  ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00 1.00  0.850 
3 ✓  ✓  X  ✓  X X  ✓  ✓  ✓  ✓  ✓ X ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00 0.858  0.572 
4 X  X  X  ✓  ✓ X  ✓  X  X  ✓  X X X ✓ X ✓ ✓ X X X X 0.572 0.429  0.00 
5 ✓  ✓  X  ✓  X X  ✓  X  X  ✓  ✓ X ✓ X X X ✓ ✓ ✓ X X 0.858 0.429  0.143 
6 ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00 1.00  1.00 
7 ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00 1.00  1.00 
8 ✓  ✓  X  ✓  ✓ ✓  ✓  ✓  X  ✓  ✓ ✓ X ✓ X ✓ ✓ ✓ ✓ X X 1.00 0.858  0.429 
9 ✓  ✓  X  ✓  ✓ X  ✓  X  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ ✓ X 1.00 0.858  0.429 
1
0 
✓  ✓  X  ✓  X ✓  X  ✓  X  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ X X 1.00 0.715  0.429 
 
The mark (✓) represents the detected lesion while mark (X) represents the missed lesion. 
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4.10 Ethical Issues  
As this study involved human participation, special care must be paid to the rights of the 
participants (Polit and Beck, 2003). Ethical approval for this study was granted by the 
University of Salford (HSCR15-107) (Appendix A and B) and with consent from The 
University Hospital of North Manchester, Nightingale Centre (Appendix C). This was a 
retrospective study of breast screening images. Ethical approval has been provided by the 
University of Salford (UOS). Most of the observation sessions took place at the University of 
Salford medical imaging facility; the sessions included the explanation of the study using an 
information sheet (Appendix D) and an explanatory PowerPoint presentation (Appendix H). 
The observers were invited to participate in the study through several ways, such as Participant 
Invitation Letter (Appendix E) and Poster (Appendix F).  
All participants in this study signed a consent form before conducting the tasks. Participants 
were informed that the results of the study would be included in a research thesis, would be 
discussed at research conferences and published in peer-reviewed research journals. Data was 
anonymised and stored on a password protected computer. No financial reward or otherwise 
was offered. Participants were advised that their involvement may help to improve quality and 
raise awareness of the impact of motion blur on cancer detection performance. All the observers 
have received feedback on the outcomes of this study. They have received e-mail told them 
there was a statistically significant impact of motion blur on the detection performance of 
malignant masses and microcalcifications.    
The Data Protection Act (DPA) 1998 (Legislation.gov.uk, 1998) can be applied to all observer 
studies. Participants should be provided with adequate information about the study to enable 
them to make a decision to participate in a study. All participants must inform and know the 
target of the data collection, the period of the data can be kept and what will be achieved with 
the data when it has been completed.  
 
4.10.1 Ethical Approval in Observers’ Studies 
In general, ethical issues aim to ensure the integrity and interests of persons and adherence to 
standards. In the observer study implemented for this Ph.D. thesis, it was necessary to conserve 
the privacy of all the observers and to make sure that any collected data was not definable to 
them. Duquenoy et al., (2008) suggested that the ethical standards for electronic collection data 
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should be established in the code of ethics to ensure security, material quality, integrity, 
accessibility, and usability. Therefore, this thesis reviewed by the University of Salford 
Research and Ethics Committee, to protect the participants’ safety, rights, wellbeing, and 
dignity. This Committee is run by the University of Salford, but its members are not connected 
to the research they examine.   
The Declaration of Helsinki (World Medical Association, 2013) summed up the role of 
individuals participant in medical researches. The integrity and interests of the participants 
should be the primary concern through the study, and while this declaration mentions to 
participants as patients, the same standards must be utilised to those who participate as 
observers. According to (Duquenoy et al., 2008), the medical informatics require that the 
regulations in place ought to support the study, prevent the participants from experiencing 
danger and keep information confidential. This is applicable to the existing work. 
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4.11 Chapter Summary  
In summary, a novel mathematical simulation method has been designed to determine whether 
simulated motion blur has an influence on lesion detection performance using observer 
performance study.  The stages of this observation method can be summarised into several 
phases. First, suitable FFDM images were selected. Next, simulated motion was applied 
through a novel mathematical technique within computer software. Then, the mammographic 
images have been evaluated using an FROC method. Finally, JAFROC was used to analyse the 
data for assessing the impact of simulated motion blur on lesion detection performance.   
In this thesis, several additional methods have been used to manipulate the data. To start with, 
two methods were used to analyse the FROC data combined two observers’ data and single 
observer data (see the results chapter 5). After that, two physical methods have been applied to 
investigate the impact of simulated motion blur on the physical parameters of the breast masses 
using conspicuity software. ImageJ software was used to investigate the impact of motion blur 
on microcalcifications. Finally, the missed lesion calculated method has been utilised to 
determine the detectability for each lesion by each observer.  
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Chapter Five: Results 
5.1 Chapter Overview  
This chapter presents the results of the free response study. The presentation of results is 
organised into three main sections. The first section shows the results of seven observers (single 
reporting) of the free response study to determine the impact of simulated motion blur on the 
detection of malignant masses and malignant microcalcifications. The results demonstrate that 
there is a statistically significant influence of simulated motion blur on lesion detection 
performance between images without motion blur (0.0 mm) and images with  two levels of 
motion blur (0.7 and 1.5 mm) for masses and microcalcification.  
Section two presents the results of second analysis method; this is where two observers’ data 
have been combined in an attempt to mimic the double reporting method in screening 
mammography. The results of combining two observers’ data demonstrate that there is a 
reduction in the impact of motion blur on detection performance compared to single observer. 
However, there is still a statistically significant impact of simulated motion blur on lesion 
detection performance between three levels of simulated motion blur for masses and 
microcalcification. 
Section three involves a comparison between the detection performance of single observer and 
the detection performance of combining two observers’ data. The result of the third section 
demonstrates that there is a significant difference between single and combined two observers 
analysis of microcalcification lesions, whereas there no statistically significant difference for 
detection performance of masses. This means that the impact of simulated motion blur remains 
significant even when double reporting implemented.       
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5.2 Section One: Results of the Free-response Study 
5.2.1 Overview of wJAFROC Analysis 
An equally weighted jackknife alternative free-response receiver operating characteristic 
(wJAFROC) analysis was performed to analyse the detection of: (i) microcalcifications, and 
(ii) masses, for three conditions (0.0 mm (no motion blur), 0.7 mm simulated motion blur, 
and 1.5 mm simulated motion blur). Random observer random case analysis was reported for 
both analyses. 
For these analyses the following data has been reported: 
 F-statistic and p-value 
 Observer averaged wJAFROC figure-of-merit (FOM) for all conditions and 95% 
confidence intervals (CI) 
 Observer averaged sensitivity and specificity derived from the highest ratings 
 FOM difference and 95% CI for all treatments pairs of simulated motion blur 
 wAFROC curves for all magnitudes of simulated motion blur 
In this analysis, the free-response data for seven observers is reported. For a difference in 
detection performance to be declared statistically significant, the result of the overall F-test 
must be significant and the 95% confidence interval of the treatments pair must not include 
zero. 
 
5.2.2 Microcalcifications 
For microcalcifications, the observer averaged wJAFROC FOM and 95% confidence intervals 
(CIs) are displayed in Table (5.1). Differences between FOM treatment pairs are displayed in 
Figure 5.1, with the p-values to indicate significance. For a difference in FOMs to be declared 
significant, the 95% CI of the FOM treatment pairs must not include zero, in addition to the 
result of the overall F-test being significant. The observer averaged wAFROC curves for 
microcalcifications are displayed in Figure 5.2. 
When sensitivity (HrSe) was used as the FOM, a significant difference was found between all 
treatment pairs of magnitudes of simulated motion blur (F(2,18) = 10.48, p=0.0010). This 
implies that the false negative rate was increasing significantly as the magnitude of simulated 
motion blur was increased. When specificity (HrSp) was used as the FOM, there was no 
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significant difference between magnitudes of simulated motion blur (F(2,13) = 0.21, 
p=0.8110). This reveals that the false positive rate did not increase significantly with image 
blurring (Table 5.3). 
Average number of non-lesion localisation marks per observer on non-
diseased cases 
0.094 
Average number of non-lesion localisation marks per observer on 
diseased cases 
0.393 
Average number of lesion localisation marks per observer 0.888 
 
 
 
Table 5.1 Demonstrates a summary of the wJAFROC FOM with confidence interval (95% CI), 
sensitivity and specificity analysis for microcalcifications case. 
Higher sensitivity (HrSe) corresponds to higher negative predictive value and higher specificity 
(HrSp) corresponds to higher positive predictive value is the ideal property of a test. 
Magnitude of 
Simulated Motion 
blur  (mm) 
wJAFROC FOM 
(95% CI) 
Sensitivity %  
(HrSe) 
Specificity % 
(HrSp) 
0 mm 0.899 (0.859,0.939) 97.9 84.8 
0.7 mm 0.813 (0.757,0.870) 86.4 84.3 
1.5 mm 0.746 (0.679,0.812) 76.5 86.6 
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Table 5.2 Demonstrates the wJAFROC FOM with confidence interval (95% CI), sensitivity and 
specificity analysis for each observer for the image with no motion blur and two levels of simulated 
motion blur of microcalcifications. 
  
wJAFROC FOM  
 
Sensitivity % 
(HrSe) 
 
 
Specificity % 
(HrSp) 
Observer  0mm 0.7mm 1.5mm 0.0mm 0.7mm 1.5mm 0.0mm 0.7mm 1.5mm 
1 0.896 0.728 0.690 98.4 72.6 53.2 85.5 90.3 98.4 
2 0.937 0.818 0.813 100 96.8 90.3 93.5 83.9 91.9 
3 0.902 0.822 0.781 95.2 82.3 74.1 96.8 96.8 98.4 
4 0.885 0.799 0.715 100 79.0 59.7 91.3 87.1 87.1 
5 0.913 0.859 0.776 96.8 82.3 80.6 98.4 100 88.7 
6 0.902 0.874 0.782 95.2 93.5 83.9 96.8 88.6 87.1 
7 0.858 0.794 0.662 100 98.4 93.5 30.6 43.5 54.8 
Average 
 
0.899 0.813 0.746 97.7 86.4 76.5 84.8 84.3 86.6 
 
 
 
 
Table 5.3 Shows a comparison of the p-values difference between treatment pairs of average 
wJAFROC FOMs (95%) of single observer for microcalcification images. 
 
Magnitude of Simulated Motion 
blur  (mm) 
The p-value difference between two pairs of 
average wJAFROC FOM (95% CI) 
0.0 – 0.7 mm 0.0016    
0.0 – 1.5 mm 0.0000    
0.7 - 1.5 mm 0.0043    
Overall F-test & average 
wJAFROC FOM (95% CI) 
F (2, 12) = 18.13, p = 0.000)  
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Figure 5.1 Demonstrates the distribution of FOM difference and 95% CIs for all FOM treatment pairs 
in the analysis of microcalcifications (this is the same data as indicated in Table 5.3).  
 
This displays the inter-levels differences for the three treatment pairs (0.0 mm v 0.7 mm; 0.0 
mm v 1.5 mm; 0.7 mm v 1.5 mm) for the analysis of microcalcifications. For a difference to 
be declared statistically significant the 95% confidence interval of the treatment pair must not 
include zero and the overall F-test must be significant.  
 
 
Figure 5.2 Demonstrates the wAFROC curve of microcalcification cases with three levels of motion 
blur. The highest performance is represented in level 0.0 mm (blue line) and the performance decreased 
with increase motion blur 0.7 mm (red line). The lowest performance is represented in level 1.5 mm of 
motion blur (green line). 
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Figure 5.3  demonstrates the highest-rating inferred ROC curve of microcalcification for the image 
with no motion blur and two levels of simulated motion blur. 
 
 
 
 
Figure 5.4 The observers averaged FOM of microcalcifications for the image without motion blur and 
two levels of simulated motion blur. 
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5.2.3 Masses 
For masses, the observer averaged wJAFROC FOM and 95% confidence intervals (CIs) are 
displayed in Table 5.4. Differences between FOM treatment pairs (magnitudes of simulated 
motion blur) are displayed in (Table 5.5) with the p-values to indicate significance. The 
observer averaged wAFROC curves for masses are displayed in Figure 5.5. 
When sensitivity (HrSe) was used as the FOM, there was no significant difference between 
magnitudes of simulated motion blur (F (2, 16) = 0.43, p=0.6575). This implies that the false 
negative rate was not changing significantly as a result of simulated motion blur. When 
specificity (HrSp) was used as the FOM, again there was no significant difference between 
magnitudes of simulated motion blur (F (2, 12) = 1.31, p=0.3043) (see Table 5.5). 
Average number of non-lesion localisation marks per observer on non-
diseased cases 
0.217 
Average number of non-lesion localisation marks per observer on 
diseased cases 
0.211 
Average number of lesion localisation marks per observer 0.885 
 
 
 
Table 5.4 A summary of the wJAFROC analysis for masses. Shows the observer averaged wJAFROC 
FOM and 95% confidence intervals (CIs), Sensitivity % (HrSe) and Specificity % (HrSp).  
Higher sensitivity (HrSe) corresponds to higher negative predictive value and higher specificity 
(HrSp) corresponds to higher positive predictive value is the ideal property of a test. 
Magnitude of 
Simulated Motion 
blur  (mm) 
wJAFROC FOM 
(95% CI) 
Sensitivity % 
(HrSe) 
Specificity % 
(HrSp) 
0 0.905 (0.859,0.952) 92.3 82.7 
0.7 0.869 (0.814,0.924) 91.19 73.3 
1.5 0.862 (0.810,0.915) 90.5 77.6 
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Table 5.5 Demonstrates a comparison of the p-value difference between two treatment pairs of average 
wJAFROC FOMs (95%) and the p-value difference between two sensitivity and specificity for single 
observer of masses cases. 
Magnitude of Simulated 
Motion blur  (mm) 
The p-value difference between two  levels  of 
average wJAFROC  
0.0 – 0.7 mm 0.0122    
0.0 – 1.5mm 0.0041    
0.7 - 1.5 mm 0.6408   
Overall F-test & average 
wJAFROC FOM (95% CI) 
F(2,21.53) = 6.01,  p= 0.0084 
 
    
 
 
Figure 5.5 Demonstrates the distribution of FOM difference and 95% CIs for all FOM treatment pairs 
in the analysis of masses (this is the same data as indicated in Table 5.5).  
 
This displays the inter- levels  differences for the three  level  pairs (0.0 mm v 0.7 mm; 0 mm 
v 1.5 mm; 0.7 mm v 1.5 mm) for the analysis of masses. For a difference to be declared 
statistically significant the 95% confidence interval of the levels pair must not include zero and 
the overall F-test must be significant. Therefore, in this case, the level pairs 0.0 mm v 0.7 mm, 
and 0.0 mm v 1.5 mm are significantly different, while 0.7 mm v 1.5 mm, which does include 
zero is not significantly different despite the overall F-test does reach significant levels. The 
treatment differences were all a lot smaller for masses than microcalcifications (see Figure 
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5.8). This means that the malignant masses is less affected by motion blur than 
microcalcifications. 
 
 
Figure 5.6 Demonstrates the wAFROC curve of masses in image with no blur (0.0 mm) and two levels 
of simulated motion blur (0.7 & 1.5 mm). 
 
The highest performance is represented in images with no simulated motion blur 0.0 mm (blue 
line) and the performance decreased with increase motion blur 0.7 mm (red line). The lowest 
performance is represented in level 1.5 mm of motion blur (green line).   
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Figure 5.7  Demonstrates the observers averaged FOM of masses at 0.0 mm, 0.7 mm, and 1.5 mm of 
simulated motion blur. 
 
 
 
Table 5.6 The wJAFROC FOM with confidence interval (95% CI), sensitivity and specificity analysis 
for each observer at 0 mm, 0.7 mm, and 1.5 mm of simulated motion blur for masses. 
Masses 
cases 
 
wJAFROC FOM (95% CI) 
 
Sensitivity %  
(HrSe)  
 
 
Specificity % 
(HrSp) 
Observer 0.0 mm 0.7 mm 1.5 mm 0.0mm  0.7mm 1.5mm 0.0mm 0.7mm 1.5mm 
1 0.898 0.833 0.802 85.5 82.3 79.0 96.8 91.9 85.5 
2 0.943 0.879 0.876 96.8 96.8 87.0 85.5 62.9 85.5 
3 0.836 0.816 0.843 90.3 87.0 88.7 69.4 80.6 83.9 
4 0.936 0.895 0.907 96.8 87.1 92.0 75.8 88.7 87.1 
5 0.925 0.922 0.900 93.5 98.4 98.4 88.7 80.6 66.1 
6 0.920 0.930 0.894 93.5 98.4 96.8 90.3 72.6 79.0 
7 0.879 0.808 0.816 90.3 93.5 91.9 72.6 35.5 56.5 
Average 0.905 0.869 0.862 92.3 91.9 90.5 82.7 73.3 77.6 
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Figure 5.8 The wJAFROC FOM and 95% confidence intervals for microcalcifications and masses at 
0.0 mm, 0.7 mm, and 1.5 mm of simulated motion blur. 
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5.3 Section Two: Results of the Combining Two Observers’ Data 
As it is recognised that double reporting is an essential element of NHSBSP standards, 
secondary analysis of the data was deemed essential to partly ‘mimic’ this combined data result. 
In this analysis ‘a single result for each observer’ is compared to ‘the combined result of this 
observer and a second observer; the latter being referred to as a ‘combined result’. The outcome 
of the combined result is classified as follows: a positive outcome is assigned if one of the two 
observers suspects a lesion; the negative outcome is assigned if both observers indicate no 
lesion present. Seven observers completed the study and their data was analysed collectively 
to establish the impact of simulated motion blur on detection of breast lesions. This means that 
observer ratings have been combined. For the TP worksheet, the highest rating of the two 
observers was adopted as the rating for each lesion. For the FP worksheet, all unique ratings 
were kept (see Appendix I and Appendix J).  
Since the results of combining two observers’ data process have used the same data of the free-
response study, the data for observers’ pairs from combining two observers’ data is 
implemented and the following data analysis will be reported: 
 F-statistic and p-value 
 Observer averaged wJAFROC figure-of-merit (FOM) for all conditions and 95% 
confidence intervals (CI) 
 Observer averaged sensitivity derived from the highest ratings 
 FOM difference and 95% CI for all treatment pairs of simulated motion blur 
 wAFROC curves for all magnitudes of simulated motion blur 
For a difference in detection performance to be declared statistically significant, the result of 
the overall F-test must be significant and the 95% confidence interval of the treatment pairs 
must not include zero. 
Two observers’ data were combined for the detection of malignant microcalcifications and 
masses for three conditions; (i) no simulated motion blur (0 mm), and for two magnitudes of 
simulated motion blur (ii) 0.7 mm, and (iii) 1.5 mm. A statistically significant difference was 
found for the detection of masses (F (2, 48) = 5.64, p< 0.0038) and for the detection of 
microcalcifications (F (2, 12) = 18.13, p < 0.0000). For both analyses, a significant difference 
was observed between 0.0 mm and 0.7 mm, and between 0.0 mm and 1.5 mm of simulated 
motion blur, and also between 0.7 mm and 1.5 mm for microcalcifications. No significant 
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difference was detected between 0.7 mm and 1.5 mm for masses. Rjafroc was also used to 
calculate observer averaged sensitivity (FOM = HrSe) and specificity (FOM = HrSp) as the 
FOM for all conditions for microcalcifications and masses, (Table 5.7 & Table 5.9). 
 
5.3.1 The Combining Two Observers’ Data of Microcalcifications  
A statistically significant difference for the detection performance of microcalcifications was 
demonstrated (F (2, 11) = 13.68, p = 0.000) between all three levels pairs 0.0 mm V 0.7 mm 
(p < 0.01). All FOM pairs (0 mm V 1.5 mm, and 0.7 mm V 1.5 mm) were significantly 
different (Figure 5.11). The observer averaged wJAFROC FOMs and 95% CIs are presented 
in (Table 5.7). 
Average number of non-lesion localisation marks per observer on non-
diseased cases 
0.459 
Average number of non-lesion localisation marks per observer on diseased 
cases 
0.126 
Average number of lesion localisation marks per observer 0.943 
 
 
Table 5.7 A summary of the wJAFROC analysis of microcalcification. Shows the observer averaged 
wJAFROC FOM and 95% confidence intervals (CIs), Sensitivity % (HrSe) and Specificity % (HrSp) 
of combining two observers’ data. 
 
These results demonstrate there is a reduction in the impact of motion blur on detection 
performance compared to single observer.  
Magnitude of 
Simulated Motion 
blur (mm) 
wJAFROC FOM (95% CI) 
 
 
Sensitivity %  
(HrSe) 
Specificity % 
(HrSe) 
0 0. 923 (0.883,0.964) 99.7 72.0 
0.7 0.876 (0.831,0.921) 96.0 70.9 
1.5 0.826 (0.771,0.880) 89.6 75.3 
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Figure 5.9  Demonstrates averaged FOM of the combining two observers’ data of microcalcifications 
at 0 mm, 0.7 mm, and 1.5 mm of simulated motion blur. 
 
 
Figure 5.10 Demonstrates wAFROC curve of combined two observers’ data of microcalcifications 
cases at 0.0 mm, 0.7 mm, and 1.5 mm of simulated motion blur. 
 
The highest performance is represented in level 0.0 mm (blue line) and the performance 
decreased with increase motion blur 0.7 mm (red line). The lowest performance is represented 
in level 1.5 mm of motion blur (green line).   
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5.3.2 Combining Two Observers’ Data  of Masses 
A statistically significant difference for the detection performance of masses was 
demonstrated (F (2,484) = 5.64, p = 0.0038). The observer averaged wJAFROC FOMs and 
95% CIs are presented in (Table 5.11). A statistically significant difference was detected 
between all motion blur levels pairs except between 0.7 and 1.5 mm for masses (Table 5.13) 
Average number of non-lesion localisation marks per observer on 
non-diseased cases 
0.369 
Average number of non-lesion localisation marks per observer on 
diseased cases 
0.392 
Average number of lesion localisation marks per observer 0.873 
 
 
 
Table 5.8 A summary of the wJAFROC analysis of masses. Shows the observer averaged wJAFROC 
FOM and 95% confidence intervals (CIs), Sensitivity % (HrSe) and Specificity % (HrSp) of 
combined two observers’ data. 
 
These results demonstrate that there is a reduction in the impact of motion blur on detection 
performance.  
Magnitude of 
Simulated Motion 
blur  (mm) 
wJAFROC FOM (95% CI)
 
 
Sensitivity % 
(HrSe) 
Specificity % 
(HrSe) 
0 0. 948 (0.915, 0.982) 98.2 
 
70.5 
0.7 0.915 (0.873,0.954) 97.9 55.1 
1.5 0.913 (0.874,0.956) 97.5 62.7 
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Figure 5.11 Demonstrates averaged FOM of the combining two observers’ data in images with no 
motion blur and two levels of simulated motion blur of masses 
 
 
Figure 5.12 Demonstrates wAFROC curve of combined two observers’ data of masses with three levels 
0.0 mm, 0.7 and 1.5 mm. 
 
The highest performance is represented in level 0.0 mm (blue line) and the performance 
decreased with increase motion blur 0.7 mm (red line). The lowest performance is represented 
in level 1.5 mm of motion blur (green line).   
0.0
0.2
0.4
0.6
0.8
1.0
0 mm 0.7 mm 1.5 mm
w
JA
FR
O
C
 F
O
M
 (9
5%
 C
I)
Levels of simulated motion blur
Average FOM for Masses cases
0
0.2
0.4
0.6
0.8
1
0 0.2 0.4 0.6 0.8 1
Le
si
on
 L
oc
al
is
at
io
n 
Fr
ac
tio
n
False Positive Fraction
wAFROC curve of combining two observers' data of 
Masses
0.0 mm
0.7 mm
1.5 mm
  
113 
5.4 Section Three: A Comparison between the Results of Single Observer 
and the Combining Two Observers’ Data  
5.4.1 Microcalcification  
A statistically significant difference for the detection performance of microcalcifications was 
demonstrated (F (2, 11) = 13.68, p = 0.000) between single observer and combined two 
observers’ data (see Figure 5.13); Figure 5.13 demonstrates the difference between 
wAFROC curve of single observer and combined two observers’ data of microcalcifications 
cases. 
Table 5.9 Demonstrates the comparison between wJAFROC FOMs, sensitivity and specificity of single 
and combined two observers’ data with three levels of simulated blur. 
Simulated 
Motion 
blur   
wJAFROC FOM (95% CI) 
 
Sensitivity %  
(HrSe) 
Specificity % 
(HrSe)
Combined two 
observers’ data  
Single Observer Combined 
two 
observers’ 
data
Single 
Observer 
Combined 
two 
observers’ 
data
Single 
Observer 
0 mm 0. 923 (0.883,0.964) 0.899  (0.859, 0.939)    99.7 97.9 72.0 84.8 
0.7 mm 0.876 (0.831,0.921) 0.813 (0.757,0.870) 96.0 86.4 70.9 84.3 
1.5 mm 0.826 (0.771,0.880) 0.746  (0.679,0.812) 89.6 76.5 75.3 86.6 
 
 
Figure 5.13 The comparison between wJAFROC FOMs for single observer and combined two 
observers’ data in microcalcification. 
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Table 5.10 Demonstrates a comparison of the p-value difference between treatment pairs of average 
wJAFROC FOMs (95%) and the p-value difference between two sensitivity and specificity for single 
observer and combined two observers’ data of microcalcifications. 
Magnitude of Simulated Motion 
blur  (mm) 
The p-value difference between two pairs of 
average wJAFROC FOM (95% CI) 
Combined two 
observers’ data  
Single Observer 
0.0 – 0.7 mm 0.0000 0.0016    
0.0 – 1.5 mm 0.0000 0.0000    
0.7 - 1.5 mm 0.0000 0.0043    
Overall F-test & average 
wJAFROC FOM (95% CI) 
F (2, 12) = 18.13,   
p = 0.0000. 
significant 
F (2, 12) = 18.13,  
p = 0.000. 
significant 
  
 
 
Figure 5.14 The difference between the wAFROC curve of single observer and combined two 
observers’ data of microcalcifications.  
 
There is a reduction in the impact of motion blur when using the combined two readers’ data 
(green line), the results demonstrate there is a statistically significant difference for detection 
performance of microcalcification. 
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5.4.2 Masses 
For masses, no significant difference for the detection performance was demonstrated (F (1,5) 
= 4.04, p = 0.1001) between single observer and combined two observers’ data (see Figure 
5.16); Figure 5.16 demonstrates the difference between wAFROC curve of single observer 
and combined two observers’ data of masses cases. 
Table 5.11 Demonstrates a comparison between wJAFROC FOMs and sensitivity and specificity for 
single observer and combined two observers’ data of masses. 
Magnitude 
of 
Simulated 
Motion 
blur  (mm) 
wJAFROC FOM (95% CI) 
 
Sensitivity % 
(HrSe) 
Specificity % 
(HrSe)
Combined two 
observers’ data  
FOMs 
Single Observer 
FOMs 
Combined 
two 
observers’ 
data
Single 
Observer 
Combined 
two 
observers’ 
data
Single 
Observer 
0 0. 948 (0.915,0.982) 0.905 (0.859,0.952) 98.2 
 
92.3 70.5 82.7 
0.7 0.913 (0.873,0.954) 0.869 (0.814,0.924) 97.9 91.19 55.1 73.3 
1.5 0.915 (0.874,0.956) 0.862 (0.810,0.915) 97.5 90.5 62.7 77.6 
 
 
Figure 5.15 The comparison between wJAFROC FOMs for single observer and combined two 
observers’ data of masses. 
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Table 5.12 Demonstrates a comparison of the p-value difference between two treatment pairs of average 
wJAFROC FOMs (95%) of masses. 
Magnitude of Simulated 
Motion blur  (mm) 
The p-value difference between two  levels pairs  
average wJAFROC  
Combined two observers’ 
data  
Single Observer 
0.0 – 0.7 mm 0.0031    0.0122    
0.0 – 1.5 mm 0.0047    0.0041    
0.7 - 1.5 mm 0.8952   0.6408   
Overall F-test & 
average wJAFROC FOM (95% 
CI) 
F(2,484.78) = 5.64,    
p = 0.0038 
significant 
F(2,21.53) = 6.01,  
p= 0.0084. 
significant 
   
 
 
Figure 5.16 The difference between wAFROC curve of single and combined two observers’ data of 
masses. 
 
Despite the slight reduction in the impact of motion blur when using combined two observers’ 
data method and increase the detection performance (green line), the results demonstrate there 
no statistically significant difference for detection performance of masses between two 
methods. This means that the impact of motion blur remains even when two observers’ data 
have been combined.  
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Table 5.13 The wJAFROC FOM and 95% confidence intervals (CI) for single and combined observers 
for masses and microcalcifications. 
 
The inter-modality difference and confidence intervals are also presented for the analysis of 
masses and microcalcifications. For a difference to be declared statistically significant, the 
result of the overall F-test must be significant and the 95% CI of the modality difference must 
not include zero. The sensitivity and specificity were calculated in Rjafroc using the HrSe and 
HrSp FOMs.  
 
 
 
 
 
 
 
 
 
 
 
Analysis Modality wJAFROC FOM 
(95% CI) 
Difference (95% 
CI) 
Sensitivity 
HrSe (%) 
Specificity 
HrSp (%) 
Masses 
1st 
(single) 
0.885 (0.844,0.927) 
-0.03 (-0.07,0.01) 
92 82 
2nd 
(combined) 
0.916 (0.885,0.947) 97 63 
Micro-
calcifications 
1st 
(single) 
0.820 (0.780,0.860) 
-0.06 (-0.10,-0.17) 
85 92 
2nd 
(combined) 
0.876 (0.842,0.909) 93 82 
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Chapter Six:  Results of Physical Measures 
6.1 Chapter Overview 
This chapter presents physical measures taken from the cases containing lesions. The results 
are organised into three main themes:  
The first theme focuses on calculating the impact of motion blur on focal lesions (masses). This 
is primarily done using conspicuity index software (Szczepura & Manning, 2016). The 
conspicuity of a lesion represents a ratio between the contrast of a lesion and its surrounding 
complexity. Conspicuity index help to explain the function of the blurring software (e.g. how 
the edge angle degreases with increasing blur simulation) and how it impacts on the visual 
characteristics of the masses’ images. 
The second theme focuses on the impact of simulated motion blur on microcalcifications. 
This includes a novel metric, that has been named the ‘dispersion index’ (DI), lesion contrast, 
and dispersion index X contrast (DI x contrast). A relationship between lesion detectability 
and these physical measures has been investigated.   
The third theme focuses on an analysis of missed lesions. This aspect focusses purely on 
detection, ignoring the confidence rating assigned for the free-response study. In this case, 
detectability is defined as the number of successful detections (for all observers) over the total 
number of opportunities to detect the lesion. 
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6.2 Part I: Physical Measures of Breast Masses 
Several parameters, such as conspicuity index (χ), maximum lesion diameter (d), edge angle of 
the lesion (θ), mean noise within the lesion (σs), and mean background noise (σn) were recorded 
for all breast masses using conspicuity index software. This was not possible for 
microcalcifications due to their size and distribution patterns; this represents a limitation of the 
conspicuity software. This prompted the development of the Dispersion Index; see section 
6.3.1). Overall, simulated motion blur has a significant impact on the edge angle of the lesion. 
In addition, these results illustrate the relationship between simulated motion blur and a change 
in grey level (ΔGL) of the image. Where ΔGL represents the difference between contrast of 
the lesion (μ L) and background (μ b). Table 6.1 displays the results of the conspicuity data of 
breast masses with different levels of motion blur. This resulted in the conspicuity index for 23 
cases out of 62 cases being measured because of limitations in the conspicuity software. Only 
masses which have clear edges can be measured by conspicuity software. The SNR for images 
is also presented to illustrate the impact of simulation motion blur on the image noise. When 
the magnitude of simulated motion blur increases, there is a reduction in the image noise as 
consequence of a smoothing effect incurred by blurring. A full range of physical measures 
acquired data for masses for image without simulated motion blur (0.0 mm), and images with 
simulated motion blur (0.7 & 1.5 mm) is presented in (Appendix K).  
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Table 6.1 Physical measurements of breast masses within mammographic images using conspicuity 
software. 
The physical measurements include the conspicuity index (χ), the θ represents the maximum slope 
angle to the edge of the lesion profile in degrees, the change of grey level (ΔGL) and SNR.  
 Magnitude of Simulated Motion Blur (mm) 
 0.0  0.7 1.5 
Case 
No. χ 
Edge 
angle 
(θ) ΔGL SNR χ 
Edge 
angle 
(θ) ΔGL SNR χ 
Edge 
angle 
(θ) ΔGL SNR 
1  51.63  63.77  63.77  2.77  66.39  61.52  93.34  4.86  74.99  59.80  93.60  6.19 
2  71.58  69.15  69.48  2.93  101.67  67.26  70.19  5.21  110.62  66.42  69.89  6.42 
3  45.00  66.95  76.64  3.60  55.62  72.36  84.80  3.74  58.38  62.93  79.35  12.15 
4  108.88  73.24  84.33  2.38  153.36  67.95  67.71  2.49  169.43  71.57  84.60  4.54 
5  66.27  70.83  66.46  1.73  78.11  67.95  67.71  2.49  81.13  66.38  68.27  2.87 
6  40.11  65.04  59.04  2.15  43.76  58.81  63.08  4.00  47.46  57.77  63.04  4.69 
7  170.73  70.65  133.19  2.99  252.59  70.53  133.54  4.12  272.50  70.26  133.61  4.54 
8  140.63  72.61  96.36  2.98  222.31  71.96  96.80  5.74  238.35  71.29  96.84  6.83 
9  113.44  72.97  99.35  2.96  150.18  71.94  99.56  4.48  162.84  71.20  98.87  5.44 
10  124.98  71.21  108.73  2.23  169.81  70.48  109.86  4.38  181.56  70.15  109.91  5.21 
11  116.22  73.52  115.36  2.72  155.95  72.93  114.86  4.01  168.74  72.24  114.26  4.83 
12  82.89  69.51  107.98  2.71  117.32  68.93  108.10  5.22  127.94  68.53  107.41  6.21 
13  123.43  71.09  86.52  2.76  179.01  69.64  87.26  4.52  192.82  68.76  87.49  5.15 
14  127.07  69.54  127.66  3.47  166.60  69.14  128.66  5.89  178.28  68.76  128.76  7.39 
15  57.37  62.53  60.31  1.92  81.94  58.64  61.53  3.87  85.67  57.08  61.61  4.66 
16  79.12  67.11  106.27  3.30  91.03  65.51  107.71  6.28  94.90  64.99  107.72  7.71 
17  80.79  71.39  70.40  2.98  111.91  69.11  71.13  5.49  116.82  67.75  71.31  7.19 
18  85.85  71.76  106.42  3.66  100.98  70.68  107.37  5.73  102.30  70.07  107.34  6.52 
19  53.48  66.07  114.96  2.85  55.35  64.89  115.66  4.62  56.32  64.52  115.58  5.24 
20  76.51  72.45  92.41  3.05  92.79  71.38  93.15  4.15  99.26  70.82  92.85  4.60 
21  53.21  62.49  101.20  1.58  53.40  60.80  102.91  2.19  51.83  59.82  103.81  2.57 
22  56.28  71.26  57.73  3.27  63.86  68.75  58.54  5.37  62.09  67.09  58.04  6.64 
23  82.01  64.38  121.77  2.08  111.60  64.82  126.05  2.23  119.60  64.76  127.35  2.43 
Max 
170.73  73.52  133.19  3.662  252.59 72.929 133.54 6.279 272.5 72.239  133.61  12.148
Min 
40.113  62.49  57.73  1.575  43.759 58.64 58.54 2.194 47.462 57.08  58.04  2.429
Ave. 
87.282  69.109  92.450  2.741  116.328 67.63 94.326 4.394 124.080 66.649  94.848  5.653
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6.2.1 Normality Test of Masses Data  
Normality test of the data of the physical measures is required to check the suitability of the 
overall data for further analysis (Field et al., 2013). For this data, the Kolmogorov-Smirnov 
test and Shapiro-Wilk test showed that the physical parameters data such as the conspicuity 
index, the change in grey level and SNR were normally distributed with P ≥ 0.05, and the edge 
angle data was not normally distributed with P ≤ 0.05 as illustrated in (Table 6.2).  
 
 
Table 6.2  Values of Kolmogorov-Smirnov test and Shapiro-Wilk normality test for the physical measures
data of breast masses 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Conspicuity Index 0.0 m  0.169 23 0.089 0.934 23 0.133 
Edge Angle 0.0 mm 0.190 23 0.031 0.899 23 0.024 
GL 0.0 mm 0.131 23 0.200* 0.945 23 0.227 
SNR 0.0 mm 0.171 23 0.080 0.955 23 0.376 
Conspicuity Index 0.7 mm 0.145 23 0.200* 0.928 23 0.099 
Edge Angle  0.7 mm 0.182 23 0.047 0.888 23 0.014 
GL 0.7 mm 0.149 23 0.200* 0.946 23 0.245 
SNR 0.7mm 0.119 23 0.200* 0.936 23 0.150 
Conspicuity Index 1.5 mm 0.138 23 0.200* 0.927 23 0.092 
Edge Angle 1.5 mm 0.138 23 0.200* 0.904 23 0.030 
GL 1.5 mm 0.114 23 0.200* 0.959 23 0.451 
SNR 1.5 mm 0.162 23 0.123 0.892 23 0.180 
*. This is a lower bound of the true significance 
a. Lilliefors Significance Correction 
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6.2.2 Conspicuity Index (χ) 
 
The conspicuity of a mass represents a ratio between the contrast of a mass and its surrounding 
complexity. A paired sample t-test (2-way) was performed to test the hypothesis that the 
conspicuity index of masses was equal on images with no motion blur (0.0 mm) (M= 87.282, 
SD= 34.715) and images with 0.7 mm motion blur (M= 116.33, SD=56.169), 1.5 mm motion 
blur (M= 124.08, SD= 61.566). Prior to conducting the analysis, the assumption of normally 
distributed difference scores was examined, and the data was normally distributed see (Table 
6.2). The Conspicuity Index difference between the two magnitudes of simulated motion blur 
and no motion blur were statistically significant for all comparisons (See Table 6.3). This could 
influence on lesion characteristics and the changes in the features of breast masses could have 
negatively influence the differential diagnosis between malignant and benign masses. Figure 
6.1 graphical represents the means and confidence interval 95% of the two magnitudes of 
simulated motion blur and no motion blur. As can be seen, the conspicuity index increases 
significantly when simulated motion blur increases from 0mm to 0.7 mm and then to 1.5mm. 
The diagram illustrates a variety of different box plot positions and shapes. The box plot of 
conspicuity index in images without motion blur (0.0 mm) is comparatively short. This 
suggests that the distribution of overall data is convergent. The median is about (80.790, 
101.672, and 110.622) for images without blur 0.0mm, images with blur 0.7 mm and 1.5mm 
respectively.  
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Table 6.3 The results of conspicuity index of 23 masses cases for images with no motion blur and two 
levels of simulated motion blur. 
 
Conspicuity Index of 23 masses  0.0 mm 
 
0.7 mm 1.5  mm 
 
Mean 87.282 116.33 124.08 
95% Confidence Interval for 
Mean 
Lower Bound 72.270 92.038 97.4570 
Upper Bound 102.294 140.617 150.703 
5% Trimmed Mean 85.449 112.939 120.307 
Median 80.790 101.672 110.622 
Std. Deviation 34.715 56.169 61.566 
Minimum 40.11 43.76 47.46 
Maximum 170.73 252.59 272.50 
Range 130.62 208.83 225.04 
Interquartile Range 59.94 89.56 94.44 
T-test Pairs Result of T-test / Difference (95% CI) 
0.0 mm – 0.7 mm t(22) = -6.158, p<0.000 / -29.046 (-38.827,-19.264) 
0.0 mm – 1.5 mm t(22) = -6.273, p<0.000 / -36.798 (-48.964, -24.633) 
0.7 mm – 1.5 mm           t(22) = -6.231, p<0.000 / -7.752 (-10.333, -5.172) 
 
 
 
 
Figure 6.1 Demonstrates the relationship between the magnitudes of simulated motion blur and 
conspicuity index of breast masses. 
 
As can be seen, the conspicuity index increases significantly  when simulated motion blur 
increases from 0mm to 0.7mm and then to 1.5mm.  
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6.2.3 Edge Angle 
The edge angle of a mass represents the maximum slope angle across the edge of a lesion 
profile in degrees. A non-parametric test was performed to test the hypothesis that edge angle 
of masses in images with 0.7mm simulated blur (M= 67.63, SD=4.308), 1.5 mm simulated 
motion blur (M= 66.650, SD= 4.546) and edge angle of masses in images with no motion blur 
(0.0mm) (M= 69.110, SD= 3.556) are equal. Prior to conducting the analysis, the assumption 
of normally distributed difference scores was examined and the data was non-normally 
distributed (See Table 6.2). The edge angle difference between the two magnitudes of 
simulated motion blur and no motion blur were statistically significant for all comparisons (see 
Table 6.4). The edge angle decreased along with the increasing level of simulated motion blur. 
Simulated motion blur has an impact on the edge angle of breast masses and this could 
influence on image of the lesion characteristics. This means that any changes in the image 
characteristics of breast masses could negatively affect the identification of malignant masses. 
Figure 6.2 demonstrates the mean of both edge angle and confidence interval 95% of the two 
magnitudes of simulated motion blur and no motion blur. Each of the box plots in (Figure 6.2) 
shows a different skewness pattern. The distribution of the 0.0mm box plots is skewed up whilst 
the distribution of box plots 0.7mm and 1.5mm are skewed down. The median was pointed by 
the horizontal line that runs up the centre of the boxes. The median was (67.750) for images 
with no motion blur and the median for blurred images 0.7mm, 1.5 mm were 68.925, 70.653,  
respectively.  
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Table 6.4 Demonstrates the results of edge angle measures for 23 masses cases of images with no 
motion blur and two levels of simulated motion blur. 
 
Edge Angle 0.0 mm 
 
0.7 mm 1.5  mm 
 
Mean 69.110 67.63 66.650 
95% Confidence Interval 
for Mean 
Lower Bound 67.571 65.770 64.683 
Upper Bound 70.647 69.492 68.615 
5% Trimmed Mean 69.233 67.838 66.870 
Median 70.653 68.925 67.750 
Variance 12.648 18.555 20.667 
Std. Deviation 3.556 4.308 4.546 
Minimum 62.490 58.64 57.080 
Maximum 73.520 72.930 72.240 
Range 11.030 14.290 15.160 
Interquartile Range 5.690 5.790 5.740 
T-test Pairs Result of T-test / Difference (95% CI)  
0.0 mm – 0.7 mm t(22) = 3.232, p<0.004/ 1.4794 (0.530, 2.429) 
0.0 mm – 1.5 mm t(22) = 6.592, p<0.000 / 1.4794 (1.686, 3.234) 
0.7 mm – 1.5 mm              t(22) = 2.234, p<0.036/ 0.980 (0.070, 1.891) 
 
 
Figure 6.2 Demonstrates the relationship between the magnitudes of simulated motion blur and edge 
angle of masses. 
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6.2.4 The Grey Level Change (ΔGL): 
The grey level change (ΔGL) represents the difference between the contrast of the lesion (μ L) 
and the background (μ b). The same analysis process used for conspicuity index has been used 
to analyse the grey level change data. A paired sample t-test was performed to test the 
hypothesis that the grey level of masses in images with 0.7 mm simulated blur (M= 94.326, 
SD=22.864), 1.5 mm level (M= 94.848, SD= 22.444) and the grey level of masses in images 
with no motion blur (0.0mm) (M= 92.450, SD= 23.394) are equal. The assumption of normally 
distributed difference scores was examined, and the data was normally distributed (see Table 
6.2). The grey level difference between the two magnitudes of simulated motion blur and no 
motion blur were no statistically significant for all comparisons of motion blur levels (see 
Table 6.5). Figure 6.3 shows the means of ΔGL and confidence interval 95% of the two 
magnitudes of simulated motion blur and no motion blur. The boxes of the ΔGL in (Figure 
6.3) have approximately the same distribution (similar position and shape).  
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Table 6.5  Demonstrates the grey level measures of 23 masses cases for images with no blur and two 
levels of simulated motion blur. 
Grey Level change 0.0mm 
 
0.7 mm 1.5  mm 
 
Mean 92.450 94.326 94.848 
95% Confidence Interval for 
Mean 
Lower Bound 82.333 84.439 85.143 
Upper Bound 102.566 104.213 104.554 
5% Trimmed Mean 92.146 94.150 94.749 
Median 96.358 96.797 96.836 
Variance 547.282 522.755 503.724 
Std. Deviation 23.394 22.864 22.444 
Minimum 57.73 58.54 58.04 
Maximum 133.19 133.54 133.61 
Range 75.46 75.00 75.57 
Interquartile Range 39.25 39.67 38.60 
T-test Pairs Result of T-test / Difference (95% CI) 
0.0 mm – 0.7 mm t(22) = -1.226, p>0.233/ -1.877 (-5.053, 1.299) 
0.0 mm – 1.5 mm t(22) = -1.868, p> 0.075/ -2.399 (-5.062, 0.264) 
0.7 mm – 1.5 mm t(22) = -0.663, p>0.514 / -0.522 (-2.154, 1.111) 
 
 
 
Figure 6.3 The relationship between the magnitude of simulated motion blur and the grey level of breast 
masses. 
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6.2.5 Signal to Noise Ratio (SNR):  
A paired sample t-test was performed to test the hypothesis that SNR in images with simulated 
blur (0.7 mm) level (M= 4.394, SD=1.188), 1.5 mm simulated motion blur (M= 5.653, SD= 
2.029) and SNR of images without motion blur (0.0mm) (M= 2.741, SD= 0.576) are equal. 
The assumption of normally distributed difference scores was examined, and the data was 
normally distributed (see Table 6.2). The SNR difference between the two magnitudes of 
simulated motion blur and no motion blur were statistically significant for all comparisons (See 
Table 6.8). Figure 6.4 illustrates relationship between the magnitude of simulated motion blur 
and SNR of breast masses. It can be noted that SNR increases significantly with increase the 
level of simulated motion blur as consequence of the smoothing process. Each of the box plots 
in (Figure 6.4) is different in size and positions. The distribution of (0.0mm) box plots is lower 
than of box plots (0.7 & 1.5 mm). The median of SNR was pointed by the horizontal line, which 
runs up the centre of the boxes. The medians of SNR were 2.848 for images without blur 
0.0mm, and (4.479,  5.653) for images with simulated motion blur 0.7mm and 1.5 mm 
respectively.  
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Table 6.6  Demonstrates SNR measures of 23 masses cases for images with no motion blur and two 
levels of simulated motion blur. 
SNR 0.0 mm 
 
0.7 mm 1.5  mm 
 
Mean 2.741 4.394 5.653 
95% Confidence Interval 
for Mean 
Lower Bound 2.492 3.880 4.776 
Upper Bound 2.990 4.908 6.531 
5% Trimmed Mean 2.754 4.414 5.503 
Median 2.848 4.479 5.238 
Variance 0.332 1.413 4.116 
Std. Deviation 0.576 1.188 2.029 
Minimum 1.581 2.191 2.430 
Maximum 3.660 6.280 12.151 
Range 2.091 4.090 9.720 
Interquartile Range 0.820 1.501 2.040 
T-test Pairs Result of T-test / Difference (95% CI) 
0.0 mm – 0.7 mm t(22) = -9.307, p<0.000 / -1.653 (-2.021, -1.285) 
0.0 mm – 1.5 mm t(22) = -8.608, p<0.000 / -2.913 (-3.614, -2.211) 
0.7 mm – 1.5 mm t(22) = -3.714, p<0.01 /-1.260 (-1.963, -0.556) 
 
 
 
 
Figure 6.4 The relationship between the magnitude of simulated motion blur and the signal to noise 
ratio (SNR) of breast masses. 
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6.3 Part II: Physical Measures of Microcalcifications 
Disperion Index (DI)  has been developed for this thesis to test the dispersion index of 
microcacifications and also to investigate the relationship between physical measures of 
microcalcifications and their detectability. Dispersion index of microcalcifications repsesents 
the number of calcifications within a specified area divided by the area. DI was measured 
within Imagej software (Schindelin et al., 2012) because the conspicuity index could not be 
applied to microcalcifications due to their individual size and their wide distribution pattern. 
This represents a limitation of the CI software. No validation has been conducted on DI, but 
this could be a focus for post doctoral work. However, during conducting this thesis no 
alternative technique existed (aside to DI) to gain a meaningful physical measure in relation to 
microcalcifications.  
6.3.1 Normality Tests of Microcalcifications Data  
For this data, the Kolmogorov-Smirnov test and Shapiro-Wilk test showed that the physical 
parameters data such as dispersion index, the contrast and DI x Contrast were not normally 
distributed with P ≤ 0.05, and that the SNR data was normally distributed with P ≥ 0.05 as 
illustrated in (Table 6.7). A normality test of the data of the physical measures of 
microcalcifications is required to check the suitability of the overall data for further analysis 
(Field et al., 2013). 
Table 6.7   Values of Kolmogorov-Smirnov test and Shapiro-Wilk normality test for the physical 
measures data of breast masses  
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Dispersion Index  0.0 mm 0.166 62 0.000 0.854 62 0.000 
Contrast 0.0 mm 0.148 62 0.002 0.913 62 0.000 
DI x Contrast 0.0 mm 0.166 62 0.000 0.849 62 0.000 
SNR 0.0 mm 0.076 62 0.200* 0.984 62 0.611 
Dispersion Index 0.7 mm 0.168 62 0.000 0.854 62 0.000 
Contrast 0.7 mm 0.188 62 0.000 0.867 62 0.000 
DI x Contrast 0.7 mm 0.159 62 0.000 0.846 62 0.000 
SNR 0.7 mm 0.065 62 0.200* 0.983 62 0.535 
Dispersion Index 1.5 mm 0.168 62 0.000 0.854 62 0.000 
Contrast 1.5 mm 0.200 62 0.000 0.841 62 0.000 
DI x Contrast 1.5 mm 0.163 62 0.000 0.846 62 0.000 
SNR 1.5 mm 0.077 62 0.200* 0.976 62 0.257 
*. This is a lower bound of the true significance. 
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a. Lilliefors Significance Correction 
 
6.3.2 Dispersion Index (DI) of Microcalcifications  
The results demonstrate that the dispersion index of clustered microcalcifications decreases 
with an increase in the level of simulated motion blur (Table 6.8). Simulated motion blur has 
a statistically significant and negative impact on DI of microcalcifications (Table 6.9). This 
means that the changes in the image characteristics of microcalcifications as motion blur 
increases from no motion blur could negatively influence the differential features of malignant 
microcalcifications. Figure 6.5 graphically illustrates of the mean and confidence interval 95% 
of the two magnitudes of simulated motion blur and no motion blur with DI. Each of the box 
plots in (Figure 6.5) demonstrates a different skewness pattern. The distribution of (0.0 mm) 
box plots is skewed up while the distribution of box plots 0.7 mm and 1.5 mm are skewed 
down. The median is (0.687, 0.541 and 0.416) for images without blur 0.0 mm and for images 
with simulated motion blur 0.7 mm and 1.5 mm respectively.  
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Table 6.8 Demonstrates dispersion index of microcalcifications between images without motion blur 
(0.0 mm), and images with simulated motion blur (0.7 mm & 1.5 mm). 
Dispersion Index   0.0 mm  
 
0.7 mm  1.5  mm
Mean 0.963 0.743 0.594 
95% Confidence Interval for 
Mean 
Lower Bound 0.765 0.592 0.468 
Upper Bound 1.161 0.894 0.7197 
5% Trimmed Mean 0.876 0.688 0.545 
Median 0.687 0.541 0.416 
Variance 0.628 0.364 0.253 
Std. Deviation 0.792 0.604 0.503 
Minimum 0.110 0.051 0.021 
Maximum 4.131 3.001 2.631 
Range 4.020 2.95 2.600 
Interquartile Range 0.801 0.610 0.470 
 
 
 
 
Figure 6.5 The relationship between the magnitude of simulated motion blur and dispersion index. 
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Table 6.9 Demonstrates the P-values of Wilcoxon Signed Ranks Test of physical measures of 
microcalcifications between images with no motion blur (0.0 mm), and images with simulated 
motion blur (0.7 mm & 1.5 mm). 
Simulated motion blur level Dispersion Index Contrast DI x Contrast 
0.0 mm - 0.7 mm 0.000 0.000 0.253 
0.0 mm- 1.5 mm 0.000 0.000 0.000 
0.7 mm- 1.5 mm 0.000 0.000 0.000 
 
6.3.3 Contrast of Microcalcifications 
The results demonstrate that the contrast of clustered microcalcifications increases with an 
increase in the level of simulated motion blur (Table 6.10). A non-parametric test (Wilcoxon 
Signed Ranks Test) was performed to investigate the hypothesis that contrast in images with 
simulated blur at 0.7 mm, 1.5 mm and contrast in images with no motion blur (0.0mm) are 
equal. Prior to conducting the analysis, the assumption of normally distributed difference 
scores was examined and the data was non-normally distributed (Table 6.8). Figure 6.6 shows 
the means of contrast and confidence interval 95% of the two magnitudes of simulated motion 
blur and no motion blur. The contrast of microcalcifications increases with increase the level 
of simulated motion blur. The diagram illustrates a variety of different box plot that positions 
and shapes. The distribution of (0.0 mm) box plots is skewed down while the distribution of 
box plot (0.7 mm) is skewed up and box plot of 1.5 mm is much higher. The three sections of 
the box plot are different in size and position.  
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Table 6.10 Demonstrates contrast of microcalcifications for images without motion blur (0.0 mm), and 
images with simulated motion blur (0.7 & 1.5 mm). 
Contrast of Microcalcifications 0.0 mm  
 
0.7 mm  1.5  mm 
 
Mean 0.839 0.897 0.916 
95% Confidence Interval for 
Mean 
Lower Bound 0.825 0.884 0.904 
Upper Bound 0.852 0.910 0.927 
5% Trimmed Mean 0.842 0.901 0.920 
Median 0.848 0.910 0.930 
Variance 0.003 0.003 0.002 
Std. Deviation 0.053 0.051 0.047 
Minimum 0.680 0.730 0.750 
Maximum 0.930 0.970 0.980 
Range 0.260 0.240 0.230 
Interquartile Range 0.060 0.050 0.040 
 
 
 
Figure 6.6 The relationship between the magnitudes of simulated motion blur and contrast of malignant 
microcalcifications. 
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6.3.4 Dispersion Index and Contrast of Microcalcifications  
The results demonstrate that DI x contrast of clustered microcalcifications decreases with an 
increase in the level of simulated motion blur (Table 6.11). A non-parametric test (Wilcoxon 
Signed Ranks Test) was performed to test the hypothesis that DI x contrast in images with 
simulated blur 0.7 mm, 1.5 mm and DI x contrast in images without motion blur (0.0mm) are 
equal. Prior to conducting the analysis, the assumption of normally distributed difference 
scores was examined and the results were non-normally distributed. Simulated motion blur has 
a statistically significant negative impact on DI x contrast of microcalcifications (Table 6.8). 
A graphical representation of the means and adjusted 95% confidence interval is displayed in 
(Figure 6.7). 
 
Table 6.11  Demonstrates measures DI x contrast of microcalcifications for images without motion blur 
(0.0 mm), and images with simulated motion blur (0.7 & 1.5 mm). 
DI x Contrast of Microcalcifications 0.0 mm  
 
0.7 mm  1.5  mm 
 
Mean 0.824 0.815 0.640 
95% Confidence Interval for 
Mean 
Lower Bound 0.646 0.655 0.508 
Upper Bound 1.002 0.975 0.771 
5% Trimmed Mean 0.742 0.761 0.592 
Median 0.587 0.596 0.466 
Variance 0.506 0.410 0.276 
Std. Deviation 0.711 0.640 0.525 
Minimum 0.080 0.060 0.030 
Maximum 3.850 3.100 2.690 
Range 3.770 3.040 2.660 
Interquartile Range 0.700 0.650 0.520 
Skewness 2.007 1.463 1.654 
Kurtosis 5.011 1.896 2.942 
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Figure 6.7 The relationship between the magnitude of simulated motion blur and DI x contrast of 
microcalcifications. 
 
6.3.5 Signal to Noise Ratio (SNR) of  Microcalcifications Images:  
A paired sample t-test was performed to test the hypothesis that SNR in images with simulated 
blur (0.7 mm) (M= 34.413, SD=13.958), 1.5 mm simulated motion blur (M= 38.035, SD= 17.361) 
and SNR in images without motion blur (0.0mm) (M=26.97, SD= 7.859) are equal. Prior to 
conducting the analysis, the assumption of normally distributed difference scores was 
examined and, the data was normally distributed. The SNR difference between the two 
magnitudes of simulated motion blur and no motion blur were statistically significant for all 
comparisons (See Table 6.12).  
A graphical representation of the means and adjusted 95% confidence interval is displayed in 
(Figure 6.8). Each of the box plots in (Figure 6.8) shows a different skewness pattern. The 
distribution of (0.0mm) box plots is skewed down while the distribution of box plots (0.7 & 
1.5mm) are skewed up. The box plot in 0.0mm is much lower than the box plots in 0.7mm and 
1.5mm respectively. The three sections of the box plot are different in size. The box plot in 
0.0mm level is comparatively short. The medians of SNR are generally close to the average, 
which are approximately (26.725, 33.065, and 37.075) for images without blur 0.0mm and for 
images with motion blur 0.7mm and 1.5 mm respectively.  
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Table 6.12 demonstrates SNR of microcalcification for images with no blur and two levels of simulated 
motion blur. 
SNR of Microcalcifications 0.0 mm  
 
0.7 mm  1.5  mm 
 
Mean 26.97 34.413 38.035 
95% Confidence Interval for 
Mean 
Lower Bound 25.011 30.926 33.702 
Upper Bound 28.938 37.899 42.375 
5% Trimmed Mean 26.963 34.132 37.427 
Median 26.725 33.065 37.075 
Variance 61.779 194.849 301.424 
Std. Deviation 7.859 13.958 17.361 
Minimum 7.740 6.480 3.850 
Maximum 43.320 66.740 82.380 
Range 35.580 60.260 78.530 
Interquartile Range 10.430 20.200 25.250 
T-test Pairs Result of T-test / Difference (95% CI) 
0.0 mm – 0.7 mm t(61) = -7.598, p<0.000 / -7.438 (-9.394, -5.482 ) 
0.0 mm – 1.5 mm t(61) = -7.705, p<0.000 / -11.064 (-13.934, -8.195) 
0.7 mm – 1.5 mm t(61) = -6.246, p<0.000 / -3.626 (-4.786, -2.466) 
 
 
 
Figure 6.8 The relationship between the magnitude of simulated motion blur and SNR of 
microcalcifications. 
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6.4 The Relationship between Physical Measures and Detectability of 
Microcalcifications   
The results of this focuses on the physical parameters of breast microcalcifications such as D.I, 
contrast, DI x contrast, signal to noise ratio (SNR) and detectability of lesions with different 
levels of motion blur (Table 6.13). A full range of physical measures acquired data for 
microcalcifications for  image without simulated motion blur (0.0 mm), and images with 
simulated motion blur (0.7 & 1.5 mm) is presented in (Appendix M). 
Some microcalcifications cases are highly affected by motion blur when the number 
calcifications is higher than 10 per cluster; where cluster refers to a collection of 
microcalcifications within a specified area. Some studies (Farshid et al., 2011) & Shao et al. 
(2011) suggested the probability of malignancy increases with the extent of the lesions on 
mammograms.  Therefore, a DI metric has been performed to investigate the relationship 
between the physical measures of microcalcifications and their detectability with three levels 
of motion blur. From Figure 6.9 to Figure 6.17 show there is no relationship between 
simulated motion blur and physical measures (D.I, contrast, DI x contrast, and SNR). 
 Table 6.13 The physical measures of microcalcifications in image with no simulated motion blur (0.0 
mm), and images with simulated motion blur (0.7 & 1.5 mm). 
 Motion blur levels  
0.0 mm  0.7 mm 1.5 mm 
Lesion 
No. 
DI  Cont. 
 
DI x 
Con 
SNR Detect 
ability  
DI Cont. DI x 
Con 
SNR Detect 
ability 
DI Cont. DI x 
Con 
SNR Detect 
ability 
1 1.384 0.890 1.231 41.937 1.00 1.092 1.064 1.162 65.903 1.00 0.801 1.043 0.836 80.936 0.57 
2 1.231 0.883 1.087 33.100 1.00 0.934 1.076 1.005 40.395 1.00 1.189 1.058 1.258 42.614 0.85 
3 0.918 0.882 0.810 31.978 1.00 0.660 1.077 0.711 38.439 0.86 0.488 1.059 0.516 40.489 0.57 
4 0.371 0.850 0.316 25.417 0.57 0.272 1.074 0.292 28.612 0.43 0.198 1.062 0.210 30.236 0.00 
5 0.343 0.705 0.242 16.994 1.00 0.225 1.360 0.306 18.511 1.00 0.216 1.296 0.279 19.178 1.00 
6 0.426 0.818 0.348 17.616 0.57 0.290 1.154 0.334 18.885 0.43 0.256 1.126 0.288 19.511 0.14 
7 0.834 0.820 0.684 26.729 1.00 0.660 1.109 0.732 36.783 1.00 0.487 1.073 0.522 42.352 1.00 
8 1.079 0.874 0.943 30.416 1.00 0.863 1.064 0.919 35.927 1.00 0.648 1.050 0.680 37.319 1.00 
9 0.292 0.835 0.244 22.641 0.86 0.243 1.146 0.279 24.575 0.57 0.178 1.129 0.202 25.472 0.14 
10 0.316 0.829 0.262 24.361 1.00 0.278 1.091 0.303 26.537 0.86 0.215 1.068 0.229 27.239 0.43 
11 0.863 0.874 0.754 30.416 1.00 0.648 1.064 0.689 35.927 0.85 0.504 1.050 0.529 37.319 0.43 
12 0.524 0.868 0.455 32.058 0.85 0.434 1.089 0.473 38.371 0.72 0.315 1.067 0.336 40.661 0.43 
13 1.091 0.861 0.940 25.826 1.00 0.755 1.078 0.814 35.850 0.57 0.587 1.059 0.622 42.052 0.86 
14 1.644 0.836 1.375 30.497 1.00 1.644 1.098 1.806 45.660 1.00 1.644 1.070 1.759 52.843 1.00 
15 1.039 0.817 0.849 19.745 1.00 0.873 1.142 0.997 26.128 0.57 0.748 1.111 0.831 29.915 0.72 
16 3.081 0.902 2.779 36.045 1.00 2.311 1.050 2.427 62.583 0.43 1.797 1.039 1.867 76.603 0.29 
17 0.135 0.755 0.102 17.475 0.57 0.072 1.177 0.084 18.153 0.14 0.024 1.151 0.027 18.432 0.29 
18 0.138 0.770 0.106 17.204 0.43 0.050 1.236 0.062 17.686 0.29 0.044 1.200 0.053 17.860 0.00 
19 0.324 0.814 0.264 19.087 1.00 0.281 1.132 0.318 20.348 0.43 0.195 1.102 0.215 20.891 0.29 
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20 0.519 0.837 0.434 26.142 1.00 0.424 1.106 0.469 29.235 0.43 0.377 1.085 0.409 29.860 0.57 
21 1.123 0.847 0.951 26.718 0.72 0.898 1.085 0.974 43.555 0.43 0.786 1.060 0.833 55.100 0.86 
22 0.527 0.816 0.430 23.446 1.00 0.461 1.121 0.517 33.045 1.00 0.395 1.089 0.430 40.379 1.00 
23 0.610 0.741 0.452 19.164 1.00 0.529 1.217 0.643 21.824 1.00 0.437 1.163 0.508 22.927 1.00 
24 0.593 0.816 0.484 23.446 1.00 0.527 1.121 0.591 33.045 0.72 0.461 1.089 0.502 40.379 0.29 
25 1.798 0.851 1.529 30.094 1.00 1.498 1.075 1.611 43.183 1.00 1.199 1.053 1.262 51.730 0.72 
26 0.400 0.818 0.328 24.267 1.00 0.308 1.120 0.345 27.066 0.14 0.246 1.100 0.271 28.234 0.43 
27 0.504 0.873 0.441 29.445 1.00 1.979 1.058 2.094 52.393 1.00 1.715 1.039 1.783 65.020 1.00 
28 3.035 0.878 2.666 30.421 1.00 0.395 1.079 0.426 32.785 0.29 0.307 1.068 0.328 34.208 0.00 
29 0.355 0.879 0.312 29.415 1.00 0.210 1.084 0.228 33.079 0.86 0.178 1.076 0.191 34.510 0.00 
30 1.807 0.813 1.469 22.563 1.00 1.536 1.113 1.709 30.590 1.00 1.084 1.073 1.164 34.509 0.72 
31 0.407 0.885 0.360 42.163 1.00 0.356 1.084 0.386 58.661 0.72 0.305 1.063 0.324 68.306 0.72 
32 0.344 0.845 0.291 30.250 0.72 0.325 1.054 0.343 50.527 0.43 0.344 1.072 0.369 36.830 0.29 
33 1.154 0.857 0.989 23.797 1.00 0.938 1.096 1.027 33.335 1.00 0.649 1.063 0.690 40.408 1.00 
34 0.708 0.918 0.650 43.316 1.00 0.472 1.043 0.492 59.089 1.00 0.393 1.035 0.407 62.587 0.72 
35 0.797 0.903 0.720 39.172 1.00 0.545 1.058 0.577 50.048 0.43 0.336 1.043 0.350 55.125 0.14 
36 1.219 0.896 1.092 37.352 0.72 0.914 1.051 0.961 50.704 0.14 0.711 1.042 0.741 58.915 0.00 
37 0.808 0.856 0.692 24.545 0.86 0.539 1.115 0.601 27.471 1.00 0.350 1.098 0.384 28.689 0.72 
38 2.195 0.877 1.926 28.573 1.00 1.596 1.072 1.711 41.712 1.00 1.397 1.055 1.474 47.745 1.00 
39 0.992 0.875 0.868 33.865 1.00 0.850 1.084 0.922 44.094 1.00 0.709 1.058 0.750 48.152 0.86 
40 0.227 0.790 0.179 15.869 0.86 0.212 1.189 0.253 16.741 0.86 0.191 1.169 0.223 17.229 0.72 
41 0.949 0.877 0.833 33.421 0.00 0.576 1.086 0.626 45.533 0.00 0.509 1.063 0.541 53.154 0.00 
42 0.577 0.778 0.449 21.297 1.00 0.577 1.185 0.684 26.301 1.00 0.577 1.148 0.663 28.756 1.00 
43 2.336 0.875 2.044 30.619 1.00 1.934 1.061 2.052 49.347 1.00 1.531 1.042 1.596 58.999 1.00 
44 0.800 0.850 0.680 30.134 1.00 0.695 1.106 0.769 40.874 1.00 0.556 1.075 0.598 46.925 0.72 
45 0.677 0.863 0.584 28.022 0.86 0.542 1.081 0.586 33.045 0.57 0.316 1.068 0.338 34.799 0.14 
46 0.476 0.883 0.421 37.722 0.72 0.278 1.065 0.296 47.684 0.29 0.238 1.046 0.249 51.536 0.00 
47 0.521 0.853 0.445 24.452 0.86 0.521 1.118 0.583 27.135 0.72 0.521 1.103 0.575 28.191 0.72 
48 0.503 0.820 0.412 21.925 0.72 0.258 1.165 0.300 23.383 0.29 0.225 1.146 0.258 24.122 0.29 
49 0.179 0.779 0.139 17.682 0.86 0.124 1.201 0.149 18.750 1.00 0.080 1.168 0.093 19.202 0.86 
50 1.605 0.847 1.359 32.138 1.00 0.843 1.088 0.917 40.854 1.00 0.522 1.063 0.554 43.838 0.57 
51 2.076 0.845 1.753 30.503 1.00 1.639 1.090 1.787 43.539 0.86 1.202 1.066 1.281 50.335 0.29 
52 4.128 0.933 3.852 42.565 1.00 3.002 1.033 3.101 66.743 0.43 2.627 1.023 2.687 82.383 0.29 
53 1.304 0.880 1.148 30.465 1.00 1.043 1.082 1.129 36.054 0.86 0.626 1.066 0.667 37.848 0.59 
54 2.207 0.812 1.792 18.588 1.00 1.891 1.113 2.106 27.941 0.86 1.366 1.082 1.479 34.383 1.00 
55 0.696 0.848 0.590 20.017 0.86 0.544 1.122 0.611 21.552 1.00 0.302 1.108 0.335 21.844 0.57 
56 2.064 0.874 1.805 31.030 1.00 1.622 1.103 1.789 6.748 0.86 1.032 1.107 1.142 4.760 0.43 
57 0.457 0.848 0.388 38.224 1.00 0.373 1.112 0.414 51.145 1.00 0.288 1.081 0.311 58.309 1.00 
58 0.608 0.847 0.515 22.595 1.00 0.405 1.110 0.450 25.336 1.00 0.262 1.097 0.288 26.495 0.86 
59 0.399 0.715 0.286 12.505 0.00 0.318 1.288 0.410 13.200 0.00 0.288 1.244 0.359 13.464 0.00 
60 0.490 0.802 0.393 19.823 1.00 0.327 1.211 0.396 21.454 1.00 0.272 1.191 0.324 22.394 0.72 
61 0.113 0.709 0.080 13.458 0.72 0.083 1.260 0.105 14.581 0.29 0.053 1.192 0.063 14.990 0.29 
62 1.266 0.675 0.854 7.745 0.86 1.022 1.363 1.393 6.480 0.72 0.876 1.336 1.171 3.848 0.43 
Min.  0.113 0.675 0.080 7.745 0.000 0.050 1.033 0.062 6.480 0.000 0.024 1.023 0.027 3.848 0.000 
Max.  4.128 0.933 3.852 43.316 1.000 3.002 1.363 3.101 66.743 1.000 2.627 1.336 2.687 82.383 1.000 
Ave.  0.977 0.838 0.837 26.911 0.890 0.754 1.119 0.827 34.438 0.715 0.603 1.096 0.649 38.118 0.556 
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Figure 6.9 Shows the relationship between dispersion index of microcalcifications and their 
detectability in images without motion blur. This figure demonstrates there is no relationship (R2= 
0.083) between the detectability and dispersion index of microcalcifications.   
 
 
Figure 6.10 Demonstrates the relationship between the contrast of microcalcifications and their 
detectability in images without simulated motion blur. There is no relationship (R2= 0.0737) between 
contrast and detectability of microcalcifications.  
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Figure 6.11 Demonstrates the relationship between the DI x contrast of microcalcifications and their 
detectability in images without simulated motion blur. There is no relationship (R2=0.070) between the 
DI x contrasts of microcalcification and the detectability of the lesion. 
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Figure 6.12 Demonstrates there is no relationship between dispersion index of microcalcifications and 
the detectability of the lesion in images with simulated motion blur (0.7mm). 
 
 
Figure 6.13 Demonstrates there is no relationship between the contrast of microcalcifications and the 
detectability of the lesion in images with simulated motion blur (0.7mm). 
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Figure 6.14 Demonstrates there is no relationship between DI x contrast of microcalcifications and the 
detectability of the lesion in images with simulated motion blur (0.7mm). 
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Figure 6.15 Shows the relationship between dispersion index of microcalcifications and their 
detectability in images with (1.5 mm) motion blur. This figure demonstrates there is no relationship 
(R2 = 0.0027) between the detectability and dispersion index of microcalcifications.   
 
 
 
Figure 6.16 Demonstrates that there is no relationship between dispersion index of 
microcalcifications and the detectability of the lesion in images with motion blur (1.5 mm). 
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Figure 6.17 Demonstrates there is no relationship between DI x contrast of microcalcifications and the 
detectability of the lesion in images with simulated motion blur (1.5 mm). 
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6.5 Missed Lesion Analysis 
Missed lesion analysis (i.e. no detection in the free-response study) has been used to evaluate 
trends and to identify particular lesion types that have been overlooked frequently. This 
analysis has been done for all magnitudes of simulated motion blur such that the impact of 
simulated motion blur can be assessed for different lesion types. Comprehensive tables 
presented in (Table 6.14 & Table 6.15) to exhibit a list of all lesions missed and detected, 
describing detectability as the primary outcome. The detectability for each lesion is represented 
by the number of observers who successfully detected the lesion divided by the total number 
of opportunities for detection. For instance, when the all observers detected the lesions (7/7), 
this means that the detectability is 100%.  
Table 6.14 The detectability of malignant masses by the observers in images without motion blur (0.0 
mm), and images with simulated motion blur (0.7mm & 1.5 mm). 
No.  Observer 
1 
Observer 
2 
 
Observer 
4 
 
Observer 
5 
 
Observer  
6 
 
Observer 
7 
 
Observer 
9 
Detect
ability
% 
Detect
ability 
%  
Detect
ability 
% 
  0
.
0 
0
.
7 
1
.
5 
0
.
0 
0
.
7 
1
.
5 
0
.
0 
0
.
7 
1
.
5 
0
.
0 
0
.
7 
1
.
5 
0
.
0 
0
.
7 
1
.
5 
0
.
0 
0
.
7 
1
.
5 
0
.
0 
0
.
7 
1
.
5 
0.0  
mm 
0.7 
mm 
1.5 
mm 
 1  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
2  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
3  X  X  X  x  X X  X  X  X  X X X X x X X X X X X X 0%  0%  0% 
4  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
5  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
6  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
7  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ 100%  86%  100%       
8  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
9  X  X  X  ✓  ✓ X  ✓  X  X  ✓ ✓ X ✓ ✓ ✓ X X X ✓ X ✓ 71%  43%  29%
10  ✓  X  X  ✓  X ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ X ✓ ✓ 86%  57%  86%
11  X  ✓  ✓  ✓  X ✓  ✓  X  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X X ✓ 71%  57%  100%
12  ✓  ✓  ✓  ✓  ✓ ✓  ✓  X  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  86%  100%
13  X  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 86%  100%  100%
14  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ ✓ 86%  100%  100%
15  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
16  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
17  ✓  X  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  86%  100%
18  ✓  ✓  X  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  86%
 19  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
20  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
21  ✓  X  ✓  ✓  ✓ ✓  ✓  X  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ ✓ X ✓ 100%  43%  100%
22  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
23  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
24  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
25  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
26  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
27  X  X  X  ✓  ✓ ✓  ✓  X  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X X X X 71%  57%  57%
28  ✓  ✓  X  ✓  X ✓  ✓  ✓  ✓  ✓ X ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ X 86%  71%  71%
29  X  X  X  X  X X  X  X  X  ✓ X X X ✓ X X X X X X X 14%  14%  0% 
30  ✓  X  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ 100%  71%  100%
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31  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
32  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
33  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
34  ✓  X  X  ✓  X X  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ X 86%  71%  57%
35  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
36  ✓  ✓  ✓  ✓  ✓ ✓  ✓  X  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  86%  100%
37  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ ✓ ✓ 100%  100%  86%
38  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
39  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ X ✓ ✓ ✓ ✓ ✓ 86%  100%  100%
40  X  X  X  X  X X  X  X  X  X X X X X ✓ X X X X X X 0%  0%  14%
41  ✓  X  X  ✓  ✓ ✓  ✓  ✓  ✓  X ✓ ✓ X ✓ ✓ X ✓ X X ✓ X 43%  86%  57%
42  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ X 86%  100%  86%
43  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 86%  100%  100%
44  ✓  X  X  ✓  X ✓  ✓  X  X  ✓ ✓ ✓ ✓ ✓ X ✓ ✓ X ✓ ✓ X 100%  57%  29%
45  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X X 100%  86%  86%
46  X  ✓  X  ✓  ✓ ✓  X  X  X  ✓ ✓ X ✓ ✓ ✓ X X X ✓ X ✓ 71%  57%  43%
47  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
48  X  X  ✓  ✓  ✓ X  ✓  ✓  ✓  ✓ X ✓ ✓ X ✓ X X X ✓ ✓ ✓ 71%  43%  71%
49  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  X  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  86%
50  X  ✓  X  X  ✓ ✓  ✓  X  ✓  ✓ ✓ ✓ X ✓ X X ✓ X X ✓ X 29%  86%  43%
51  ✓  X  X  ✓  ✓ ✓  ✓  ✓  ✓  ✓ X ✓ X ✓ X X X ✓ ✓ X X 71%  43%  57%
52  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
53  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
54  X  X  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 86%  86%  100%
55  ✓  X  X  ✓  ✓ X  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ X ✓ ✓ ✓ ✓ ✓ 86%  86%  71%
56  X  X  X  ✓  ✓ ✓  X  ✓  X  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X X 57%  71%  57%
57  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  X  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ 100%  86%  86%
58  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X 100%  100%  86%
59  ✓  ✓  ✓  ✓  ✓ X  ✓  ✓  X  ✓ ✓ ✓ ✓ ✓ X ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  57%
60  ✓  ✓  X  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ 100%  86%  86%
61  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 100%  100%  100%
62  ✓  X  X  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ X ✓ X ✓ ✓ ✓ ✓ X X 86%  71%  57%
The mark (✓) represents the detected lesion while mark (X) represents the missed lesion. The 
highlighted results in three columns on the right side represents the average performance of the 
observers for lesion which is highly affected by motion blur. The detectability of each lesion 
represents the number of observers who detected the lesion divided by the total number of 
observers. For instance, when all the observers detected the lesions (7/7), this means that the 
percentage detecting the abnormality is 100%. While if only four observers detected the lesion 
from seven (4/7) the detectability will be 57.1 %. The highlighted cases represent the affected 
cases due to reduce in the detectability of the seven observers as the level of motion blur 
increases. The non-highlighted cases represent the non-affected cases due to the detectability 
of the observers remaining the same as increase the level of motion blur increases. This means 
that some lesion types are not affected by simulated motion blur at all. This table is 
complimented by an explanation in the discussion (Chapter Seven) as to why one type is not 
affected and why another is affected by simulated motion blur according to lesion features and 
breast characteristics.   
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Table 6.15 The detectability of malignant microcalcifications by the observers in images without 
motion blur (0.0 mm), and images with simulated motion blur (0.7mm & 1.5 mm). 
No.  Observer 
1 
Observer 
2 
 
Observer 
4 
 
Observer 
5 
 
Observer  
6 
 
Observer 
7 
 
Observer 
9 
Detectability of each 
lesion by each 
observer  
  0.
0 
0
.
7 
1
.
5 
0
.
0 
0
.
7 
1
.
5 
0
.
0 
0
.
7 
1
.
5 
0
.
0 
0
.
7 
1
.
5 
0
.
0 
0
.
7 
1
.
5 
0
.
0 
0
.
7 
1
.
5 
0
.
0 
0
.
7 
1
.
5 
0.0 mm  0.7 mm  1.5 mm
1  ✓  ✓  X  ✓  ✓ X  ✓  ✓  X  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  0.572
2  ✓  ✓  X  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  0.85
3  ✓  ✓  X  ✓  X X  ✓  ✓  ✓  ✓ ✓ X ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  0.858  0.572
4  X  X  X  ✓  ✓ X  ✓  X  X  ✓ X X X ✓ X ✓ ✓ X X X X 0.572  0.429  0.00
5‐1  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  1.00
5‐2  ✓  ✓  X  ✓  X X  ✓  X  X  ✓ ✓ X ✓ X X X ✓ ✓ ✓ X X 0.858  0.429  0.143
6  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  1.00
7  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  1.00
8  ✓  X  X  X  X X  ✓  ✓  X  ✓ ✓ X ✓ ✓ ✓ ✓ ✓ X ✓ X X 0.858  0.572  0.143
8  ✓  ✓  X  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ X ✓ X ✓ ✓ ✓ ✓ X X 1.00  0.858  0.429
 9  ✓  ✓  X  ✓  ✓ ✓  ✓  X  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ ✓ ✓ 1.00  0.858  0.429
10  ✓  ✓  X  ✓  X ✓  X  ✓  X  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ X X 1.00  0.715  0.429
11  ✓  ✓  ✓  ✓  ✓ ✓  ✓  X  X  ✓ X ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ 1.00  0.572  0.858
12  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  1.00
13  ✓  X  ✓  ✓  ✓ ✓  ✓  X  X  ✓ ✓ ✓ ✓ X X ✓ ✓ ✓ ✓ ✓ ✓ 1.00  0.572  0.715
14  ✓  X  X  ✓  X X  ✓  ✓  X  ✓ X X ✓ ✓ ✓ ✓ ✓ X ✓ X ✓ 1.00  0.429  0.286
15  X  X  X  ✓  X X  ✓  X  X  ✓ X ✓ X ✓ ✓ X X X ✓ X X 0.572  0.143  0.285
15  X  X  X  ✓  X X  ✓  X  X  ✓ X X X X X X X X X ✓ X 0.429  0.285  0.00
16  ✓  X  X  X  X X  ✓  X  X  X X ✓ ✓ ✓ X X X X X X X 0.429  0.143  0.143
16‐2  ✓  X  X  ✓  ✓ ✓  ✓  ✓  X  ✓ X ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ X 0.858  0.715  0.572
17  ✓  ✓  X  ✓  ✓ ✓  ✓  X  X  ✓ X ✓ ✓ X X ✓ ✓ X ✓ X X 1.00  0.428  0.285
18  ✓  X  X  ✓  ✓ ✓  ✓  X  X  ✓ ✓ ✓ ✓ X ✓ ✓ ✓ ✓ ✓ X X 1.00  0.428  0.572
19  X  ✓  ✓  ✓  X ✓  ✓  X  ✓  X X X ✓ X X ✓ ✓ ✓ ✓ ✓ ✓ 0.715  0.428  0.858
20  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  1.00
21  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  1.00
22  ✓  X  X  ✓  ✓ ✓  ✓  ✓  X  ✓ X X ✓ ✓ ✓ ✓ ✓ X ✓ ✓ X 1.00  0.715  0.286
23  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  X  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ ✓ ✓ 1.00  1.00  0.715
24  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X 1.00  1.00  0.858
25  ✓  X  X  ✓  X ✓  ✓  X  X  ✓ X ✓ ✓ X X ✓ ✓ X ✓ X X 1.00  0.143  0.286
26  ✓  ✓  X  X  ✓ ✓  ✓  ✓  X  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ ✓ X 1.00  1.00  0.43
27  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  1.00
28  ✓  X  X  ✓  X X  ✓  ✓  X  ✓ X X ✓ ✓ X ✓ X X ✓ X X 1.00  0.286  0.00
29  ✓  X  X  ✓  ✓ X  ✓  ✓  X  ✓ ✓ X ✓ ✓ X ✓ ✓ X ✓ ✓ X 1.00  0.858  0.00
30  ✓  ✓  ✓  ✓  ✓ X  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ ✓ ✓ 1.00  1.00  0.715
31  ✓  X  X  ✓  ✓ ✓  ✓  X  ✓  ✓ ✓ X ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  0.858  0.715
32‐1  X  ✓  X  X  ✓ X  ✓  X  X  ✓ X X ✓ ✓ X ✓ X X ✓ X X 0.858  0.429  0.285
32‐2  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ X ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  0.858  1.00
33  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  1.00
34  ✓  ✓  X  ✓  ✓ X  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  0.715
35‐1  ✓  X  X  ✓  X ✓  ✓  ✓  X  ✓ X X ✓ X X ✓ ✓ X ✓ X X 1.00  0.429  0.143
35‐2  ✓  X  X  ✓  X X  ✓  X  X  ✓ X X ✓ ✓ X X X X ✓ X X 0.715  0.143  0.00
36  ✓  ✓  X  ✓  ✓ ✓  ✓  ✓  X  ✓ ✓ ✓ ✓ ✓ ✓ X ✓ ✓ ✓ ✓ ✓ 0.858  0.858  0.715
37  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  1.00
38  ✓  ✓  ✓  ✓  ✓ ✓  ✓  X  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  0.858
39  ✓  X  X  ✓  ✓ ✓  ✓  ✓  ✓  X ✓ X ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 0.858  0.858  0.715
40  X  X  X  X  X X  X  X  X  X X X X X X X ✓ X X X X 0.00  0.00  0.00
41  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  1.00
42  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  1.00
43  X  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 0.858  1.00  1.00
44  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ X ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  0.715
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45‐1  ✓  X  X  ✓  ✓ X  ✓  X  X  ✓ ✓ X ✓ ✓ ✓ X ✓ X ✓ X X 0.858  0.572  0.143
45‐2  ✓  X  X  X  X X  ✓  X  X  ✓ X X ✓ ✓ X X ✓ X ✓ X X 0.715  0.286  0.00
46‐1  ✓  X  X  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ X ✓ ✓ ✓ ✓ X ✓ ✓ ✓ ✓ 0.858  0.715  0.715
46‐2  ✓  ✓  ✓  X  X X  X  X  X  X X X X X X ✓ ✓ ✓ X X X 0.715  0.285  0.285
47  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ X 0.858  1.00  0.858
48‐1  ✓  ✓  X  ✓  ✓ X  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X ✓ ✓ ✓ 1.00  1.00  0.572
48‐2  ✓  X  X  ✓  ✓ X  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ X ✓ ✓ X ✓ ✓ ✓ 1.00  0.858  0.286
49  ✓  X  X  ✓  ✓ ✓  ✓  X  ✓  ✓ ✓ X ✓ ✓ X ✓ X X ✓ X X 1.00  0.429  0.286
50  ✓  X  X  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ X ✓ ✓ X ✓ ✓ ✓ ✓ ✓ ✓ 1.00  0.858  0.585
51  X  X  X  ✓  X ✓  ✓  ✓  X  ✓ X ✓ ✓ X ✓ ✓ X X X X X 0.715  0.143  0.572
52  ✓  X  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  0.858  1.00
53  ✓  ✓  X  X  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ X ✓ ✓ X ✓ ✓ ✓ 1.00  1.00  0.572
54  ✓  ✓  ✓  ✓  ✓ ✓  ✓  X  X  ✓ ✓ ✓ ✓ ✓ X ✓ ✓ X ✓ ✓ X 1.00  0.858  0.429
55  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  1.00
56  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  0.858
57  X  X  X  X  X X  X  X  X  X X X X X X X X X X X X 0.00  0.00  0.00
58  ✓  ✓  X  ✓  ✓ ✓  ✓  ✓  X  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ X 1.00  1.00  0.715
59  ✓  X  X  ✓  X X  X  X  X  ✓ ✓ ✓ X X X ✓ ✓ X ✓ X X 0.715  0.286  0.286
60  ✓  X  X  ✓  ✓ ✓  X  ✓  X  ✓ ✓ ✓ X ✓ ✓ ✓ ✓ ✓ X X X 0.858  0.715  0.429
61  ✓  ✓  ✓  ✓  ✓ ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 1.00  1.00  1.00
62  ✓  ✓  X  ✓  X ✓  ✓  ✓  X  ✓ ✓ ✓ ✓ ✓ ✓ ✓ X X ✓ ✓ X 1.00  0.715  0.429
 
The mark (✓) represents the detected lesion while mark (X) represents the missed lesion. The 
highlighted results in three columns on the right side represents the average performance of the 
observers for lesion which is highly affected by motion blur. The highlighted cases were 
selected according to the decrease of the detectability when increases simulated motion blur. 
The detectability of each lesion represents the number of observers who detected the lesion 
divided by the total number of observers. For instance, when all the observers detected the 
lesions (7/7), this means that the percentage detecting the abnormality is 100%. While if only 
four observers detected the lesion from seven (4/7) the detectability will be 57.1 %. The 
highlighted cases represent the affected cases due to reduce in the detectability of the seven 
observers as the level of motion blur increases. The non-highlighted cases represent the non-
affected cases due to the detectability of the observers remaining the same as increase the level 
of motion blur increases. This means that some lesion types are not affected by simulated 
motion blur at all. 
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Chapter Seven: Discussion 
7.1. Overview  
This chapter evaluates the results of the free-response study and the physical measures 
performed on the lesions under different magnitudes of simulated blur. The discussion is 
organised into five main themes. The first theme will discuss the impact of motion blur on the 
detection performance of breast masses and microcalcifications for single observer data. The 
second theme will focus on the result of simulating a dual read versus a single read via the 
combination of observer data. The third theme will focus on the impact of simulated motion 
blur on the physical characteristics of breast masses and microcalcifications. The fourth theme 
will focus on the commonly missed lesions in this study and the impact of motion blur on lesion 
characteristics. The physical measures of malignant masses include the conspicuity index, edge 
angle, grey level change, image noise and SNR. The physical measures of malignant 
microcalcifications include a new novel metric known as the ‘dispersion index’, contrast, 
image noise and SNR with the impact of motion blur. The fifth theme will focus on the impact 
of motion blur on the image characteristics of malignant masses; discussing the cases where 
observer performance was affected by simulated motion blur and those that were not. Finally, 
the limitations of the work will be discussed.  
7.2 Free-response Performance Study (single observer) 
This thesis has investigated the impact of computer simulated motion by means of shifting 
accumulated pixel points to blur the resultant image. The results of the single observer free-
response study demonstrate that simulated motion blur had a significant effect on observer 
performance, with performance becoming statistically worse for the detection of 
microcalcifications as motion blur increased from 0 mm to 0.7 mm, and then on to 1.5 mm. A 
similar trend was observed for masses, with the only difference being that there was no 
statistically significant difference in lesion detection performance as the magnitude of 
simulated motion blur was increased from 0.7 mm to 1.5 mm. For both broad categories of 
lesions, it should be noted that motion blur in the magnitude of 0.7 mm and above will have an 
adverse impact on lesion detection performance. 
 Previous work by Ma et al., (2015) suggested that motion blur could be visible at 0.7 mm for 
‘soft-edged’ motion blur using software simulation, and the findings of my PhD thesis appear 
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to confirm that a similar effect was observed with a computer simulation motion blur on clinical 
mammographic images. This observation may have implications for practice. It suggests that 
if motion blur is identified in an image, repeat imaging should be considered as in clinical work 
one would simply not know how much motion blur is present or what impact it is having in 
terms of masking lesions or potentially changing the appearance of lesions. If image motion 
blur has this type of impact it could lead to an incorrect classification of disease status. In order 
to explain the significance of motion blur, several scenarios are presented: 
Scenario 1– repeated case 
Motion blur is detected at the time of image acquisition and a decision is made to repeat the 
image while the client is still within the mammography department. The image is repeated 
directly after image acquisition and the client is still in the mammography department. This 
occurs when the radiographer detects blur during the quality assessment of the image whilst 
still in the mammography imaging room. This process will lead to increased cost and radiation 
dose, lost time and effort. From the clients perspective, repeating the image at the time of 
attendance is better than a recall (i.e. reduced anxiety). However, the image blurring could go 
undetected in imaging rooms if low resolution monitors are used (Ma et al., 2016). 
Scenario 2– recall case 
If motion blur is not identified at the time of acquisition, and is only picked up during the 
review of images (on a higher specification of monitor display) then the client may be recalled 
for further imaging. This scenario can lead to an increase in client and family anxiety because 
they might suspect that an abnormality has been detected. In addition, the decision to recall a 
client means a new appointment must be scheduled, which can ultimately lead to delays in the 
detection and treatment of breast cancer.	
Scenario 3– missed lesion 
If motion blur is not detected at any point during the diagnostic decision making stage and a 
lesion is ‘missed’, there is a chance that this lesion could later present at follow-up imaging or 
as an interval cancer. An interval cancer represents a breast cancer which is detected in the 
interval between scheduled screening sessions (Hofvind & de Wolf, 2015).  
In the performance study, there were several categories of lesion. First, lesions that are detected 
by all observers when motion blur is absent and then missed by the observers in images 
containing simulated motion blur (0.7 mm and 1.5 mm), providing a clear indication about the 
impact of motion blur on detection performance. Second, some lesions were not affected by 
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the magnitudes of simulated motion blur used in this study. Third, lesions that are either 
difficult to detect or decide if they are malignant, when lesions are missed by all observers in 
images without blur and in images with motion blur (0.7 mm & 1.5 mm); this means that in 
some difficult cases, lesions were missed anyway and blurring had no impact on their detection 
performance. In this study, we do not know if it is due to decision or detection error; further 
work with eye-tracking may help to answer this. 
The impact of motion blur on lesion detection performance could vary with lesion 
characteristics. Each lesion within the mammography image has a range of characteristics along 
with a range of background features in which the lesion sits. Some of the lesion types, such as 
spiculated or indistinct masses, could be affected by motion blur due to the impact of simulated 
blur on the edge between the lesion and background tissues; while others, such as well 
circumscribed oval or round masses, might be affected or not affected at all. A lesion-by-lesion 
analysis of detection performance revealed that larger malignant masses were not affected by 
simulated motion blur. In addition, breast masses that have high lesion-to-background contrast 
did not demonstrate a detection deficit in the observer study. However, some smaller, low-
contrast breast masses were associated with poorer detection performance. For example, some 
small breast masses were detected in images without motion blur by all observers and missed 
when simulated motion blur was applied (at 0.7mm and 1.5mm simulated motion blur ) (See 
Table 6.15 on page 155). 
In the observer study, a high FOM and sensitivity were achieved for images without motion 
blur for microcalcifications and masses. For microcalcifications, the observer averaged 
wJAFROC FOM was 0.899 (0.757,0.870) in images without motion blur, whereas this 
decreased to 0.813 (0.757,0.870) in 0.7mm and 0.746 (0.679,0.812) in 1.5mm levels of 
simulated motion blur . For masses, the FOMs in images without motion blur was 0.905 
(0.859,0.952) compared with blurred images 0.7mm 0.869 (0.814,0.924) and 0.862 
(0.810,0.915) in1.5mm . However, it should be noted that there is no statistically significant 
difference between 0.7mm and 1.5mm levels of simulated motion blur for the latter; this gives 
an indication that the levels between 0.7 and 1.5 have the same impact on lesion detection 
performance.  
There are many factors that affect lesion detection performance and these should be taken into 
account in both the empirical work presented here and in clinical practice. Many studies suggest 
that detection performance is related to the observer in terms of experience, cognitive skills and 
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visual performance (Reed,  2005; Manning et al., 2006; Sabih et al., 2011; Burgess, 2011; Lança 
et al., 2015). Other studies suggest that lesion characteristics could contribute to the challenges 
of interpreting an image accurately. Lesion characteristics are particularly important in breast 
disease. Malignant breast lesions with indefinite edges for normal and pathological tissue can 
lead to difficulties in perception (Van Overveld, 1995; Tabar et al., 2005; Kopans, 2006). Other 
studies suggest that factors related to the characteristics of mammographic images (e.g. image 
quality, artefacts, spatial resolution, sharpness and contrast resolution) can also influence 
detection performance (Li et al., 2010; Spuur et al., 2011; Zanca et al., 2012).  
7.2.1  Microcalcifications 
Free-response data were analysed for the detection of malignant microcalcifications for three 
conditions; (i) no simulated motion blur (0.0 mm), and for two magnitudes of simulated motion 
blur (0.7 and 1.5 mm). A significant difference was observed between 0 mm and 0.7 mm, and 
between 0 mm and 1.5 mm of simulated motion blur, and also between 0.7 mm and 1.5 mm. 
This means all levels equal to and above 0.7mm have the potential to obscure lesions or cause 
interpretation error. In addition, an even higher significant difference was detected between 
(0.0 mm V 1.5 mm, p= 0.004) compared with 0.0mm and 0.7mm (p= 0.0016). This suggests 
that the negative impact of simulated motion blur on detection performance increases as the 
level of simulated motion blur  increases. It should be noted that no study was found in the 
literature to compare the results of the impact of motion blur on lesion detection performance 
in FFDM, so comparisons to what is already known cannot be done. 
Lesions which contain less than 10 calcifications in a cluster and are classified as punctate or 
granular types of microcalcifications illustrating irregularity in density, variety, size, or shape 
were affected by simulated motion blur and tended to be associated with poorer detection rates. 
Figure 7.1 provides an illustration of this, where the calcifications are indicated by red arrows. 
The microcalcifications appear as non-focal clusters with irregular outlines. In contrast, the 
results demonstrated that the microcalcifications which have definite edges (similar shape, 
density and size of individual microcalcifications) with focal clustering were not affected by 
motion blur. Overall, detection performance decreased as simulated motion blur increased. In 
the case described in Figure 7.1, 100% (7/7) of the observers detected microcalcifications with 
no blur (0.0mm), this decreased to 14.3% (1/7) at 0.7mm and 29% (2/7) at 1.5mm of simulated 
motion blur.  
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Figure 7.1 Magnified area of right cranio-caudal projection. Demonstrates a cluster of 
microcalcifications have irregular shapes. 
 
The cases used in this observer study have been classified into two types according to the 
influence of motion blur on detection performance; affected and not affected. The detection 
performance of some image characteristics of malignant calcifications are affected by motion 
blur more than others. Figure 7.2 describes an example that contains several different shapes 
of calcification, such as pleomorphic, diffuse and punctate. These have all been detected by the 
observer in images without motion blur (0.0mm). The same microcalcifications have been 
missed by the observers when simulated motion blur had been applied in the magnitude of 
0.7mm and 1.5mm levels of simulated motion blur. This suggests that motion blur could 
obscure certain types of small calcifications. In general, sensitivity represents a measure of 
accuracy determined by the true positive rate which is the ability of the observer to accurately 
identify cases of disease while specificity represents a measure of the true negative rate or the 
ability of the observer to accurately identify cases without lesion. Since the FOM decreased as 
simulated motion blur increased, this implies that the false negative rate also increased. This 
relationship, between the FOM and motion blur, was significant (F(2,18) = 10.48, p=0.0010). 
The results demonstrate that the sensitivity of images without simulated motion blur (0.0mm) 
was 97.9, and the sensitivities for blurred images (0.7mm and 1.5mm) were 86.4 and 76.5 %, 
respectively. When specificity (HrSp) is used as the FOM, there was no significant difference 
between magnitudes of simulated motion blur (F(2,13) = 0.21, p=0.8110). This suggests that 
the false positive rate did not increase significantly with increasing motion blur. Although the 
false positive (FP) rate at the 1.5mm level was more than 0.0mm level, a low confidence level 
  
155 
was provided by the observers (1.5 mm) and the free-response study is designed to not penalise 
errors if the observers gives low confidence level.   
 
Figure 7.2 Magnified views of images without simulated motion blur (0.0mm) and blurred 
mammography images (0.7mm & 1.5mm). The images illustrate a cluster of malignant 
microcalcifications, which were affected by simulated motion blur. 
 
7.2.2 Masses Cases 
For masses, a statistically significant difference was detected between two levels (0 mm V 1.5 
mm, p=0.0041), this means that detection performance was reduced between images containing 
no blur and those containing 1.5mm of simulated motion blur. The result also showed that there 
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was no significant difference between the two magnitudes of simulated motion blur (0.7 mm 
and 1.5 mm; p=0.640). This means that all magnitudes of motion blur above 0.7 have a similar 
negative impact on mass detection. When sensitivity (HrSe) was used as the FOM, there was 
no significant difference between different magnitudes of simulated motion blur (F (2, 16) = 
0.43, p=0.6575). This implies that the false negative rate did not change significantly as a result 
of simulated motion blur. The sensitivity of images without motion blur (0.0 mm) was 92.3% 
and the sensitivity for blurred images were 91.9% and 90.5% for levels 0.7mm and 1.5mm, 
respectively. The sensitivity of lesion detection decreases with increasing levels of motion blur, 
but not to a significant level. When specificity (HrSp) was used as the FOM, again there was 
no significant difference between magnitudes of simulated motion blur (F (2,12) = 1.31, 
p=0.3043). Specificity reduces with an increase in the level of simulated motion blur especially 
in cases of breast masses, with magnitudes shifting from 82.7% for images without motion blur 
(0.0 mm) to 73.3% in blurred images (0.7 mm). 
In summary, for both microcalcifications and masses, there was a reduction in sensitivity as 
the magnitude of simulated motion blur increased. For masses, this was not statistically 
significant and the values in (Table 5.5 on page111) demonstrate that the false negative rate 
did not change that much as motion blur increased. For microcalcifications, this was not the 
case and there was a statistically significant reduction in sensitivity, (Table 5.3 on page 107) 
suggests that an increase in motion blur caused the smaller lesions to become visually 
imperceptible. The change in specificity was not significantly different for masses or 
microcalcifications. 
The literature is relatively sparse on studies that have looked at the impact of motion blur 
artefacts, however there are some isolated cases from other image modalities that have assess 
the impact of motion blur. Let us now compare the mass results in this thesis with other studies. 
Donnelly and Thompson, (2017) assessed the impact of simulating respiratory motion on the 
detection of lung nodules in CT. Low-dose images were generated with the intention with the 
primary application of CT attenuation correction (CTAC) of nuclear medicine SPECT image 
data. They used an anthropomorphic chest phantom and a variety of simulated spherical lung 
nodules of different size and density. Physical motion blur was introduced through use of a 
mechanical device used to simulate the rate and amplitude of respiratory motion. Five 
observers assessed the images with and without simulated motion using a free-response study 
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to determine the detection performance of the nodules. Data were analysed using the 
wJAFROC FOM. It was concluded that simulated respiratory motion has a significant negative 
impact on nodule detection performance (F(1,4.00) =10.88, p=0.0300). 
In comparison to other previous observer studies, the FOM achieved in images containing no 
simulated motion blur were associated with generally better performance. This must be 
considered in some caution due to differences in study design, purpose of the research, and the 
population of client images, and the experience of the observers. For instance, a study by 
(Debono, 2012a) evaluated the diagnostic accuracy of reporting radiographers in screening 
mammography according to types of breast lesions. Debono used ROC method to assess the 
accuracy of 10 radiographers through measuring the area under the curve (AUC). Debono 
found that individual sensitivity levels ranged between 76.0% and 92.0%, and individual 
specificity levels ranged between 74.8% and 96.2%. Debono (2012a) also summarised 
previous studies and found that radiographer sensitivity levels varied between 61.0% and 
91.42%, and specificity levels varied between 45.0% and 99.1%. Debono’s study found 
radiologist sensitivity levels were between 63.9% and 100%, and specificity levels between 
81.0% and 99.2% (Debono, 2012a). In my thesis, the FROC method was used to determine the 
detection performance; this is more advanced method than ROC, since ROC ignores location 
information. Typically, it is expected that an inflated FOM is generated if location information 
is ignored. However, this general level of agreement in performance is encouraging. 
 
7.2.3 Reflection – comparison of laboratory and clinical studies 
A laboratory study, as conducted in this thesis, is very different to the clinical reality of 
reviewing mammographic images. In a laboratory study there is a heightened expectation of 
disease since there is an enriched dataset and the observers know they are probably looking for 
a higher proportion of lesions. The consequence of this is that observers are more likely to 
indicate the presence of a lesion. This can lead to changed behaviour and in this situation the 
likelihood of making more localisation, leading to increased true and false decisions, has little 
consequence other than an increase in sensitivity or a reduction in specificity (Table 5.2 on 
page 101 and Table 5.6 on page 107). When compared to the clinical scenario, the image 
reader also has to consider their recall rate and the risk of over-investigation. It is difficult to 
predict how image readers will behave during a laboratory study and consequently this can lead 
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to differences in sensitivity and specificity. This is why laboratory studies are conducted using 
multiple readers and cases. 
 
7.3 The Combined two Observers’ Data 
Double reading is a routine procedure to interpret mammographic images in breast cancer 
screening programmes. In the UK NHSBSP, double reading  is ideally conducted blinded for 
all cases (Wilson et al., 2011). Discordant cases are arbitrated under locally agreed protocols. 
In the case of a suspicious area being noted, a decision is then made to either recall the client 
for further assessment or allow them to carry on as normal in routine triennial screening. 
Double reading is standard and recommended in many breast screening programmes (e.g. 
European and Australia breast cancer screening programmes) due to the advantages of 
increased accuracy and sensitivity through decreasing the chance of undetected lesions (Perry 
et al., 2008; Debono et al., 2015). With the above in mind, there was an opportunity to combine 
the data from individual observers to simulate the outcome of a double reading. The purpose 
of combined two observers’ data was to assess the impact of combined observer free-response 
data on lesion detection performance in blurred images. Since this was a retrospective analysis 
of the data acquired by individual observers, the method to achieve this in my thesis cannot be 
generalised to NHSBSP practice as no consensus meeting or arbitration process took place for 
discordant cases. However, it is reasonable to assume that the combined read used in this thesis 
will give a higher positive outcome rate because in the clinical setting within NHSBSP the 
double reading consensus meeting will result in some cases being ‘downgraded’ from positive 
to negative. 
Different combinations of two observers’ data was likely to enhance the detection performance 
of the observers. For random reader random case analysis of breast masses, there was no 
statistically significant difference in lesion detection performance between single and 
combined free-response data (F(1,6)=4.04, p=0.1001). For the analysis of microcalcifications, 
a statistically significant difference in lesion detection performance was demonstrated between 
single and combined free-response data (F(1,6)=12.28, p=0.0122). For both masses and 
microcalcifications, there was an increase in sensitivity (HrSe) when using two observers in 
combination rather than one observer in isolation.  This is due to the method used to combine 
the data, where the highest rating was taken as the single rating. This means that if one of the 
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two observers correctly localised the lesion it would be classed as true positive.  Conversely, 
the simulation of a double reading also increased the number of false positive localisations thus 
reducing the specificity, as shown by the HrSp FOM (Tables 5.11 on page 122 & Table 5.13 
on page 124). These results agree with previous studies (Husien, 1995; Taplin et al., 2000), 
where double image reader interpretation resulted in an increase in sensitivity of 10%.  
However, there was a decrease in specificity of 1.8%. For my thesis, in the single observer 
data, there was a negative significant difference in the impact of motion blur on breast mass 
detection performance. A statistical difference in detection performance was found when 
motion blur was applied to the images at 0.7 mm for the combined observer data.  
 
Many studies have discussed the advantages and disadvantages of double reporting. Firstly, 
double reporting can increase sensitivity through decreasing the chance of undetected lesions 
(Blanks et al., 1998; Dinnes et al., 2001; Harvey et al., 2003; Klompenhouwer et al., 2015). 
Accordingly, double reporting of mammographic images became normal practice in European 
breast screening programmes (Perry et al., 2008). However, there are some disadvantages of 
double reporting related to its cost-effectiveness. First, double reporting effectiveness can be 
less important when a high level of agreement between image readers is achieved (Taplin et 
al., 2000). Second, the benefit of double reporting might be restricted to specific situations 
when the detection of cancer is difficult, i.e. mammographic images of females in prevalent 
screening (first participation) when previous mammograms do not exist, females with small 
lesions that are difficult to detect, or when the image readers are less experienced (Dinnes et 
al., 2001; Sickles, 2010). Finally, double reporting increases staff costs and resources utilised 
in the interpretation procedure and takes longer time (Posso et al., 2016). However, others 
argued that in some contexts more advantages can be achieved from single reporting as it may 
decrease costs and FP without significantly decreasing the detection rate of breast cancer 
(Varela et al., 2005). Overall, double reporting in clinical practice remains controversial, with 
benefits and values being noted in the literature. 
7.3.1  Microcalcifications Combined two Observers’ Data 
This part of the discussion will focus on the comparison between images which contain two 
levels of motion blur (0.7mm & 1.5mm) and images which have no blur (0.0mm). The purpose 
of this discussion is to determine whether the combination of two observers’ data reduces the 
impact of simulated motion blur in FFDM images in microcalcifications or not. The results of 
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two combined observers’ data for microcalcifications demonstrated that there is an 
improvement in detection performance. The p-values indicated a statistically significant 
difference between all three comparisons (0.0-0.7, 0.0-1.5 and 0.7-1.5mm) (see Table 5.11 on 
page 122). Differences between FOM pairs of images without motion blur (0.0mm) was 0.923 
(0.883, 0.964) and images with magnitudes of simulated motion blur  (0.7mm and 1.5mm) 
were 0.876 (0.831, 0.921), 0.826 (0.771, 0.880) for (0.7mm and 1.5mm) respectively. The 
sensitivity of images without motion blur (0.0 mm) was 99.7, and the sensitivities for blurred 
images (0.7mm and 1.5mm) were 96.0 and 89.6, respectively. It can be noticed that the 
sensitivity of detected lesion decreases when levels of motion blur increase. In contrast, 
specificity decreased with the increasing levels of motion blur (0.0mm and 0.7mm was 72.0 
and 70.9). This means there is an increase in FP in microcalcification cases between these two 
levels (0.0mm and 0.7mm). These findings suggest that there is some advantage of having a 
second observer for the detection of microcalcifications when motion blur is present. Given the 
method used to combine the free-response data, an expected increase in sensitivity and decrease 
in specificity when the data has been combined leads to decrease in specificity due to an 
increase in the false positive fraction.  
7.3.2  Masses Combined Two Observers’ Data 
For combined two observers’ masses data, a statistically significant difference was found for 
the detection of masses (F(2,21)=6.01, P=0.0084). A significant difference was observed 
between 0 mm and 0.7 mm, and between 0 mm and 1.5 mm of simulated motion blur . No 
significant difference was detected between 0.7 mm and 1.5 mm. Rjafroc was also used to 
calculate observer averaged sensitivity (FOM=HrSe) and specificity (FOM=HrSp) as the FOM 
for all comparisons between 0.0mm, 0.7mm and 1.5mm (Table 5.13 on page 124). There was 
no significant difference in detection performance between images blurred with a magnitude 
of 0.7 mm and those with 1.5 mm, for cases containing masses for both single observer data 
and combined two observers’ data methods. This was not the case for microcalcifications, 
where detection performance became statistically worse as the magnitude of motion blur  was 
increased.  
Summarising of combined observers’ data for masses and microcalcification, this must be 
evaluated with some caution given the differences between an observer study of this type and 
a clinical evaluation. Since it was a retrospective decision (secondary analysis of data) to 
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combine the free-response data, there was no opportunity for arbitration to occur in cases in 
which they did not agree. Had this occurred, it is possible that the values of specificity could 
have been more favourable (i.e. a consensus decision may have reduced the number of non-
lesion localisation marks). However, the converse could be true for sensitivity, where a 
consensus decision may result in a true lesion being downgraded. A study by (Tanaka et al., 
2015) investigated the impact of combining data from a free-response study to simulate a dual-
read. They found a general improvement in performance when combining the interpretation of 
a radiographer with a radiologist, demonstrated by an inflated FOM, but the overall 
significance of combined observations was not stated. The key finding, of Tanaka’s study and 
the current thesis, is that a combined read is unlikely to be detrimental to patient outcomes. 
7.4 Physical Measures:  
7.4.1 Physical Measures of Microcalcifications 
This part of the discussion focusses on the impact of motion blur on the physical characteristics 
of malignant microcalcifications, including a new experimental metric  (dispersion index, DI), 
contrast, image noise and SNR. The DI of microcalcifications represents the number of 
calcifications within a specified area divided by the area. DI was measured within ImageJ 
software because the conspicuity index could not be applied to microcalcifications due to their 
small individual size and wide distribution pattern. No validation has been conducted on DI, 
but this could be a focus for post-doctoral work. A literature search conducted prior to this 
research did not reveal any validated method for achieving a physical measure of 
microcalcification clusters; this led to the development of the new DI metric. The result 
demonstrates that the DI decreases when the level of simulated motion blur increases (see 
Table 6.8 on page 139). Simulated motion blur has a significant negative impact on the 
dispersion of calcifications image. Figure (7.3) demonstrates magnified mammographic 
images which contain clustered microcalcifications. The DI in the image without motion blur 
(0.0mm) was 0.608 per cm2 , while the DI for images with motion blur (0.7 and 1.5mm) 
decreased to become 0.405 and 0.262 per cm2, respectively. In general, the lesion background 
can have a negative impact on the search pattern. This is referred to as the crowding effect	
(Levi 2009). The contrast threshold represents the contrast essential for the visibility of a test 
object for a determined task of the image reader, e.g. for detecting an object. A mammographic 
image can contain anatomical noise and this can have an impact on the perception of structures 
(e.g. lesions). The results of this thesis show that the contrast of clustered microcalcifications 
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increases when in the level of simulated motion blur  increases  (Table 6.10 page 141). In 
addition, the results demonstrate that there is no relationship between (DI. x contrast) and the 
detectability of lesions by the observers.	 
 
Figure 7.3 Magnified mammographic images contain clustered microcalcification. The DI in the image 
without motion blur (0.0mm) was 0.608 per cm2, while the DI for images with motion blur (0.7 and 
1.5mm) were 0.405 and 0.262 per cm2 respectively. 
                    
Many researchers define a cluster of microcalcifications or suspicious group as at least five 
calcifications in a breast volume of 1 cm3 (e.g. Evans et al., 2002; Shetty, 2015). Small subtle 
microcalcifications with a size of less than 0.5 mm are a distinctive feature of malignancy, 
although this threshold will differ somewhat in the thickness and density of the breast. With 
the exception of motion blur, the key determinant for visibility of small calcifications is the 
magnitude of image noise relative to the calcification’s signal (Ruschin, Timberg and Båth, 
2007b). Since smaller calcifications will provide a signal sometimes as small as a single pixel, 
the pixel-to-pixel difference depends on the image noise and it will reduce the visibility of 
small calcifications to a much higher extent than the visibility of the mass due to mass being 
larger than the size of the individual calcifications. To ensure better visualisation of structures 
as small as 0.1 mm in size, the European guidelines for quality assurance in breast cancer 
screening determined acceptable threshold levels of contrast for objects ranging from 0.1 to 2.0 
mm in size, which should be available in digital mammography at acceptable glandular dose 
levels (Perry et al., 2006). For optimal visualisation of microcalcifications at a given glandular 
dose, it is typically beneficial to enhance the SNR. The SNR difference between the two 
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magnitudes of simulated motion blur and no motion blur were statistically significant for all 
comparisons between 0.0mm, 0.7mm and 1.5mm (Table 6.12 on page 144). A graphical 
representation of the means and adjusted 95% confidence intervals are displayed in (Figure 
6.8 page 144). The average of SNR was 26.97 for images without simulated motion blur and 
the average for blurred images (0.7 mm and 1.5mm motion blur) are 34.413 and 38.035, 
respectively. However, there is no relationship between the physical measures and the lesion 
detection performance of the observers (lesion detectability). 
 
7.4.2 Physical Measures of Malignant Masses  
The physical characteristics of malignant breast masses were determined by physical 
parameters including conspicuity index, edge angle, grey level change, and image noise. The 
physical measures of malignant masses have been analysed using conspicuity software 
(Szczepura and Manning, 2016), partly to demonstrate the behaviour of blurring software and 
partly to assess the impact of motion blur on the physical characteristics of breast mass images.  
7.4.2.1	The	Lesion	Conspicuity	and	Edge	Angle	
The results demonstrated that the conspicuity index increases significantly when simulated 
motion blur increased from 0mm to 0.7mm and then to 1.5mm (See Table 6.3 page 130). This 
change in the image lesion characteristics and may negatively impact on the differential 
diagnosis. It is reasonable to hypothesize that, when the conspicuity of lesions increase this 
does not necessarily mean that the detectability of the lesion should also increase. The 
observers may see the lesion but it is possible they might not be able to decide if the lesion is 
malignant or benign due to the influence of motion blur. It is hypothesised that the motion blur 
may cause a decision error rather than a detection error; in the other words, decision-making 
errors can happen when the lesion is obvious, but the assessment of its nature is made 
incorrectly. It should be noted that further studies are required in future work to evaluate 
decision error with eye-tracking. This result in a lesion being falsely dismissed as benign when 
it is actually malignant, false-negative (FN). Manning et al., 2004 concluded that most errors 
in image perception were failures of decision-making instead of detection errors (Manning, 
Ethell and Donovan, 2004b). According to (Zuley, 2010) the mistakes in perceiving 
mammographic images can be categorised into three types: search errors, recognition errors 
and decision-making errors. If a lesion is not identified by the observer this is considered a 
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search error. However, if the lesion catches the observer’s eye but is then quickly dismissed it 
is considered a recognition error. This will lead to the lesion going undiagnosed. Manning et 
al., (2002) also demonstrated a poor relationship between conspicuity index and missed lesions 
in chest radiography and pointed out the decision errors were mainly related to detection 
(Manning and Ethell, 2002).  
Perception errors can be considered as the main cause of missed cancers in mammography. 
Misdiagnosed breast cancers can be attributed to their subtle characteristics. A suboptimal 
technique related to technical factors and/or poor positioning can also lead to reduced lesion 
conspicuity leading to poor detection (Goergen et al., 1997). The average of conspicuity index 
for malignant masses in this thesis is 87.28 for images without simulated motion blur to 116.33 
and 124.08 for images with simulated motion blur (0.7 mm and 1.5mm motion blur), (see 
Figure 6.1 on page 130). The size of a focal lesion is a significant factor used to determine the 
conspicuity of the lesion. This thesis included a wide range of lesion sizes from approximately 
5 mm to 30 mm (see tables of the collected data Appendix G). The cancer lesion sizes were 
similar to lesion sizes used in other observer based studies (Michaelson et al., 2003; 
Obuchowski et al., 2000). For example, a study by Michaelson et al., (2003) demonstrated that 
the size of lesions detected by screening mammography varies between 5 mm and 32 mm 
(Michaelson et al., 2003). Some image characteristics of malignant masses can be difficult to 
interpret due to their small size due to their relatively low contrast with background tissue; this 
can have an impact on visual perception. The difference in edge angle between the two 
magnitudes of simulated motion blur and no motion blur were statistically significant for all 
comparisons between 0.0mm, 0.7mm and 1.5mm (Table 6.4 on page 132).  Edge angle 
magnitude decreased as simulated motion blur level increased. The results of edge angle 
correlated with the results of the free-response study. The detection performance of breast 
masses reduced with a reduction in edge angle, as the magnitude of simulated motion blur was 
increased. Simulated motion blur has an impact on edge angle of breast masses and this could 
therefore influence the image characteristics of lesions. This suggests that any impact on the 
image characteristics of breast masses appearance could negatively affect differentiation 
between malignant and benign masses. Figure 6.2 (on page 132) demonstrates the means of 
edge angle (confidence interval 95%) of the two magnitudes of simulated motion blur and no 
motion blur. The average edge angle is 69.11 for images without simulated motion blur and 
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the range for blurred images (0.7 mm and 1.5mm motion blur) are 67.63 and 66.65, respectively 
(Figure 6.2).  
  
7.4.2.2	Change	in	grey	level	(ΔGL)	of	masses	
The results demonstrated that there was no difference in the change of grey level when the 
level of motion blur increases. The change of the grey level difference between the two 
magnitudes of simulated motion blur  and no motion blur  was not statistically significant for 
all comparisons (0.0mm, 0.7mm and 1.5mm) of simulated motion blur. A previous study by 
Rawashdeh et al., (2014) measured breast lesion ΔGL for global background regions as the 
mean grey level value of lesion minus the mean grey level value of the whole breast without 
pectoralis muscle. The aim was to establish the key morphological criteria of the global 
background (i.e. the breast that contains the lesion) that impacted on breast cancer detection. 
They suggested that there was a relationship between “rating of detectability” and breast 
density, lesion size, lesion edge and solidity. Some of these previous results agreed with the 
results that have been established in this thesis, however, there is no relationship between 
detectability and the change in grey level. This could be related to there being no impact of 
motion blur on ΔGL. An early study by (Aldrich & Desai, 1994) used grey level to evaluate 
the textual content of digitized mammography images. Statistics calculated from the GL were 
utilised to highlight image lesion characteristics. They reported that GL has an apparent 
capability to provide discrimination between normal and abnormal areas to enhance breast 
cancer diagnosis. A study by (Boher and Collomb-patton, 2012) used temporal measurements 
to characterise the motion blur of liquid-crystal display (LCD) displays. This calculation was 
conducted automatically for each grey level transition. The contrast sensitivity function of the 
human eye was introduced to assess perceived blur edge width and time for each grey level 
transition providing a powerful process for a full characterisation of motion blur in such 
displays (Boher and Collomb-patton, 2012). The results of my thesis demonstrated that there 
was no impact of motion blur on GL and there is no relationship between GL and detection 
performance.  
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7.4.2.3	Image	Noise	and	Signal	to	Noise	Ratio	(SNR)	
Both the noise and signal to noise ratio (SNR) of mass images were analysed to investigate the 
impact of simulated motion blur on the physical characteristics of the images. The difference 
in SNR between the two magnitudes of simulated motion blur and no motion blur were 
statistically significant for all comparisons between (0.0-0.7, 0.0-1.5 and 0.7-1.5mm) (Table 
6.6 on the page 136). Image noise decreased as the level of simulated motion blur increased; 
this is believed to be a consequence of the smoothing process induced by the motion blur 
software (Dougherty, 2009). The average of SNR (Figure 6.4 on page 136) is 2.741 for images 
without simulated motion blur and the average for blurred images (0.7 mm and 1.5mm motion 
blur) are 4.394 and 5.653 , respectively. The results in my thesis showed noise had a statistically 
significant difference between 0.0–0.7mm t(22)=22.95 (p<0.000), 0.0–1.5mm t(22)=24.66 
(p<0.000), and for 0.7–1.5mm t(22)=18.11 (p<0.000). Noise decreased as the magnitude of 
simulated motion blur increased, this finding is in line with the smoothing effect imposed by 
simulated motion blur. Saunders et al., (2007) have examined the impact of different noise 
levels and resolution on cancer detection performance in digital mammography. They used 
images at three different resolution levels and three different noise levels. For the detection of 
malignant masses and microcalcifications, reducing the display resolution demonstrated a 
small influence on overall accuracy and individual detection performance. They found noise 
changed the detection performance of microcalcification. It decreased from 89% to 67% and 
the discrimination performance of masses fell from 93% to 79%, while malignant mass 
detection performance remained relatively constant with values of 88% and 84%, respectively.	  
 
7.5 The Impact of Motion Blur on Mammographic Features of 
Microcalcifications  
The distribution and shape of calcifications are considered a good indicator for the likelihood 
of malignancy. It is reasonable to hypothesise that when the distribution and/or shape is 
changed due to motion blur that this could affect the differential diagnosis of the lesion. For 
instance, there are several distributions of breast microcalcifications. Tables 7.1 provide an 
overview of the findings from the microcalcifications cases. 
Firstly, diffuse and scattered microcalcifications, which are commonly benign especially when 
bilateral. Such a distribution is predominantly seen with amorphous and punctate types of 
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microcalcifications, this type of distribution was frequently affected by motion blur in this 
study with a reduction in detection performance; this was characterized by a reduction in the 
dispersion index (DI). It should be noted that this understanding has been generated from cases 
in my thesis and this would need evaluating over a larger sample of each type of cluster/lesion 
feature. Figure 7.4 shows an example of amorphous and punctuate microcalcifications, which 
were affected by motion blur. 
Secondly, regional calcifications could comprise most of a quadrant or more than a single 
quadrant and do not conform to a ductal distribution. This type of distribution is also affected 
by motion blur that can lead to a change in shape and/or distribution. Consequently, the 
detection performance can be decreased. 
Thirdly, clustered or grouped calcifications when five or more small calcifications are shown 
in a small area of breast tissue (see Figure 7.4). 
Fourthly, linear distribution microcalcifications which are arranged in a line; such a distribution 
is highly suspicious of cancer and indicates that microcalcifications are intra-ductal. 
Fifthly, segmental distribution of microcalcifications imply calcifications in ducts and their 
branches and could suggest multifocal or extensive breast cancer in a segment or lobe of the 
breast. The exception is in the incident of coarse rod-like microcalcifications in older females, 
where this is related to secretory microcalcifications. The granular calcifications showing an 
irregularity in density, size or shape and they are tiny with dot-like or elongated shapes and are 
innumerable. Motion blur has a negative impact on the detection of granular calcification, 
especially when they are located in a high density breast. The amorphous microcalcifications 
presentation is considered the most difficult lesion to identify due to its poor contrast and small 
size (Liu, 1999). Figure (7.4) shows a group of malignant microcalcifications, which were 
affected by simulated motion blur, whereas the Figure (7.5) demonstrates a group of malignant 
microcalcifications, which were not affected by simulated motion blur in this study. 
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Table 7.1 The types of clustered microcalcifications and the impact of motion blur on each type. It 
should be noted that this table generated from cases of current study and this would need evaluating 
over a larger sample of each type of cluster/lesion feature. 
Types  
Calcification 
 
Size of  individual 
Calcifications  
Lesion features Motion blur effect 
Cluster with ≤10  
amorphous 
calcifications 
 
Small size 
(heterogeneous) 
clustered non-focal 
lesion 
affected by motion 
blur 
rod shaped  Large size of  individuals 
calcifications  
(Homogeneous) 
focal lesion with 
dense central area 
 Not affected by 
motion blur 
 Punctate  Small size (similar size of 
individual calcifications)  
small cluster size 
with same density 
and shape of 
individual 
calcifications 
affected by motion 
blur 
Granular granular calcifications 
which vary in size 
showing irregularity 
in density, size or 
shape  
affected by motion 
blur 
Branching Large size with irregularly 
shaped cluster  
(Heterogeneous) 
showing irregularity 
in density 
not affected by motion 
blur 
ductal distribution Large size with irregularly 
shaped 
Similar in density & 
size 
 Not affected by 
motion blur 
 
 
  
169 
 
Figure 7.4 A group of malignant microcalcifications, which were affected by motion blur. 
 
 
Figure 7.5 A group of malignant microcalcifications, which are not affected by motion blur. 
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Figure 7.6 (A) Right CC projection demonstrates (B) Magnified areas of FFDM images at 0 mm, 0.7 
mm, and 1.5 mm of simulated motion blur. 
 
Particular image lesion characteristics in mammography images have different degrees of 
lesion detection difficulty. Microcalcifications may be missed due to the difficulty in 
identifying suspicious or normal appearance and we know that the visibility of 
microcalcifications is decreased with increasing magnitudes of simulated motion blur. Figure 
7.6 (A) shows an example of an image without motion blur  (0.0mm) and blurred 
mammographic images (0.7 and 1.5mm). It contains a small cluster of calcifications of 
approximately (6.5 mm in size) in the right breast. The DI in the image without motion blur 
(0.0mm) was 0.519 cm2, while the DI for images with motion blur (0.7 and 1.5mm) were 0.424 
and 0.377 per cm2 respectively. Figure 7.6 (B) shows magnified views of the left image 
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without motion blur  (0.0mm) and images with motion blur (0.7 and 1.5mm). The calcifications 
are less well seen on the 0.7mm and 1.5mm due to motion blur.  
Microcalcification images: not affected by motion blur 
 
Figure 7.7 (A) left CC projection demonstrates (B) Magnified areas of FFDM images at 0 mm, 0.7 
mm, and 1.5 mm of simulated motion blur. 
 
Figure (7.7) shows a single cluster of granular microcalcifications of varying shapes and 
densities in the outer half of the left breast from ductal carcinoma in situ. This type of lesion 
was not affected by simulated motion blur at both levels (0.7 mm and 1.5mm). Observer 
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detectability remained the same when simulated motion blur increased. Almost 100% of the 
observers detected the lesion in all three comparisons (0.0-0.7mm, 0.0-1.5mm and 0.7-1.5mm). 
The calcifications appear as focal clusters with an irregular outline. The microcalcifications of 
similar shape, density and size of of individual calcifications within a focal cluster were not 
affected by simulated motion blur. A cluster of about 2.0 cm2 was detected in the left breast. 
The DI in the image without motion blur (0.0mm) was 1.798 per cm2 , while the DI for images 
with motion blur (0.7 and 1.5mm) were 1.498 and 1.199 per cm2 respectively. 
    
Figure 7.8 (A) Screening mammography image of right CC Projection. Magnified areas of a cluster of 
microcalcifications. 
Calcifications can appear as a focal cluster (Figure 7.8). In this example the microcalcifications 
have similar shape, density and size of flecks. This type of calcification was not affected by 
simulated motion blur for the three conditions (0.0-0.7 mm, 0.0-1.5 mm and 0.7-1.5mm) due 
to the large size of the individual calcifications and also that the calcifications have high 
contrast with their background tissues. Observer detectability remained the same when 
simulated motion blur increased. A 100% of the observers detected the lesion in images without 
motion blur (0.0 mm) and in both levels of blurred images (0.7 mm and 1.5 mm). The DI in 
the image without motion blur (0.0 mm) was 0.863 per cm2, while the DI for images with 
motion blur (0.7 and 1.5mm) were 0.648 and 0.504 per cm2, respectively. It is reasonable to 
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suggest that the impact of motion blur does not necessarily mean that the lesion has been 
obscured completely by motion blur. The lesion may still appear, but it might not be determined 
whether it is malignant or benign.  
 
 
Figure 7.9 Screening mammography image of right cranio-caudal projection. 
 
A cluster of microcalcifications that have a punctate shape is presented in Figure 7.9. For this 
case, the BIRADS breast density is low dense (category B). This type of microcalcification is 
considered difficult to see due to the small lesion size (less than 0.7 cm2) and low contrast in 
relation to the background breast tissues. This type of lesion was affected by simulated motion 
blur at 1.5 mm and its detectability decreased with increasing levels of motion blur. The 
detectability at 0.0mm was 100%, while at 0.7 mm it decreased to 85%, but at a level of 1.5mm, 
it became 42%. The DI in the image without motion blur (0.0 mm) was 0.863 per cm2, while 
the DI for images with motion blur (0.7 and 1.5 mm) was 0.648 and 0.504 per cm2 respectively. 
High-density breast tissue can make breast lesions difficult to see. Burrell et al., (2001) 
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reviewed 28 females who had breast cancer identified in screening mammography.  They found 
microcalcifications demonstrated high levels of FNs when compared with the other types of 
breast lesions. However, Tot et al. (2005) found that some microcalcifications were diagnosed 
with high accuracy. The results of by Debono (2012) found levels of sensitivity for diagnosis 
microcalcifications of 90.0%, confirm the results of Tot et al. (2005). Tot et al., (2005) also 
found that stellate lesions are diagnosed with high accuracy (Tot et al., 2005). However, the 
findings of a study by Debono (2012) indicated levels of sensitivity to be lower, at 
approximately 77.6% for the observers diagnosing stellate lesions (Debono, 2012b). 
   
Figure 7.10 (A) a magnified mediolateral Projection demonstrates a small irregular mass with 
pleomorphic clustered microcalcifications. (B) Magnified cranio-caudal Projection demonstrates a 
small irregular mass with pleomorphic clustered microcalcifications. 
 
During a clinical evaluation, regions of microcalcifications can be assessed with magnification 
views to help determine their morphologic appearances as well as their distribution and number 
of calcifications per cluster. Image blurring can obscure very small calcifications due to using 
the magnification zoom (e.g. see Figure 7.10). Rosen et al., (2002) demonstrated that in 62% 
of breast cancers that were identified as microcalcifications they were incorrectly followed up 
with imaging rather than biopsy; it was noted that image blurring on magnification views 
compromised image quality which compromised the follow up decision (Majid et al., 2003).   
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7.6 The Impact of Motion Blur on Mammographic Image Features of 
Breast Masses:    
This part of the discussion focuses on the impact of motion blur on the image characteristics 
of breast lesions. Tables 7.2 provides an overview of the findings from the FROC study, 
generalising to different types of malignant mass present in this study. It is worth remembering 
that the following ‘evaluation of image appearances’ in relation to cancer detection is based on 
a limited number of cases. Consequently, caution should be exercised, as the evaluation would 
need extending to a larger sample of each type of mass/lesion feature in order to have 
confidence in the results. A larger sample size of different lesion types would be required to 
make population based generalisations. Nevertheless, the following presents the first 
discussion ever about lesion features in relation to cancer detection performance in blurred and 
non-blurred mammographic images. 
 
Table 7.2 Summary of the impact of motion blur on detection performance on each type of breast 
masses. It is worth mentioning that this table was generated from cases in the current study and this 
would need evaluating over a larger sample of each type of masses/lesion feature. 
 
Types  Mass Lesion density  Size of mass 
 
 
Motion blur  
effect 
Spiculated Low contrast ratio with 
its background 
Small size   affected  by 
motion blur 
Irregular shape low or equal density Small size  
which vary in size 
 affected by 
motion blur 
Obscured  Low contrast ratio with 
its background 
vary in size  affected by 
motion blur 
Oval or round/ 
 Circumscribed 
High contrast ratio with 
its background 
Large size with 
regularly shaped 
Not affected by 
motion blur 
Microlobulated High contrast ratio with 
its background 
Large size with 
irregularly shaped  
Not affected by 
motion blur 
Indistinct High contrast ratio with 
its background 
small size with 
irregularly shaped 
affected by motion 
blur 
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There are many factors related to the appearance of breast lesions within mammographic 
images that could have an effect on lesion detection performance, such as lesion location within 
the breast, lesion size, lesion shape and its contrast against background structures. Firstly, 
lesion location within the breast, when the lesion is located within the fibro-glandular region 
within an area of high breast density, or when the lesion has overlapping anatomical structures, 
this makes lesion visibility more challenging. Secondly, lesion size, small types of breast 
calcifications which have indefinite edges are considered the most difficult lesions to identify 
due to their poor contrast and small size. Thirdly, lesion shape this can affect whether the 
malignancy of a breast lesion is determined or not (Berlin, 2001; Fujihashi, 1994; Yankaskas 
et al. 2001). Fourth, lesion contrast this can be calculated for both local and global background 
areas (Rawashdeh et al., 2014; Mello-Thoms et al., 2005; Manning & Ethell, 2002); it 
represents the ratio of the signal intensity of the lesion to its background. Figure (7.11) shows 
examples of mammography images containing breast masses with different appearances due 
to location, size and tissue background. The lesions have low contrast against background 
tissues, thus making lesion visibility difficult, especially in the presence of simulate motion 
blur. Some lesion locations within the breast present additional difficulties in the detection of 
the lesion. For instance, when a breast lesion is located in the glandular area (appearing as 
‘white’ in the image) this can be affected by motion blur. In contrast, a lesion located in the 
fatty area (appearing as ‘dark’ in the image) will have high contrast in relation to the 
background breast tissues, and this may not be greatly affected by motion blur. Generally, 
cancers in some locations, such as in the inframammary fold or the axillary tail, are 
predominantly perceived on only one mammographic image projection; this can lead to 
difficulties in detection because an alternative image is not available. Such a difficulty extends 
to when motion blur is present, as the diagnostic decision has to be made on a [potentially] 
deficient image. A study by Bird et al., (1992) found a significant proportion of undetected 
cancers in these difficult regions - approximately (25%) of cancers were in the retro-glandular 
area of the breast and the sensitivity was between 85% and 90% (Bird et al., 1992). However, 
Goergen et al., (1997) reported that no statistically significant differences exist between 
regions, in terms of detection efficiency. 
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Figure 7.11 Demonstrates mammography images containing breast masses with different lesion 
appearance due to location, size and tissue background. 
 
A clear finding from this thesis is that motion blur has a high impact on low-density and 
isodense masses. This thesis has assessed the combined influence of lesion density and motion 
blur on detection performance and it has been generally demonstrated that better lesion 
detection performance is associated with masses of higher density; this is in contrast to low-
density masses, which tend to have a poorer detection performance in the presence of simulated 
motion blur. Previous studies have confirmed that mammographic density contributes to 
challenges in screen reading accuracy (American College of Radiology, 2013; The Radiology 
Assistant, 2013). It can be reasoned that small differences in contrast between the lesion density 
and density of breast tissues (density of normal and abnormal tissue) could create difficulties 
in the perception of important lesion characteristics, such as the edge angle of the lesion. The 
assessment of lesion density is important in the differential diagnosis of breast masses. The 
lesion density should be assessed in comparison with the surrounding parenchyma, or in 
relation to the nipple in the case of fatty involution. The breast mass, in relation to the 
surrounding parenchyma, is either low density radiopaque, high density radiopaque, 
radiolucent, radiolucent and radiopaque combined. Figure (7.12) shows a group of malignant 
breast masses, which were not affected by motion blur due to their having higher densities than 
the background breast tissue. When the relevant lesion density is assessed, the choices of lesion 
diagnosis will be restricted to the following probabilities; radiolucent circular/oval lesions such 
as galactocele, lipoma and oil cyst. Low density radiopaque is considered equivalent to the 
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density of the surrounding parenchyma. In this thesis, low-density masses were affected by 
motion blur, and they became more difficult to diagnose due to blurring. Figure (7.13) shows 
a group of malignant breast masses. In these cases lesion detection performance was affected 
by motion blur due to small differences in density between the lesions and background tissues. 
 
 
Figure 7.12 Demonstrates a group of malignant of breast masses, which are not affected by motion 
blur. 
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Figure 7.13 Demonstrates a group of malignant of breast masses, which are not affected by motion 
blur. 
 
To simplify the analysis of lesion characteristics, breast masses can also be classified according 
to shape and edge features into one of the following types; spiculated or stellate shaped, 
obscured/indistinct, oval/round/circumscribed and microlobulated. Stellate/spiculated masses 
are radiating structures with ill-defined boundaries. The thesis demonstrated that 
stellate/spiculated mass detection performance was adversely affected by simulated motion 
blur. Circular/oval masses may have poorly or well outlined circular, lobulated or oval, 
multiple or solitary, for these lesions, detection performance was not adversely affected by 
simulated motion blur. However, any combination of two or more of these lesion characteristics 
such as irregular shape, obscured, microlobulated and indistinct, did adversely affect detection 
performance in the presence of simulated motion blur.  
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7.6.1   Examples of Masses Affected by Simulated Motion Blur 
 
Figure 7.14 (A) mammography images with left MLO Projection, contains different magnitudes of 
motion blur (0.7 & 1.5 mm) and image without motion blur (0.0mm). (B) Magnified views show small 
malignant mass (signposted by red arrows). 
 
Figure (7.14) demonstrates a small speculated malignant mass (measuring approximately 7.0 
mm in diameter), indicated by the red arrow, in the upper half of the breast. This mass has an 
irregular outline with fuzzy edges and it is pressing on the tissues around it. It is difficult to see 
it. 29% of observers missed the mass even when no motion blur (0.0 mm) was present. The 
detection performance relating to this malignant mass was worse in the presence of simulated 
motion blur. Lesion detection performance decreased as the level of simulated motion blur 
increased. 71% (5/7) of the observers detected the lesion in 0.0 mm level, whereas this 
decreased to 43% (3/7) at 0.7mm and only 29% (2/7) at 1.5mm.      
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Figure 7.15 Left CC Projection, this mammography image shows a spiculated mass (arrow) that has an 
irregular shape with indefinite edges. 
 
Figure (7.15) is a cancerous mass which appears as partially round with irregular / spiked 
outline (see arrows). Its BI-RADS breast density is category B. This mass is considered 
difficult to see because the lesion size is very small (approximate lesion area <0.8 cm2) and it 
has a low contrast, compared with the surrounding background tissues. Detection performance 
was adversely affected by simulated motion blur and its detection performance decreased as 
simulated motion blur increased. 100% (7/7) of the observers detected the lesion with no 
motion blur (0.0 mm), whereas this decreased to 57% (4/7) at 0.7mm and only 29% (2/7) at 
1.5mm of simulated motion blur. 
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Figure 7.16 Left Cranio-Caudal Projection mammography image contains a stellate mass (arrow) that 
has an irregular outline (Lesion size 2.2 cm2). 
 
Figure (7.16) shows a stellate mass (see arrow) with an irregular outline (approximate lesion 
area 2.2 cm2); it has a BI-RADS breast density grade B. Although its density is higher than the 
surrounding breast tissue and its size is fairly large, its detection performance was adversely 
affected by simulated motion blur; detectability decreased as simulated motion blur increased. 
71% (5/7) of the observers detected it with no motion blur (0.0mm); this decreased to 43% 
(3/7) at 0.7mm and only 57% (4/7) detected the lesion at 1.5mm of simulated motion blur . 
This thesis suggests that stellate masses are affected by simulated motion blur.   
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Figure 7.17 Mammography image left Medio-lateral oblique Projection shows indistinct breast mass 
(arrow) that has an irregular outline. 
 
Figure (7.17) demonstrates an indistinct partially round mass (arrow). It has an irregular 
outline (approximate area of 1.7 cm2); it has a BI-RADS breast density grade B, and is located 
in lower part of the breast (see red arrow). Its detection performance was adversely affected by 
simulated motion blur, meaning its detectability decreased as simulated motion blur increased. 
71% (5/7) of observers detected the lesion with no blur (0.0mm), and this decreased to 57% at 
0.7mm and only 43% (3/7) at 1.5mm of simulated motion blur.  
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Figure 7.18 Mammography image with left Cranio-Caudal Projection demonstrates a stellate mass 
(arrow) that has an irregular outline. 
 
Figure (7.18) shows a large stellate mass (approximate area of 1.4 cm2) located in the middle 
part of the breast (see arrow), it has a BI-RADS breast density C. It was adversely affected by 
simulated motion blur. Its detectability decreased with increasing simulated motion blur. 
Approximately 86% (6/7) of observers detected the lesion with no motion blur (0.0mm). This 
decreased to 71% (5/7) at 0.7mm and only 57% (4/7) at 1.5mm of simulated motion blur. 
Stellate masses may be difficult to diagnose due to the surrounding tissue obscuring its spicules. 
Also, architectural distortion has subtle appearances and may present similarly to normal 
overlapping breast tissue, causing it to be a typically undetected cancer and FN presentation. 
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Figure 7.19 Mammography image with left mediolateral oblique Projection contains breast mass 
(arrow) that has an irregular outline (fuzzy edges). 
 
Figure (7.19) shows a spiculated mass with a multi-pointed star-shaped outline. Its size is 
approximately 1.4 cm2 and it is located in the upper part of the breast (see arrow). Its BI-RADS 
grade is C. Lesion detection performance was adversely affected by motion blur. This 
spiculated mass has a very small mass centre and a lace-like, fine reticular radiating structure 
which causes parenchymal distortion and/or asymmetry. Detectability decreased with 
increasing simulated motion blur. Approximately 86% (6/7) of the observers detected the lesion 
with no motion blur (0.0 mm). This decreased to 57% (4/7) at 0.7mm and 57% (4/7) at 1.5mm 
of simulated motion blur. 
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7.6.2 Masses Not Affected by Simulated Motion Blur 
 
 
Figure 7.20 Mammography images of left CC projection contain focal breast mass (arrow) with the 
dense central area. 
Figure (7.20) shows mammography images without motion blur (0.0 mm), and two simulated 
levels of motion blur (0.7 and 1.5 mm). The Figure shows a small malignant mass in the lower 
part of the breast (see arrows). These images demonstrate a malignant mass which is partially 
round and partially spiked / irregular shape with definite edges. This mass was not affected by 
motion blur; this is likely due to its high contrast against surrounding background tissues. Its 
BIRADS breast density is grade B. 100% (7/7) of the observers detected the mass at (0.0mm) 
and at both levels (0.7 and 1.5 mm) of simulated motion blur. 
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Figure 7. 21 Screening mammography image of right Medio-lateral Oblique projection. 
Figure (7.21) demonstrates a microlobulated mass which has an irregular shape with definite 
edges. It is in the upper half of the breast (see arrow). Its density is higher than the surrounding 
background breast tissues and its BIRADS density grade is C. Its detection performance was 
not adversely affected by simulated motion blur. 100% (7/7) of the observers detected the mass 
at (0.0mm) and at both levels (0.7 and 1.5 mm) of simulated motion blur.  
 
 
Figure 7.22 Screening mammography image of left CC projection. 
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Figure (7.22) demonstrates a well circumscribed microlobulated mass with definite edges. It 
has an approximate area of 12 mm2; it is depicted by (arrow) and is located in the lower half of 
the breast. Its detection performance was not adversely affected by simulated motion blur. 
100% (7/7) of the observers detected it with no blur (0.0mm) and at both levels of simulated 
motion blur (0.7 and 1.5 mm).  
 
 
 
Figure 7.23 Left MLO projection, mammography images show malignant breast mass, with an oval or 
round shape and definite edges. 
 
Figure (7.23) illustrates a large malignant mass (approximate area of 1.9 mm2) in the upper 
half of the breast (see arrow). Its detection performance was not adversely affected by 
simulated motion blur. 100% (7/7) of the observers detected it with no motion blur (0.0 mm) 
and also at 0.7 and 1.5 mm levels of simulated motion blur.  
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7.7 Limitations of this Thesis: 
While there is some promise in the results generated in this novel work, there are some 
limitations to the results achieved. In clinical mammography, the image reader does not know 
what magnitude of motion blur is present in an image, so it could be argued that it was 
superfluous to investigate two different magnitudes of motion blur. However, it is known from 
previous work (Ma et al., 2015) that motion blur is visible at around 0.7 mm of simulated 
motion blur , so it is of interest to understand if this caused a reduction in observer performance; 
if it didn’t, it was necessary to understand whether a higher magnitude of motion blur did cause 
an effect. In this thesis the simulated motion blur had a global effect on the whole image and 
in reality this is not always the case, as ‘real motion blur’ may affect only one region, several 
regions or the whole mammographic image. Consequently, the results in this thesis are not able 
to predict the impact of regional blurring on lesion detection performance. 
 Further limitations are related to the process of introducing simulated motion blur into the 
image: It is possible that any image noise present in the original image may be blurred through 
the mathematical simulation, while in real motion blur this would not occur. For the 
mathematical simulation of blurring, as is the case in this thesis, the image would appear to be 
slightly smoother than the non-blurred image. To overcome this potential smoothing effect, it 
may be possible to adapt the mathematical simulation by adding noise back into the newly 
created blurred image. Despite this, the current method gives us a certain level of control on 
motion blur that could not be achieved with ‘real’ blurred images from a clinical setting.  
The mathematical blurring process is enacted as a convolution mask that, in effect spreads each 
pixel, redistributing its intensity into the neighbouring pixels based on a function and mask size 
determined by the modelling of the pixel motion as a random vector path parameterised by the 
characteristics of breast tissue (generalised) elastic coefficient, required duration and required 
displacement. The latter two factors act as input to the simulation to determine the magnitude 
of the blur effect. This creates a controllable blur mask for convolution that has a distribution 
curve reflective of the intensity spread within a collimated light (energy) propagation system 
reflective of the X-ray system used. Without modelling actual motion within the breast it is not 
possible to determine the direction of motion at a specific locality within the breast, so this is 
an approximation to the blur effect that is uniform for the entire image region. Localisation is 
possible, but requires each source image to have a specific region of blur defined and in this 
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case motion is assumed to be radial, and the mask application adjusted accordingly on a per-
pixel basis, from the centre of the defined region, with maximum motion at the centre, reducing 
to zero motion at the perimeter of the region. Given a large number of source images processed 
for this study and the requirement for a consistent blur effect on all the generated image sets, 
regional blurring was not used in this study. This is a limitation in that the blur effect is 
indicative of the blur that would be present within a ‘real’ patient image in terms of magnitude 
and effect, but does not replicate the directional nature of the blur that would occur for a ‘real’ 
image. 
In respect of the power of the study, it should be noted that the prevalence of disease is much 
higher than would be expected in a screening population, but this is difficult to overcome in 
observer studies because the proportion of cancer cases to normal cases in clinical practice 
cannot be represented exactly in a small sample as in observer studies. However, all 
participants in observer studies have a heightened expectation of disease, since they are always 
aware that their detection performance is being assessed. There are also many differences 
between observer studies and clinical practice. For instance, in clinical practice, the observer 
can review many images for each client (e.g. right and left for CC & MLO) as well as previous 
screening mammograms. In addition, full patients’ information, risk factors and clinical 
examination information is often available. With a free-response study of the type detailed in 
this thesis, the observer can only see one image for each case and no information about the 
client. Also they do not have available to them other clinical information which could help 
inform their decision making. 
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7.8 Chapter Summary: 
In summary, free-response data were analysed for the detection of malignant 
microcalcifications and masses for three conditions; (i) no simulated motion blur (0.0 mm), 
and for two magnitudes of simulated motion blur (0.7 and 1.5 mm). A statistically significant 
difference was found for the detection of masses and microcalcifications. For both analyses, a 
significant difference was observed between 0 mm and 0.7 mm, and between 0 mm and 1.5 
mm of simulated motion blur , and also between (0.7and 1.5 mm) for microcalcifications. No 
significant difference was detected between (0.7 and 1.5 mm) for masses. These trends were 
similar, but not exactly the same as those observed in the combined two observers’ data 
analysis. Comparison between single observer free-response data and combined two observers’ 
data demonstrates that the detection performance of microcalcifications improved, while there 
was no improvement in detection performance for malignant masses. Regarding, the impact of 
motion blur on physical characteristics, the results demonstrate that there were significant 
differences in the physical measures of both masses and microcalcifications for all three 
comparisons of simulated motion  blur (0.0-0.7, 0.0-1.5 and 0.7-1.5 mm). 
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Chapter 8: Conclusion, Recommendations and Future work 
 This thesis used a novel mathematical algorithm to apply simulated motion blur to clinical 
FFDM images which were either normal or had proven breast cancer present. Using this 
blurring approach, this thesis represents the first study to investigate the impact of simulated 
motion blur on cancer detection performance in FFDM using observer performance methods 
and characterisation of lesion types.  
For the single observer study, the results from this thesis are likely to have implications for 
clinical practice. It could mean that when blur is observed in an image, a repeat image should 
be considered as one would simply not know how much motion blur is present and what impact 
it is having, in terms of cancer detection performance. In view of this, a key outcome of the 
thesis is that caution should be exercised when making decisions about the acceptability of 
images that appear to contain motion blur. This may also have implications for the type of 
monitor used for the initial evaluation of technical quality of mammograms. For both masses 
and microcalcifications, the findings indicate that simulated motion blur has a significant 
detrimental effect on cancer detection performance.  
When two observers’ data were combined to simulate double reporting, as occurs in 
mammography screening, the key finding was that a combined read is likely to only have 
beneficial outcomes. While there was no statistically significant benefit for breast masses, for 
microcalcifications, there was a statistically significant difference between single and 
combined free-response data. Given that image readers do not have a prior expectation of 
masses or microcalcifications occurring in the image, the only recommendation can be that all 
images have to receive double reporting.  
For the physical measures of malignant masses, simulated motion blur had a negative impact 
on edge angle and this appeared to have only a weak correlation with a reduction in detection 
performance. It is reasonable to hypothesise that when the conspicuity of the mass increases it 
does not necessarily mean that the detectability of mass would also increase. However, 
conspicuity index did get statistically as the magnitude of simulate motion blur increased. The 
edge angle was decreased with increasing the level of simulated motion blur. The change in 
grey level was not statistically significant between the different magnitudes of simulated 
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motion blur. Image noise was statistically worse with an increasing level of simulated motion 
blur. 
For microcalcifications, the dispersion index was statistically worse with an increasing level of 
simulated motion blur. This negative impact on the dispersion index was due to some small 
calcifications/tight clusters becoming obscured. There are many factors related to the 
appearance of breast lesions within mammographic images that could have an impact on lesion 
detection performance, such as lesion location within the breast, lesion size, and lesion shape. 
The calculation of missed lesions was used to identify the detectability of different lesion types. 
The analysis of missed lesions should provide a less abstract concept which can be used to 
evaluate lesion types. In summary, microcalcification clusters of small size or individual 
calcifications are likely to be missed in the presence of simulated motion blur. For masses, 
large lesions and those with high lesion-to-background contrast were not affected by simulated 
motion blur. However, those with an irregular outline, with stellate shape, or those that have 
fuzzy edges, have multi-pointed star-shaped are difficult to detect with simulated motion blur 
present. Finally, high breast density was also a strong factor linked to poorer detection. Images 
readers and technical staff need to be aware of the impact of motion blur on the detection of 
cancer during the acquisition and reporting of FFDM images. For the benefit of clients, further 
work is required to ensure that motion is recognised at the earliest possible opportunity. 
8.2 Statement of Novelty 
The main novel contributions of this PhD are summarised as follows: 
1. Research problem: This is the first study to evaluate the impact of motion blur on 
mammography lesion detection performance.  
2. Novel method:  This is the first study to use mathematical simulation for blur induction in 
order to assess its impact on mammography breast cancer detection performance.  
3. Novel method for physical measures: This is the first study to assess the impact of 
simulated motion blur on the physical characteristics of microcalcification and masses in 
mammography images. The impact of simulated motion blur on the physical characteristics of 
malignant microcalcification images have been assessed using dispersion index, which is a 
novel measure. 
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4. Novel analysis of data: This is the first study to use free-response data assess the impact of 
mimic double reporting, using combined two observers’ data on blurred FFDM images. 
5. New method: This is the first study to conduct a missed lesions analysis to establish reasons 
why observers failed to detect lesions in the presence of simulated image blurring. 
 
 
8.7 Recommendations and Future work   
 
Future work 
1. Evaluation of regional simulated motion blur 
The simulated blur applied in this study was global in effect (i.e. the entire image). In clinical 
mammography, motion blur may be global or regional. This study is not able to predict the 
impact of regional blurring on lesion detection performance. In future work, it is important to 
study the impact of regional blurring on lesion detection performance. 
2. Evaluation of ‘real’ motion blur 
Further studies are required to investigate the impact of real motion blur on lesion detection 
performance. This will be a prospective study, collecting an appropriate number of real blurred 
mammograms and their repeated images (containing no motion blur). A free-response study 
will be used to measure detection performance.  
3. Validation of Dispersion Index 
The dispersion index was develeoped as a novel metric for this work since existing conspicuity 
software could not be applied to microcalcifications due to their small individual size and wide 
distribution pattern. No validation has been conducted on DI, but this could be a focus for post-
doctoral work.  
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Recommendations 
There are significant consequences to motion blur in clinical practice and consequently this 
thesis provides a number of recommendations to breast imaging professionals. Image readers 
should be aware of the impact of motion blur on cancer detection and they should evaluate 
images carefully for its presence prior to making an interpretation. In addition, staff should be 
aware of motion blur during quality assessment of images in the mammography imaging room. 
Within the UK, blurred images may need to be repeated, however due regard should be given 
to NHSBSP quality assurance recommendations in which a repeat threshold of 3% has been 
set. When motion blur is detected, this could lead to repeated images and increased recall rates, 
both of which will increase radiation dose and represent a negative physical and psychological 
experience for the client. If motion blur is not recognised, this could lead to misdiagnosis, late 
detection and even symptomatic presentation as an interval cancer. On the other hand, motion 
blur also has the potential to increase the number of lesion mimics (false positives), which may 
lead to unnecessary biopsy, with the consequence of an unnecessary invasive procedure and 
increased client anxiety. 
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Appendix A: Ethics Application HSCR 15-107  
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Appendix B: Ethics Application HSCR 15-110  
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Appendix D: Participant Invitation Letter 
                                                                            Directorate of Radiograph,  
                                                                                                Centre of Health Sciences Research, 
University of Salford, 
Allerton Building, 
Salford, M6 6PU                                                      
31 May 2018 
 
Dear Sir or Madam: 
RE: Research Involvement: Image blurring and lesion detection in mammography 
Research Governance and Ethics Committee Approval: RGEC  
I am a PhD student under the supervision of Professor Peter Hogg, Dr John Thompson, Dr Claire Mercer, Mrs 
Judith Kelly and Dr Rob Aspin at the University of Salford. I am currently investigating the impact of image 
blurring caused by unwanted motion on an observers’ ability to detect clinically significant lesions in full field 
digital mammography (FFDM) images. This research uses the latest and most advanced techniques in observer 
performance, namely free-response receiver operating characteristics (FROC) method and a statistically powerful 
jackknife alternative FROC (JAFROC) analysis. For this research I require expert observers to examine a series 
of images that are either normal (no lesions) or contain lesions with varying degrees of simulated image blurring. 
In this study an advanced computer algorithm developed at the University has been used to introduce the image 
blurring. 
I am approaching you as an experienced professional and potential volunteer to take part in the observer study. If 
you are happy to take part in the research, please respond to the email address at the bottom of this letter and I 
will be happy to give you more information. Your contribution will be appreciated, though no financial reward or 
otherwise will be offered. It is expected that you will be required to make 3-4 visits to the University to complete 
image evaluations using our 5 megapixel monitors. Each evaluation is expected to last up to 90 minutes. This 
contract lays out the standards by which the observer group will adhere to and the conditions under which the 
evaluations will be completed, thereby ensuring respect is afforded to all who are directly involved in this study. 
If you have any further questions about the study that will help you decide whether to volunteer for this research, 
or if you have any further queries, please get in touch via telephone or e-mail. Thank you for taking the time to 
read this letter and I hope to hear from you in the near future. 
Sincerely 
Student name------- 
Email ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ 
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Appendix E: Participant Information Sheet 
 
 
Participant information sheet for observers participants in 
observation study (FROC study)   
 
Study title: Determine the impact of image blurring on lesion 
detection performance in full field digital mammography 
images (FFDM)  
Chief investigator  
Telephone number  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
You will be given a copy of this information sheet to keep 
We would like to invite you to take part in our research study. Before you decide 
we would like you to understand why the research is being done and what it would 
involve for you. Talk to others about the study if you wish and please ask if there 
is anything that is not clear. This is a Student project, required for successful 
completion of a Doctoral programme. 	
I am currently investigating the impact of image blurring caused by unwanted 
motion on an observers’ ability to detect clinically significant lesions in full field 
digital mammography (FFDM) images.	The aim of the study is to determine the 
impact of image blurring on lesion detection performance in full field digital 
mammography images (FFDM) using free-response receiver operating 
characteristics (FROC) method  
Participant name: 
Study Sponsor: University of Salford 
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1. What is the purpose of this study? 
The purpose of this study to determine the impact of image blurring on lesion 
detection performance in full field digital mammography using the free-response 
receiver operating characteristics (FROC) method.   
 
2. Why have I been invited? 
This research uses the latest and most advanced techniques in observer 
performance, namely the Free-response Receiver Operating Characteristics (FROC) 
method and the statistically powerful jackknife alternative FROC (JAFROC) 
analysis. For this research I require expert observers to examine a series of full field 
digital mammographic (FFDM) images that are either normal (no lesions) or contain 
lesions with varying degrees of simulated image blurring. In this study an advanced 
computer algorithm developed at the University has been used to introduce image 
blurring to clinical images. 
You have been invited because you are considered an expert observer in 
mammography.  
 
3. Do I have to take part? 
Your decision to take part in this study is entirely voluntary.  You may refuse to 
participate or you can withdraw from the study at any time.   
 
4. What will happen to me if I take part? 
It is expected that you will need to make 3-4 visits to the University of Salford to 
complete image evaluations using our 5 megapixel monitors. Each evaluation is 
expected to last up to 90 minutes. You will be asked to assess and localise lesions 
in mammographic images .The information you provide will be kept confidential 
and will be used only towards achieving the aim of the research. 
 
5. Expenses and payments 
Your contribution will be appreciated, though no financial reward or otherwise will 
be offered. 
 
6. What are the possible disadvantages and risks of taking 
This research does not pose any risk to its participants.  
 
7. What are the possible benefits of taking part? 
Your participation may help improve understanding of the impact of image blurring 
on cancer detection performance. Better awareness of the impact of image blurring 
may result in better breast cancer detection rates at the early stage and overall 
result in to the reduction of the mortality rate due to breast cancer. Alternatively, it 
may reduce the number of repeated images, if blurring is found to have no 
significant impact.  
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8. What if there is a problem or I want to complain? 
If you wishes to complain in the first instance this can be discussed with 
researcher:   
If you have any queries or questions please contact: 
Principal investigator: ----------------------  
Email ---------------------------- 
Phone number ------------------ 
University of Salford, School of Health Sciences 
Or if preferred with researcher’s supervisor  
  
Professor ------------- 
Email ---------------------------- 
 
 
If you remain dissatisfied, please contact: 
 
Research Centres Manager  
Research and Enterprise 
G-08, Joule House, Acton Square, 
 University of Salford, 
 U.K, M5 4WT 
 
 
9. Will my taking part in this study be kept confidential? 
The information you give during FROC study will be kept in a locked cabinet within 
the University.  The documents will be destroyed in five year after the end of the 
study.   
 
10. What will happen to the results of the research study? 
The results of the study will be included in a research thesis, would be discussed at 
research conferences and published in peer reviewed research journals. 
 
11. Who is sponsoring the study? 
 
The sponsor of the study has the duty to ensure that it runs properly and that it is 
insured.  In this study, the sponsor is the University of Salford.  
 
12. Who has reviewed this study? 
This research was reviewed by the University of Salford Research and Ethics 
Committee, to protect your safety, rights, wellbeing and dignity.  This Committee is 
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run by University of Salford but its members are not connected to the research they 
examine.  This study has been reviewed and given a favourable opinion. 
 
13. Further information and contact details 
If you have any queries or questions please contact: 
Principal investigator: ----------------------  
Email ---------------------------- 
Phone number ------------------ 
University of Salford,  
School of Health Sciences 
 
Alternatively, you can contact my supervisory team: 
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Appendix F: Poster to Invite the Participants  
 
Experts of diagnostic mammography field are invited to participate in a PhD study, to 
determine lesion detection performance FFDM images   
	
This	research	uses	the	latest	and	most	advanced	techniques	in	observer	performance	study,	namely	
Free‐response	 Receiver	 Operating	 Characteristics	 (FROC)	 method	 and	 a	 statistically	 powerful	
jackknife	 alternative	 FROC	 (JAFROC)	 analysis.	 For	 this	 research	 I	 require	 expert	 observers	 to	
examine	a	series	of	images	that	are	either	normal	(no	lesions)	or	contain	lesions	(malignant	masses	
and	calcifications)	with	varying	degrees	of	 simulated	 image	blurring.	 In	 this	 study	an	advanced	
computer	algorithm	developed	at	the	University	of	Salford	has	been	used	to	 introduce	the	 image	
blurring.	
As	a	participant	 in	 this	 study,	 it	 is	 expected	 that	 you	will	be	 required	 to	make	3‐4	 visits	 to	 the	
University	 to	 complete	 image	 evaluations	 using	 our	 5	megapixel	monitors.	 Each	 evaluation	 is	
expected	to	last	up	to	90	minutes.	
If	you	decide	that	you	would	 like	to	 take	part	 in	 the	study	and	for	 further	 information,	please	
contact	the	researcher:       
Mr.	Ahmed	Abdullah,	PhD	student	
	E‐mail:	(a.k.abdullah@edu.salford.ac.uk ).	
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Appendix G: Tables of the Collected Data  
Table (G-1) Demonstrates the features of mammographic images (Projection of image, breast density, 
and number of lesions per image). The characteristics of malignant breast masses with different shape 
of margin, lesions’ BI-RADS and size of lesions are presented. 
 
 
 
 
 Image 
NO. 
Projection 
of image 
& Side 
Sharpness   Type of lesion   
Number of 
lesion per 
image 
Breast 
density 
shape of 
margin 
Lesion  
BI-RADS 
Lesion 
size in 
mm 
1 LCC acceptable Malignant 1 C irregular  R5 16 
2 RCC acceptable Malignant 1 D irregular  R4 14 
3 LCC acceptable Malignant 1 C irregular  R5 10 
4 RMLO acceptable Malignant 1 B irregular  R5 16 
5 RMLO acceptable Malignant 1 B Spiculated R5 14 
6 LCC acceptable Malignant 1 C irregular  R4 25 
7 LMLO acceptable Malignant 1 B irregular  R5 20 
8 LCC acceptable Malignant 1 C irregular  R4 25 
9 LCC acceptable Malignant 1 B irregular  R5 12.5 
10 LMLO acceptable Malignant 1 C irregular  R4 7 
11 RMLO acceptable Malignant 1 C Spiculated R4 16 
12 LCC acceptable Malignant 1 C lobulated  R4 22.6 
13 RMLO acceptable Malignant 1 B Spiculated R5 10 
14 RCC acceptable Malignant 1 C Irregular  R5 21 
15 LCC acceptable Malignant 1 B Spiculated R5 9 
16 LMLO acceptable Malignant 1 C irregular  R5 8 
17 LMLO acceptable Malignant 1 B irregular  R5 15 
18 LCC acceptable Malignant 1 B irregular  R5 11 
19 LMLO acceptable Malignant 1 B irregular  R5 5 
20 LCC acceptable Malignant 1 C irregular  R4 8 
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Table (G-2) Demonstrates the features of mammographic images (Projection of image, breast density, 
and number of lesions per image). The characteristics of malignant breast masses with different shape 
of margin, lesions’ BI-RADS and size of lesions are presented. 
 
 
 
 
 Image 
NO. 
Projection 
of image 
& Side 
Sharpness   Type of lesion   
Number 
of lesion 
per 
image 
Breast 
density 
the shape 
of margin 
Lesion 
BI-
RADS 
Lesion 
size in 
mm 
21 RCC acceptable Malignant 1 C Round  R3 9 
22 RMLO acceptable Malignant 1 B irregular  R4 14 
23 RCC acceptable Malignant 1 C irregular  R5 17 
24 LMLO acceptable Malignant 1 B lobulated  R4 23 
25 LMLO acceptable Malignant 1 B irregular  R5 25 
26 LCC acceptable Malignant 1 B irregular  R4 12 
27 LCC acceptable Malignant 1 B Spiculated R5 10 
28 RMLO acceptable Malignant 1 B Spiculated R4 12 
29 LMLO acceptable Malignant 1 C irregular  R4 16 
30 LCC acceptable Malignant 1 C Spiculated R3 10 
31 LCC acceptable Malignant 1 B irregular  R4 14 
32 RCC acceptable Malignant 1 D irregular  R5 17 
33 LMLO acceptable Malignant 1 D irregular  R4 20 
34 RMLO acceptable Malignant 1 D irregular  R4 21 
35 RCC acceptable Malignant 1 B irregular  R4 9 
36 LCC acceptable Malignant 1 C Spiculated R5 14 
37 CC acceptable Malignant 1 B irregular  R4 17 
38 LCC acceptable Malignant 1 C lobulated  R5 23 
39 LCC acceptable Malignant 1 B Spiculated R4 14 
40 LCC acceptable Malignant 1 D Spiculated R4 15 
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Table (G-3) Demonstrates the features of mammographic images (Projection of image, breast density, 
and number of lesions per image). The characteristics of malignant breast masses with different shape 
of margin, lesions’ BI-RADS and size of lesions are presented. 
 
 
 
 
No. Projecti
on of 
image 
sharpness Type of 
lesion 
lesion
s per 
image 
Breast 
density  
Shape of 
margin 
Lesion 
BIRADS 
LESION 
SIZE in 
mm 
41 
LCC 
acceptable Malignant 1 B 
Spiculated 
R4 12 
42 
RCC 
acceptable Malignant 1 B 
Spiculated 
R4 8 
43 
RCC 
acceptable Malignant 1 C 
Round  
R4 7 
44 
RMLO 
acceptable Malignant 1 C 
irregular  
R5 15 
45 
RMLO 
acceptable Malignant 1 C 
irregular  
R5 20 
46 
LMLO 
acceptable Malignant 1 C 
lobulated  
R3 14 
47 
LCC 
acceptable Malignant 1 B 
irregular  
R4 10 
48 LMLO acceptable Malignant 1 B irregular  R4 8 
49 LMLO acceptable Malignant 1 D irregular  R5 18 
50 LCC acceptable Malignant 1 C Spiculated R5 10 
51 LCC acceptable Malignant 2 C irregular  R3&R3 14&19 
52 R acceptable Malignant 1 C irregular  R5 15 
53 RCC acceptable Malignant 1 B irregular  R4 10 
54 RMLO acceptable Malignant 1 C Spiculated R5 17 
55 RMLO acceptable Malignant 1 B irregular  R5 28 
56 LMLO acceptable Malignant 1 C irregular  R4 23 
57 RCC acceptable Malignant 1 B irregular  R4 11 
58 LMLO acceptable Malignant 1 D distortion R4 27 
59 LCC acceptable Malignant 1 B irregular  R5 22 
60 RCC acceptable Malignant 1 C Spiculated R4 13 
61 RMLO acceptable Malignant 1 B Spiculated R4 8 
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Table (G-4) Demonstrates the features of mammographic images (Projection of image, breast density, 
and number of lesions per image), and the characteristics of malignant breast masses with different 
shape of margin, lesions’ BI-RADS and size of lesions are presented. 
 
 
Image 
No. 
Projection 
of image 
sharpness Type of 
lesion 
lesions 
per 
image 
Breast 
density 
Shape of 
margin 
Lesion 
BIRADS 
LESION 
SIZE in 
mm 
62 LCC acceptable Malignant 1 B Spiculated R4 8 
63 LCC acceptable Malignant 1 C Spiculated R4 5 
64 LMLO acceptable Malignant 1 C irregular  R4 13 
65 RMLO acceptable Malignant 1 C irregular  R4 14 
66 LMLO acceptable Malignant 1 C irregular  R4 17 
67 RMLO acceptable Malignant 1 C irregular  R5 22 
68 RCC acceptable Malignant 1 A Spiculated R5 27 
69 RCC acceptable Malignant 1 C Spiculated R4 15 
70 RMLO acceptable Malignant 1 B Spiculated R4 6 
71 LMLO acceptable Malignant 1 C irregular  R4 15 
72 LCC acceptable Malignant 1 D irregular  R4 10 
73 RCC acceptable Malignant 1 B irregular  R4 10 
74 RMLO acceptable Malignant 1 B irregular  R5 17 
75 LMLO acceptable Malignant 1 D irregular  R5 13.5 
76 LCC acceptable Malignant 1 C Spiculated R4 17 
77 RMLO acceptable Malignant 1 B irregular  R4 9 
78 RCC acceptable Malignant 1 C irregular  R5 16 
79 LMLO acceptable Malignant 1 C Spiculated R5 12 
80 LCC acceptable Malignant 1 A irregular  R4 8 
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Table (G-5) Demonstrates the features of mammographic images (Projection of image, breast density, 
and number of lesions per image), and the characteristics of malignant breast masses with different 
shape of margin, lesions’ BI-RADS and size of lesions are presented. 
 
 
 
Image 
No. 
Projection 
of image 
sharpness Type of 
lesion 
lesions 
per 
image 
Breast 
density 
Shape of 
margin 
Lesion 
BIRADS 
Lesion 
Size in 
mm 
81 RCC acceptable Malignant 1 C irregular  R4 8 
82 LCC acceptable Malignant 1 B Spiculated R4 9 
83 LCC acceptable Malignant 1 B irregular  R5 15 
84 RCC acceptable Malignant 1 D irregular  R4 22 
85 LCC acceptable Malignant 1 C irregular  R5 13 
86 RCC acceptable Malignant 1 C Spiculated R5 10 
87 LCC acceptable Malignant 1 B Spiculated R5 18 
88 LCC acceptable Malignant 1 B Lobulated R4 10 
89 LCC acceptable Malignant 1 A irregular  R4 9 
90 RCC acceptable Malignant 1 C Spiculated R5 11 
91 RMLO acceptable Malignant 1 C irregular  R4 17 
92 RMLO acceptable Malignant 1 D irregular  R4 10 
93 RCC acceptable Malignant 1 B irregular  R4 9 
94 LCC acceptable Malignant 1 D Spiculated R5 23 
95 RCC acceptable Malignant 1 D Spiculated R5 21 
96 LMLO acceptable Malignant 1 D irregular  R4 15 
97 LCC acceptable Malignant 1 B Spiculated R5 16 
98 LMLO acceptable Malignant 1 D irregular  R4 12.5 
99 RCC acceptable Malignant 1 B irregular  R4 27 
100 RCC acceptable Malignant 1 B Spiculated R4 13 
101 RMLO acceptable Malignant 1 C Spiculated R4 20 
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Table (G-6) Demonstrates the features of mammographic images (Projection of image, breast density, 
and number of lesions per image), and the characteristics of malignant breast microcalcifications with 
different shape, distribution, lesions’ BI-RADS and size of lesions are presented. 
 
 
Image 
No. 
Projection 
of image Sharpness   
Type of 
lesion   
lesion 
per 
image 
Breast 
density 
Calci. 
Distribution 
Lesion BI-
RADS 
Lesion 
size in 
mm 
1 LMLO 
acceptable Malignant 1 B Clustered  R4 5 
2 RCC 
acceptable Malignant 1 B Clustered  R4 8 
3 RCC 
acceptable Malignant 1 D Clustered  R5 7 
4 RCC 
acceptable Malignant 3 D Clustered  R3 Whole group=9.6 
5 LMLO 
acceptable Malignant 2 C Clustered  R5 30&13 
6 RCC 
acceptable Malignant 1 B Clustered  R5 12 
7 
RCC acceptable Malignant 1 C Clustered  R5 10 
8 
RCC acceptable Malignant 2 C Clustered  R5 16&11 
9 
RMLO acceptable Malignant 1 B Clustered  R3 10 
10 RMLO 
acceptable Malignant 1 C Clustered  R5 17.5 
11 LCC 
acceptable Malignant 1 B Clustered  R3 6 
12 RCC 
acceptable Malignant 1 C Clustered  R4 9 
13 LCC 
acceptable Malignant 1 C Clustered  R4 7.5 
14 
RCC acceptable Malignant 1 C Clustered  R4 7 
15 RCC 
acceptable Malignant 2 D Clustered  R5 26&26 
16 
LMLO acceptable Malignant 2 D Clustered  R5 27&9 
17 LMLO 
acceptable Malignant 1 D Clustered  R3 12.5 
18 RCC 
acceptable Malignant 1 B Clustered  R4 11.6 
19 RCC 
acceptable Malignant 1 B Clustered  R4 5.4 
20 
RMLO acceptable Malignant 1 B Clustered  R4 10 
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Table (G-7) Demonstrates the features of mammographic images (Projection of image, breast density, 
and number of lesions per image), and the characteristics of malignant breast microcalcifications with 
different shape, distribution, lesions’ BI-RADS and size of lesions are presented. 
 
 
 
 
 Image 
No. 
Projection 
of image Sharpness   
Type of 
lesion   
lesion 
per 
image 
Breast 
density 
Calci. 
Distribution 
Lesion 
BI-
RADS 
Lesion 
size in 
mm 
21 LMLO 
acceptable Malignant 1 C Clustered  R5 22 
22 LCC 
acceptable Malignant 1 C Clustered  R4 13 
23 RMLO 
acceptable Malignant 1 B Clustered  R4 15 
24 LMLO 
acceptable Malignant 1 B Clustered  R5 9 
25 RCC 
acceptable Malignant 1 B Clustered  R4 13.7 
26 RCC 
acceptable Malignant 3 C Clustered  R4 10 
27 LMLO 
acceptable Malignant 2 B Clustered  R5 5 
28 
LMLO acceptable Malignant 1 B Clustered  R4 12 
29 LCC 
acceptable Malignant 1 B Clustered  R4 15 
30 
RCC acceptable Malignant 1 C Clustered  R4 6 
31 
RCC acceptable Malignant 1 B Clustered  R3 8 
32 
RMLO acceptable Malignant 1 C Clustered  R4 18 
33 
RCC acceptable Malignant 1 D Clustered  R5 7 
34 
RCC acceptable Malignant 1 B Clustered  R4 7 
35 
LMLO acceptable Malignant 2 C Clustered  R3 12, 5 
36 
RCC acceptable Malignant 1 B Clustered  R5 12 
37 
RMLO acceptable Malignant 1 C Clustered  R4 15.6 
38 
RCC acceptable Malignant 1 B Clustered  R3 6.5 
39 
LMLO acceptable Malignant 1 C Clustered  R4 19 
40 
RCC acceptable Malignant 1 B Clustered  R5 8 
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Table (G-8) Demonstrates the features of mammographic images (Projection of image, breast density, 
and number of lesions per image), and the characteristics of malignant breast microcalcifications with 
different shape, distribution, lesions’ BI-RADS and size of lesions are presented. 
 
 
   
 Image 
No. 
Projection 
of image Sharpness   
Type of 
lesion   
lesion per 
image 
Breast 
density 
Calci. 
Distribution 
Lesion 
BI-RADS 
Lesion 
size in 
mm 
41 LMLO acceptable Malignant 1 D Clustered  R5 16 
42 LCC acceptable Malignant 1 D Clustered  R4 6 
43 RCC acceptable Malignant 1 C Clustered  R4 24 
44 LCC acceptable Malignant 1 D Clustered  R4 8 
45 RCC acceptable Malignant 3 D Clustered  R3,R3,R4 7.5,5.5,14 
46 LCC acceptable Malignant 2 B Clustered  R4,R5 10.5,25 
47 RCC acceptable Malignant 1 C Clustered  R5 20 
48 RCC acceptable Malignant 2 C Clustered  R5,R4 6, 6 
49 RCC acceptable Malignant 1 D Clustered  R3 6 
50 LCC acceptable Malignant 1 B Clustered  R4 11 
51 RCC acceptable Malignant 1 B Clustered  R5 14 
52 LCC acceptable Malignant 1 C Clustered  R3 5 
53 RCC acceptable Malignant 1 D Clustered  R4 14 
54 LCC acceptable Malignant 1 C Clustered  R3 6.4 
55 RMLO acceptable Malignant 2 B Clustered  R4 13 
56 LCC acceptable Malignant 1 B Clustered  R4 18 
57 RCC acceptable Malignant 1 D Clustered  R4 18 
58 LMLO acceptable Malignant 1 B Clustered  R4 12.5 
59 LMLO acceptable Malignant 1 D Clustered  R4 15  
60 RCC acceptable Malignant 1 C Clustered  R4 12 
61 RCC acceptable Malignant 1 C Clustered  R4 14 
62 LCC acceptable Malignant 1 C Clustered  R4  11 
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Appendix H: ROCView Instructions  
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Appendix I:   
Table (I-1) The results of observation session for one observer represent true positive 
cases (images contain malignant masses without image blurring).  
 
Reader 
_ID 
Modality 
_ID 
Case _ID Lesion _ID TP _rating 
 
2 0 1 1 5 
2 0 2 1 10 
2 0 4 1 9 
2 0 5 1 10 
2 0 6 1 8 
2 0 7 1 7 
2 0 8 1 10 
2 0 9 1 5 
2 0 10 1 9 
2 0 11 1 3 
2 0 12 1 9 
2 0 13 1 9 
2 0 14 1 9 
2 0 15 1 9 
2 0 16 1 10 
2 0 17 1 3 
2 0 18 1 5 
2 0 19 1 9 
2 0 20 1 7 
2 0 21 1 9 
2 0 22 1 7 
2 0 23 1 7 
2 0 24 1 10 
2 0 25 1 9 
2 0 26 1 4 
2 0 27 1 4 
2 0 28 1 4 
2 0 30 1 7 
2 0 31 1 9 
2 0 32 1 9 
2 0 33 1 10 
2 0 34 1 5 
2 0 35 1 10 
2 0 36 1 4 
2 0 37 1 8 
2 0 38 1 8 
2 0 39 1 5 
2 0 41 1 7 
2 0 42 1 10 
2 0 43 1 9 
2 0 44 1 6 
2 0 45 1 6 
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2 0 46 1 4 
2 0 47 1 9 
2 0 48 1 2 
2 0 49 1 4 
2 0 51 1 9 
2 0 52 1 9 
2 0 53 1 9 
2 0 54 1 6 
2 0 55 1 9 
2 0 56 1 7 
2 0 57 1 7 
2 0 58 1 6 
2 0 59 1 6 
2 0 60 1 2 
2 0 61 1 9 
2 0 62 1 4 
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Table (I-2) The results of observation session for one observer represent true positive 
cases (images contain malignant masses with image blurring 0.7 mm).  
 
Reader _ID  Modality _ID  Case _ID  Lesion _ID TP _rating 
 
2  0.7  1  1  5 
2  0.7  2  1  4 
2  0.7  4  1  6 
2  0.7  5  1  6 
2  0.7  6  1  7 
2  0.7  7  1  7 
2  0.7  8  1  4 
2  0.7  9  1  3 
2  0.7  12  1  8 
2  0.7  13  1  7 
2  0.7  14  1  2 
2  0.7  15  1  8 
2  0.7  16  1  8 
2  0.7  17  1  4 
2  0.7  18  1  4 
2  0.7  19  1  8 
2  0.7  20  1  7 
2  0.7  21  1  6 
2  0.7  22  1  4 
2  0.7  23  1  7 
2  0.7  24  1  9 
2  0.7  25  1  6 
2  0.7  26  1  5 
2  0.7  27  1  4 
2  0.7  30  1  1 
2  0.7  31  1  6 
2  0.7  32  1  9 
2  0.7  33  1  6 
2  0.7  35  1  8 
2  0.7  36  1  6 
2  0.7  37  1  5 
2  0.7  38  1  3 
2  0.7  39  1  6 
2  0.7  41  1  5 
2  0.7  42  1  6 
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2  0.7  43  1  6 
2  0.7  45  1  3 
2  0.7  46  1  4 
2  0.7  47  1  6 
2  0.7  48  1  2 
2  0.7  49  1  6 
2  0.7  50  1  3 
2  0.7  51  1  5 
2  0.7  52  1  6 
2  0.7  53  1  6 
2  0.7  54  1  2 
2  0.7  55  1  5 
2  0.7  56  1  5 
2  0.7  57  1  6 
2  0.7  58  1  2 
2  0.7  59  1  3 
2  0.7  60  1  4 
2  0.7  61  1  6 
2  0.7  62  1  4 
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Table (I-3) The results of observation session for one observer represent true positive cases 
(images contain malignant masses with image blurring 1.5 mm). 
 
Reader _ID Modality 
_ID 
Case 
_ID 
Lesion 
_ID 
TP _rating 
 
2  1.5  1  1  7 
2  1.5  2  1  6 
2  1.5  4  1  6 
2  1.5  5  1  5 
2  1.5  6  1  2 
2  1.5  7  1  7 
2  1.5  8  1  8 
2  1.5  10  1  7 
2  1.5  11  1  2 
2  1.5  12  1  6 
2  1.5  13  1  7 
2  1.5  14  1  5 
2  1.5  15  1  8 
2  1.5  16  1  7 
2  1.5  17  1  2 
2  1.5  18  1  5 
2  1.5  19  1  7 
2  1.5  20  1  4 
2  1.5  21  1  8 
2  1.5  22  1  5 
2  1.5  23  1  6 
2  1.5  24  1  8 
2  1.5  25  1  8 
2  1.5  26  1  6 
2  1.5  27  1  2 
2  1.5  31  1  5 
2  1.5  32  1  8 
2  1.5  33  1  8 
2  1.5  35  1  6 
2  1.5  36  1  3 
2  1.5  37  1  5 
2  1.5  38  1  4 
2  1.5  39  1  4 
2  1.5  41  1  2 
2  1.5  42  1  8 
2  1.5  43  1  7 
2  1.5  44  1  2 
2  1.5  46  1  6 
2  1.5  47  1  5 
2  1.5  49  1  7 
2  1.5  50  1  2 
2  1.5  51  1  6 
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2  1.5  52  1  7 
2  1.5  53  1  3 
2  1.5  54  1  5 
2  1.5  56  1  3 
2  1.5  57  1  2 
2  1.5  58  1  5 
2  1.5  60  1  3 
2  1.5  61  1  6 
2  1.5  62  1  5 
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Table (I-4) The results of observation session for one observer represent false positive 
cases (images contain malignant masses with image blurring). 
Reader _ID  Modality 
_ID 
Case _ID  FP _rating 
 
2  0  1  4 
2  0  3  7 
2  0  3  8 
2  0  8  4 
2  0  16  4 
2  0  22  4 
2  0  27  4 
2  0  28  5 
2  0  33  3 
2  0  40  4 
2  0  44  6 
2  0  54  2 
2  0  58  5 
2  0  59  4 
2  0  74  2 
2  0  77  7 
2  0  86  4 
2  0  99  3 
2  0  100  4 
2  0  109  4 
2  0  111  2 
2  0  116  6 
2  0  119  4 
2  0.7  3  1 
2  0.7  8  3 
2  0.7  10  9 
2  0.7  11  4 
2  0.7  22  5 
2  0.7  28  2 
2  0.7  40  1 
2  0.7  40  2 
2  0.7  44  1 
2  0.7  54  2 
2  0.7  58  1 
2  0.7  59  4 
2  0.7  64  1 
2  0.7  66  1 
2  0.7  67  1 
2  0.7  72  1 
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2  0.7  74  1 
2  0.7  77  5 
2  0.7  79  1 
2  0.7  80  1 
2  0.7  82  2 
2  0.7  86  3 
2  0.7  88  1 
2  0.7  89  1 
2  0.7  94  1 
2  0.7  94  2 
2  0.7  99  4 
2  0.7  100  3 
2  0.7  102  2 
2  0.7  104  2 
2  0.7  106  1 
2  0.7  106  1 
2  0.7  110  1 
2  0.7  111  4 
2  0.7  116  5 
2  0.7  119  5 
2  0.7  121  1 
2  1.5  8  2 
2  1.5  22  2 
2  1.5  27  4 
2  1.5  28  2 
2  1.5  40  4 
2  1.5  58  2 
2  1.5  59  5 
2  1.5  74  2 
2  1.5  86  3 
2  1.5  89  2 
2  1.5  97  4 
2  1.5  100  3 
2  1.5  104  3 
2  1.5  108  3 
2  1.5  111  3 
2  1.5  116  4 
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Appendix J: The Results of Combined Two Observers Data 
Table M-1 Demonstrates the FOMs of the 21 pairs of combining two observers’ data for three levels 
of motion blur for microcalcification cases. 
 
Observers 
pairs 
FOMs for three levels motion blur  
 
0.0  mm 0.7 mm 1.5 mm 
 
1 0.944 0.860 0.853 
2 0.923 0.850  0.796 
3 0.908 0.860 0.781 
4 0.936 0.884 0.811 
5 0.947 0.898 0.8487 
6 0.901 0.853 0.730 
7 0.946 0.857 0.888 
8 0.914 0.892 0.855 
9 0.947 0.882 0.871 
10 0.950 0.874 0.882 
11 0.896 0.869 0.815 
12 0.907 0.923 0.792 
13 0.948 0.878 0.859 
14 0.942 0.886 0.846 
15 0.923 0.870 0.763 
16 0.907 0.901 0.855 
17 0.903 0.867 0.837 
18 0.887 0.877 0.800 
19 0.950 0.902 0.847 
20 0.916 0.872 0.818 
21 0.909 0.893 0.799 
Average 
across 
Observers 
0.923 0.876 0.826 
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Table M-2 Demonstrates the FOMs of the 21 pairs of the observers for three levels of motion blur for 
masses. 
Observers 
pairs 
FOMs for three levels of motion blur 
 
0.0  mm 0.7 mm 1.5 mm 
 
1 0.958 0.905 0.917 
2 0.906 0.880 0.836 
3 0.958 0.912 0.918 
4 0.966 0.940 0.923 
5 0.957    0.934    0.907 
6 0.941 0.870 0.836 
7 0.929 0.926 0.959 
8 0.962 0.928 0.962 
9 0.971 0.925 0.939 
10 0.951 0.938 0.940 
11 0.948 0.890 0.866 
12 0.941 0.905 0.944 
13 0.951 0.950 0.948 
14 0.934 0.933 0.923 
15 0.931 0.881 0.882 
16 0.974 0.947 0.920 
17 0.958 0.897 0.959 
18 0.920 0.905 0.877 
19 0.965 0.931 0.949 
20 0.960 0.862 0.905 
21 0.938 0.928 0.907 
Average 
across  
Observers 
0.948 0.913 0.915 
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Appendix K: Conspicuity Index  
Table: Measurement of conspicuity index of breast masses within mammographic images using 
conspicuity software. The physical parameters includes the maximum lesion diameter, the θ represents 
is the maximum slope angle to the edge of the lesion profile in degrees, σs = mean noise within the 
lesion, σn= mean background noise and SNR of lesions. 
 
Blur  
Level 
mm 
Conspicuity 
Index 
d (max  
diameter) 
θ 
(degrees) 
ΔGL σ (l) σ (b) μ 
Lesion 
μ 
Background 
 
Case 1 
  
0.0 51.631 24.450 63.765 88.903 42.734 69.744 192.939 104.036 
0.7 66.389 18.589 61.030 93.344 21.061 40.134 194.894 101.550 
1.5 74.993 17.133 59.797 93.600 16.109 31.417 194.417 100.817 
Case 2 
0.0 71.577 42.183 69.151 69.483 60.864 82.009 178.011 108.528 
0.7 101.672 39.644 67.259 70.189 34.217 51.973 178.272 108.083 
1.5 110.622 38.578 66.415 69.886 27.714 45.491 178.044 108.158 
Case 3 
0.0 45.003 24.917 66.945 76.644 51.102 80.162 184.039 107.394 
0.7 55.621 18.911 64.153 79.006 22.724 47.957 185.694 106.689 
1.5 58.383 16.928 62.927 79.353 15.307 40.332 185.950 106.597 
Case 4 
0.0 108.879 44.567 73.240 84.333 73.301 79.006 174.361 90.028 
0.7 153.361 43.294 72.357 84.797 46.650 53.463 174.311 89.514 
1.5 169.432 42.367 71.568 84.600 38.306 46.135 174.033 89.433 
Case 5 
0.0 66.273 48.606 70.833 66.464 96.237 91.397 166.844 100.381 
0.7 78.105 45.194 67.952 67.706 67.191 62.960 167.272 99.567 
1.5 81.129 43.583 66.377 68.269 58.253 54.862 167.417 99.147 
Case 6 
0.0 40.113 32.456 65.036 59.036 56.479 80.202 172.139 113.103 
0.7 43.759 20.461 58.806 63.083 16.520 43.842 175.272 112.189 
1.5 47.462 19.394 57.771 63.042 12.358 37.331 175.161 112.119 
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Blur  
Leve 
mm  
Conspicuit
y Index 
d (max  
diamete
r) 
θ 
(degrees) 
ΔGL σ (l) σ (b) μ 
Lesion 
μ 
Background 
 Case 7 
   
0.0 170.73 51.667 70.653 133.19 69.05 83.929 206.483 73.29 
0.7 252.59 51.306 70.526 133.54 50.13 52.581 206.556 73.01 
1.5 272.5 50.544 70.256 133.61 45.48 47.03 206.622 73.00 
 Case 8 
   
0.0 140.63 40.339 72.605 96.358 54.27 62.947 161.567 65.20 
0.7 222.31 38.761 71.959 96.797 28.2 39.953 161.783 64.98 
1.5 238.35 37.289 71.290 96.836 23.71 35.017 161.806 64.96 
 Case 9 
0.0 113.44 36.4 72.974 99.35 63.11 74.922 186.967 87.61 
0.7 150.18 34.85 71.939 99.558 41.68 52.282 186.678 87.11 
1.5 162.84 34.039 71.200 98.869 34.17 46.13 185.956 87.08 
 Case 10 
0.0 124.98 66.322 71.213 108.73 84.55 136.28 188.722 79.9 
0.7 169.81 64.222 70.483 109.86 43.24 102.26 189.556 79.69 
1.5 181.56 63.439 70.149 109.91 36.41 94.026 189.6 79.69 
 Case 11 
0.0 116.22 31.567 73.520 115.36 65.99 74.468 179.561 64.2 
0.7 155.95 30.883 72.929 114.86 44.59 53.584 178.733 63.87 
1.5 168.74 30.144 72.239 114.26 36.81 47.5 177.933 63.6 
 Case 12 
   
0.0 82.89 24.728 69.508 107.98 57.51 58.192 155.578 47.60 
0.7 117.32 23.311 68.925 108.1 29.77 43.803 155.344 47.24 
1.5 127.94 22.811 68.526 107.41 24.9 39.023 154.589 47.18 
 Case 13 
0.0 123.43 46.761 71.087 86.517 62.41 65.514 171.939 85.42 
0.7 179.01 44.483 69.64 87.256 38.04 40.341 172.022 84.76 
1.5 192.82 43.056 68.755 87.494 33.39 34.163 171.972 84.47 
 Case 14 
0.0 127.07 47.378 69.536 127.66 58.45 106.01 202.578 74.916 
0.7 166.60 45.644 69.144 128.66 34.55 80.8 203.35 74.69 
1.5 178.28 44.361 68.758 128.76 27.53 73.348 203.506 74.74 
 Case 15        
0 212.32 8.11 87.472 89.713 6.6268 55.20 252.00 162.29 
0.7 229.83 7.055 86.018 87.172 5.8137 30.145 250.90 163.73 
1.5 211.05 6.577 84.963 84.161 5.8231 24.110 247.86 163.7 
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 Case 16        
0 145.51 4.694 87.822 70.497 26.845 30.94 218.9 148.40 
0.7 165.40 4.105 85.892 53.644 8.6917 12.09 205.17 151.52 
1.5 116.77 3.711 83.104 40.697 4.7621 8.018 192.83 152.1 
 Case 17        
0 239.96 4.1 88.336 133.43 17.60 45.73 239.56 106.13 
0.7 221.32 2.85 87.149 113.26 8.718 19.83 222.47 109.20 
1.5 198.75 2.838 86.088 90.783 6.846 13.44 200.50 109.72 
 Case 18        
0 246.51 21.916 86.026 129.00 107.6 76.10 229.96 100.9 
0.7 344.10 22.361 84.444 140.12 63.27 47.69 229.87 89.75 
1.5 351.86 22.438 83.122 143.65 56.6 34.25 226.48 82.836 
 Case 19        
0 542.70 9.383 88.400 133.98 29.39 41.71 242.04 108.06 
0.7 553.27 8.533 87.386 128.25 17.49 25.98 237.85 109.6 
1.5 451.24 7.205 86.277 121.58 12.44 19.93 231.17 109.58 
 Case 20        
0 199.30 5.53 87.823 94 14.73 44.65 233.1 139.1 
0.7 191.61 4.677 86.252 80.68 8.919 21.97 220.51 139.83 
1.5 131.28 3.366 83.692 71.23 4.024 13.66 209.28 138.04 
 Case 21        
0 124.32 5.1 87.425 90.563 32.9 49.50 217.84 127.28 
0.7 128.06 3.35 85.811 84.266 10.14 22.09 213.58 129.316 
1.5 116.57 3.233 84.238 70.694 6.947 15.00 200.4 129.70 
 Case 22        
0 466.85 11.866 88.764 121.24 52.78 58.70 234.53 113.34 
0.7 552.188 10.72 87.862 119.13 24.32 34.48 234.42 115.28 
1.5 472.39 9.6 86.963 112.48 17.95 26.96 229.25 116.77 
 Case 23        
0 192.33 4.255 88.092 112.89 15.30 46.7 222.43 109.53 
0.7 162.39 3.35 86.562 89.40 9.191 21.91 200.35 110.9 
1.5 91.292 3.616 82.005 68.65 8.410 14.98 180.15 111.5 
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Appendix M: Dispersion Index Tables 
Table 7 The physical measures of the microcalcification in image without blurring 
 
Area1 Mean
1 
StdDev
1 
Min1 Max1 Calc. 
NO. 
D.I contras
t 
DI x 
Con 
SNR Detect-
ability 
1 13.7 2610 62 2457 2933 11 0.801 0.890 0.713 41.94 1.00 
2 23.5 2968 90 2702 3361 25 1.062 0.883 0.937 33.10 1.00 
3 34.8 2965 93 2683 3361 29 0.832 0.882 0.734 31.98 1.00 
4 40.4 2673 105 2381 3145 13 0.322 0.850 0.273 25.42 0.57 
5 315.3 2889 170 2511 4095 61 0.193 0.705 0.274 16.99 1.00 
5 58.7 2898 164 2520 3544 9 0.153 0.818 0.188 17.62 0.57 
6 28.8 2704 101 2503 3298 24 0.834 0.820 0.684 26.73 1.00 
7 13.9 2571 85 2361 2943 12 0.863 0.874 0.754 30.42 1.00 
8 61.6 2520 111 2247 3017 15 0.243 0.835 0.291 22.64 0.86 
8 79.2 2803 115 2335 3379 22 0.278 0.829 0.335 24.36 1.00 
9 13.9 2571 85 2361 2943 9 0.648 0.874 0.566 30.42 1.00 
10 66.7 2603 81 2368 3000 30 0.449 0.868 0.390 32.06 0.85 
11 11.9 2787 108 2556 3236 9 0.755 0.861 0.651 25.83 1.00 
12 18.2 2760 91 2572 3300 30 1.644 0.836 1.375 30.50 1.00 
13 24.1 2765 140 2540 3385 25 1.039 0.817 0.849 19.74 1.00 
14 3.9 2706 75 2549 3000 9 2.311 0.902 2.084 36.04 1.00 
15 376.7 2809 161 2361 3722 27 0.072 0.755 0.095 17.48 0.57 
16 159.3 2897 168 2278 3760 18 0.113 0.770 0.147 17.20 0.43 
17 46.2 2720 143 2393 3342 9 0.195 0.814 0.158 19.09 1.00 
18 21.2 2676 102 2453 3197 11 0.519 0.837 0.434 26.14 1.00 
19 8.9 2906 109 2740 3433 10 1.123 0.847 0.951 26.72 0.72 
20 15.2 2944 126 2732 3608 8 0.527 0.816 0.430 23.45 1.00 
21 98.4 2613 136 2257 3528 60 0.610 0.741 0.452 19.16 1.00 
22 15.2 2944 126 2732 3608 9 0.593 0.816 0.484 23.45 1.00 
24 6.7 2624 87 2409 3085 10 1.498 0.851 1.274 30.09 1.00 
25 32.5 2179 90 1911 2664 10 0.308 0.818 0.252 24.27 1.00 
27 45.6 2393 81 2203 2740 23 0.504 0.873 0.441 29.44 1.00 
28 7.6 2710 89 2515 3086 15 1.979 0.878 1.739 30.42 1.00 
29 61.9 2670 91 2418 3037 13 0.210 0.879 0.185 29.41 1.00 
30 11.1 2875 127 2595 3536 20 1.807 0.813 1.469 22.56 1.00 
31 19.7 2663 63 2527 3008 8 0.407 0.885 0.360 42.16 1.00 
32 63.9 2626 87 2397 3108 22 0.344 0.845 0.408 30.25 0.72 
32 15.4 2654 67 2465 2915 5 0.325 0.910 0.357 39.52 1.00 
33 13.9 2912 122 2646 3398 16 1.154 0.857 0.989 23.80 1.00 
34 12.7 2857 66 2650 3113 8 0.629 0.918 0.578 43.32 1.00 
35 23.8 2427 62 2256 2689 17 0.713 0.903 0.790 39.17 1.00 
35 9.8 2539 68 2375 2835 9 0.914 0.896 1.021 37.35 0.72 
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36 37.1 2849 116 2411 3328 20 0.539 0.856 0.461 24.55 0.86 
37 5.0 2744 96 2527 3128 8 1.596 0.877 1.401 28.57 1.00 
38 14.1 2660 79 2490 3040 10 0.709 0.875 0.810 33.86 1.00 
39 136.5 2276 143 1950 2881 42 0.308 0.790 0.390 15.87 0.86 
40 29.5 2584 77 2408 2946 22 0.746 0.877 0.850 33.42 0.00 
41 69.3 2579 121 2312 3314 40 0.577 0.778 0.449 21.30 1.00 
42 12.4 2840 93 2659 3246 29 2.336 0.875 2.044 30.62 1.00 
44 28.8 2719 90 2485 3200 20 0.695 0.850 0.591 30.13 1.00 
45 22.2 2686 96 2465 3114 7 0.316 0.863 0.366 28.02 0.86 
45 25.2 2738 73 2500 3099 9 0.357 0.883 0.404 37.72 0.72 
46 92.1 2737 112 2447 3207 48 0.521 0.853 0.611 24.45 0.86 
46 155.2 2545 116 2312 3104 35 0.225 0.820 0.275 21.93 0.72 
47 201.2 2518 142 2194 3232 25 0.124 0.779 0.159 17.68 0.86 
48 24.9 2728 85 2344 3223 35 1.404 0.847 1.659 32.14 1.00 
48 9.2 2595 85 2425 3072 8 0.874 0.845 1.035 30.50 1.00 
49 2.7 2612 61 2485 2799 8 3.002 0.933 2.801 42.56 1.00 
50 19.2 2985 98 2719 3391 20 1.043 0.880 0.919 30.47 1.00 
51 34.1 2889 109 2577 3340 13 0.382 0.865 0.330 26.42 0.57 
52 9.5 2628 141 2369 3237 21 2.207 0.812 1.792 18.59 1.00 
53 33.1 2349 117 2017 2770 18 0.544 0.848 0.462 20.02 0.86 
54 13.6 2834 91 2596 3242 28 2.064 0.874 1.805 31.03 1.00 
55 59.1 2472 65 2305 2914 15 0.254 0.848 0.215 38.22 1.00 
56 83.9 2701 120 2431 3190 43 0.513 0.847 0.434 22.60 1.00 
57 135.3 2637 211 2252 3686 54 0.399 0.715 0.286 12.50 0.00 
58 55.1 2453 124 2267 3061 18 0.327 0.802 0.262 19.82 1.00 
59 361.5 2319 172 1845 3269 60 0.166 0.709 0.118 13.46 0.72 
60 20.5 2102 271 1775 3114 26 1.266 0.675 0.854 7.74 0.86 
61 90.5 2532 119 2225 3154 32 0.354 0.803 0.284 21.33 1.00 
62 115.7 2616 72 2366 2927 50 0.432 0.894 0.386 36.54 1.00 
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Table 7.7: The physical and clinical measures of the microcalcification cases in image with 
0.7mm level of simulated blurring  
 
Area1 Mean1 StdDev1 Min1 Max1 Calc. 
NO.  
DI  contrast DI 
x 
Con 
SNR Detect-
ability 
1 13.731 2607 39.558 2544 2774 11 0.80 0.94 0.75 65.90 1.00 
2 23.55 2966 73.434 2766 3191 25 1.06 0.93 0.99 40.39 1.00 
3 34.85 2964 77.104 2758 3191 29 0.83 0.93 0.77 38.44 0.86 
4 40.41 2672 93.39 2420 2870 13 0.32 0.93 0.30 28.61 0.43 
5 315.28 2888 156.028 2576 3928 61 0.19 0.74 0.26 18.51 1.00 
5 58.66 2896 153.375 2589 3343 9 0.15 0.87 0.18 18.88 0.43 
6 28.77 2702 73.459 2568 2996 24 0.83 0.90 0.75 36.78 1.00 
7 13.90 2569 71.498 2405 2733 12 0.86 0.94 0.81 35.93 1.00 
8 61.63 2519 102.512 2298 2887 15 0.24 0.87 0.28 24.58 0.57 
8 79.18 2801 105.569 2375 3056 22 0.28 0.92 0.30 26.54 0.86 
9 13.90 2569 71.498 2405 2733 9 0.65 0.94 0.61 35.93 0.85 
10 66.74 2602 67.821 2419 2835 30 0.45 0.92 0.41 38.37 0.72 
11 11.92 2781 77.574 2617 2999 9 0.76 0.93 0.70 35.85 0.57 
12 18.25 2757 60.373 2657 3028 30 1.64 0.91 1.50 45.66 1.00 
13 24.06 2760 105.626 2598 3152 25 1.04 0.88 0.91 26.13 0.57 
14 3.90 2702 43.168 2600 2838 9 2.31 0.95 2.20 62.58 0.43 
15 376.66 2808 154.694 2407 3304 27 0.07 0.85 0.08 18.15 0.14 
16 159.29 2896 163.738 2317 3579 18 0.11 0.81 0.14 17.69 0.29 
17 46.24 2718 133.598 2463 3078 9 0.19 0.88 0.17 20.35 0.43 
18 21.21 2674 91.463 2497 2958 11 0.52 0.90 0.47 29.24 0.43 
19 8.91 2892 66.389 2765 3136 10 1.12 0.92 1.04 43.56 0.43 
20 15.18 2941 88.99 2775 3297 8 0.53 0.89 0.47 33.04 1.00 
21 98.37 2612 119.705 2315 3180 60 0.61 0.82 0.50 21.82 1.00 
22 15.18 2941 88.99 2775 3297 9 0.59 0.89 0.53 33.04 0.72 
24 6.68 2620 60.679 2479 2818 10 1.50 0.93 1.39 43.18 1.00 
25 32.46 2178 80.464 1971 2439 10 0.31 0.89 0.28 27.07 0.14 
27 7.58 2705 51.628 2592 2862 15 1.98 0.95 1.87 52.39 1.00 
28 45.60 2392 72.971 2244 2581 23 0.50 0.93 0.47 32.79 0.29 
29 61.94 2669 80.685 2464 2894 13 0.21 0.92 0.19 33.08 0.86 
30 11.07 2871 93.864 2669 3195 20 1.81 0.90 1.62 30.59 1.00 
31 19.66 2661 45.362 2574 2885 8 0.41 0.92 0.38 58.66 0.72 
32 15.37 2651 52.472 2517 2794 5 0.33 0.95 0.34 50.53 0.43 
33 13.86 2907 87.203 2710 3185 16 1.15 0.91 1.05 33.34 1.00 
34 12.71 2855 48.317 2736 2977 8 0.63 0.96 0.60 59.09 1.00 
35 23.83 2426 48.466 2286 2566 17 0.71 0.95 0.75 50.05 0.43 
35 9.85 2537 50.029 2420 2667 9 0.91 0.95 0.96 50.70 0.14 
36 37.12 2847 103.645 2465 3176 20 0.54 0.90 0.48 27.47 1.00 
37 5.01 2736 65.585 2565 2932 8 1.60 0.93 1.49 41.71 1.00 
38 14.11 2660 60.335 2534 2884 10 0.71 0.92 0.77 44.09 1.00 
39 136.47 2275 135.88 1999 2704 42 0.31 0.84 0.37 16.74 0.86 
40 29.49 2583 56.726 2448 2805 22 0.75 0.92 0.81 45.53 0.00 
41 69.29 2578 98.026 2346 3054 40 0.58 0.84 0.49 26.30 1.00 
42 12.41 2837 57.486 2711 3011 29 2.34 0.94 2.20 49.35 1.00 
44 28.76 2718 66.485 2539 3005 20 0.70 0.90 0.63 40.87 1.00 
45 22.16 2686 81.269 2543 2904 7 0.32 0.92 0.34 33.05 0.57 
45 25.21 2737 57.389 2576 2915 9 0.36 0.94 0.38 47.68 0.29 
46 92.06 2736 100.833 2499 3059 48 0.52 0.89 0.58 27.13 0.72 
46 155.22 2544 108.818 2362 2965 35 0.23 0.86 0.26 23.38 0.29 
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47 201.23 2517 134.244 2241 3023 25 0.12 0.83 0.15 18.75 1.00 
48 24.92 2727 66.746 2388 2966 35 1.40 0.92 1.53 40.85 1.00 
48 9.15 2593 59.546 2481 2827 8 0.87 0.92 0.95 43.54 0.86 
49 2.67 2609 39.09 2543 2695 8 3.00 0.97 2.91 66.74 0.43 
50 19.17 2982 82.713 2774 3226 20 1.04 0.92 0.96 36.05 0.86 
51 34.07 2888 99.713 2614 3157 13 0.38 0.91 0.35 28.96 0.14 
52 9.52 2621 93.8 2405 2918 21 2.21 0.90 1.98 27.94 0.86 
53 33.07 2348 108.941 2060 2635 18 0.54 0.89 0.49 21.55 1.00 
54 13.56 2772 410.758 2596 3057 28 2.06 0.91 1.87 6.75 0.86 
55 59.05 2470 48.297 2360 2748 15 0.25 0.90 0.23 51.15 1.00 
56 83.90 2699 106.534 2485 2996 43 0.51 0.90 0.46 25.34 1.00 
57 135.26 2636 199.71 2305 3396 54 0.40 0.78 0.31 13.20 0.00 
58 55.11 2452 114.308 2296 2970 18 0.33 0.83 0.27 21.45 1.00 
59 361.54 2318 158.994 1916 2921 60 0.17 0.79 0.13 14.58 0.29 
60 20.54 2072 319.739 1775 2823 26 1.27 0.73 0.93 6.48 0.72 
61 90.48 2531 108.622 2276 2960 32 0.35 0.86 0.30 23.30 0.72 
62 115.70 2614 59.432 2413 2814 50 0.43 0.93 0.40 43.99 0.72 
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Table The physical measures of the microcalcification in image with 1.5mm level of 
simulated blurring  
 
Area
1 
Mean1 StdDev
1 
Min1 Max
1 
Calc. 
NO.  
DI  contrast DI x 
Con 
SNR Detect-
ability 
1 13.7 2605 32 2555 2718 11 0.80 0.96 0.77 80.94 0.572 
2 23.5 2966 70 2776 3137 25 1.06 0.95 1.00 42.61 0.850 
3 34.8 2963 73 2769 3137 29 0.83 0.94 0.79 40.49 0.572 
4 40.4 2672 88 2433 2838 13 0.32 0.94 0.30 30.24 0.000 
5 315.3 2888 151 2590 3742 61 0.19 0.77 0.25 19.18 1.000 
5 58.7 2896 148 2600 3260 9 0.15 0.89 0.17 19.51 0.143 
6 28.8 2701 64 2585 2898 24 0.83 0.93 0.78 42.35 1.000 
7 13.9 2568 69 2414 2697 12 0.86 0.95 0.82 37.32 1.000 
8 61.6 2519 99 2316 2845 15 0.24 0.89 0.27 25.47 0.143 
8 79.2 2801 103 2384 2990 22 0.28 0.94 0.30 27.24 0.430 
9 13.9 2568 69 2414 2697 9 0.65 0.95 0.62 37.32 0.430 
10 66.7 2602 64 2426 2777 30 0.45 0.94 0.42 40.66 0.430 
11 11.9 2776 66 2634 2940 9 0.76 0.94 0.71 42.05 0.858 
12 18.2 2754 52 2672 2946 30 1.64 0.93 1.54 52.84 1.000 
13 24.1 2756 92 2605 3061 25 1.04 0.90 0.94 29.91 0.715 
14 3.9 2698 35 2616 2803 9 2.31 0.96 2.22 76.60 0.286 
15 376.7 2808 152 2430 3231 27 0.07 0.87 0.08 18.43 0.290 
16 159.3 2895 162 2333 3475 18 0.11 0.83 0.14 17.86 0.000 
17 46.2 2717 130 2474 2995 9 0.19 0.91 0.18 20.89 0.286 
18 21.2 2673 90 2508 2901 11 0.52 0.92 0.48 29.86 0.572 
19 8.9 2882 52 2771 3055 10 1.12 0.94 1.06 55.10 0.858 
20 15.2 2938 73 2786 3199 8 0.53 0.92 0.48 40.38 1.000 
21 98.4 2612 114 2323 3038 60 0.61 0.86 0.52 22.93 1.000 
22 15.2 2938 73 2786 3199 9 0.59 0.92 0.54 40.38 0.286 
24 6.7 2617 51 2498 2755 10 1.50 0.95 1.42 51.73 0.720 
25 32.5 2177 77 1978 2395 10 0.31 0.91 0.28 28.23 0.430 
27 7.6 2700 42 2601 2806 15 1.98 0.96 1.90 65.02 1.000 
28 45.6 2392 70 2255 2555 23 0.50 0.94 0.47 34.21 0.000 
29 61.9 2668 77 2474 2871 13 0.21 0.93 0.20 34.51 0.000 
30 11.1 2869 83 2687 3079 20 1.81 0.93 1.68 34.51 0.715 
31 19.7 2660 39 2590 2828 8 0.41 0.94 0.38 68.31 0.715 
32 63.9 2625 71 2470 2814 22 0.34 0.93 0.37 36.83 0.290 
32 15.4 2648 46 2530 2752 5 0.33 0.96 0.34 57.99 1.000 
33 13.9 2902 72 2730 3085 16 1.15 0.94 1.09 40.41 1.000 
34 12.7 2853 46 2744 2954 8 0.63 0.97 0.61 62.59 0.715 
35 23.8 2425 44 2299 2530 17 0.71 0.96 0.74 55.12 0.143 
35 9.8 2534 43 2431 2641 9 0.91 0.96 0.95 58.91 0.000 
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36 37.1 2845 99 2476 3123 20 0.54 0.91 0.49 28.69 0.715 
37 5.0 2729 57 2564 2879 8 1.60 0.95 1.51 47.75 1.000 
38 14.1 2661 55 2536 2815 10 0.71 0.95 0.75 48.15 0.860 
39 136.5 2274 132 2017 2659 42 0.31 0.86 0.36 17.23 0.720 
40 29.5 2582 49 2460 2745 22 0.75 0.94 0.79 53.15 0.000 
41 69.3 2577 90 2355 2958 40 0.58 0.87 0.50 28.76 1.000 
42 12.4 2834 48 2718 2954 29 2.34 0.96 2.24 59.00 1.000 
44 28.8 2716 58 2557 2921 20 0.70 0.93 0.65 46.92 0.715 
45 22.2 2685 77 2558 2869 7 0.32 0.94 0.34 34.80 0.143 
45 25.2 2736 53 2594 2861 9 0.36 0.96 0.37 51.54 0.000 
46 92.1 2736 97 2518 3018 48 0.52 0.91 0.58 28.19 0.720 
46 155.2 2544 105 2374 2916 35 0.23 0.87 0.26 24.12 0.290 
47 201.2 2517 131 2252 2939 25 0.12 0.86 0.15 19.20 0.860 
48 24.9 2726 62 2398 2896 35 1.40 0.94 1.49 43.84 0.572 
48 9.2 2591 51 2488 2762 8 0.87 0.94 0.93 50.34 0.290 
49 2.7 2607 32 2555 2667 8 3.00 0.98 2.93 82.38 0.290 
50 19.2 2979 79 2778 3175 20 1.04 0.94 0.98 37.85 0.585 
52 9.5 2615 76 2424 2831 21 2.21 0.92 2.04 34.38 1.000 
53 33.1 2347 107 2062 2601 18 0.54 0.90 0.49 21.84 0.572 
54 13.6 2709 569 2596 2998 28 2.06 0.90 1.87 4.76 0.429 
55 59.1 2469 42 2373 2669 15 0.25 0.93 0.24 58.31 1.000 
56 83.9 2698 102 2498 2959 43 0.51 0.91 0.47 26.49 0.858 
57 135.3 2636 196 2323 3280 54 0.40 0.80 0.32 13.46 0.000 
58 55.1 2452 109 2301 2920 18 0.33 0.84 0.27 22.39 0.715 
59 361.5 2318 155 1938 2763 60 0.17 0.84 0.14 14.99 0.286 
60 20.5 1986 516 1775 2653 26 1.27 0.75 0.95 3.85 0.429 
61 90.5 2531 104 2290 2878 32 0.35 0.88 0.31 24.23 1.000 
62 115.7 2613 56 2425 2782 50 0.43 0.94 0.41 46.92 0.429 
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